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The nature of the ferriprotoporphyrin IX (Fe(III)PPIX) antimalarial drug target and its 
interactions with aminoquinolines was investigated spectrophotometrically. Fe(III)PPIX was 
found to be extensively dimerised in aqueous solution (log Ko = 7.2 ± 0.2) and is proposed to 
exist as a stacked, 1t-1t dimer and not a Il-oXO dimer as previously thought. Sensitivity of the 
spectrum charge transfer region of the visible spectrum to pH further conforms that the 
dimer is not a Il-oXO dimer. A series of 17 synthesised compounds and 7 commercially 
available quinolines were investigated for their ability to interact with Fe(III)PPIX, inhibit 13-
haematin formation and for anti plasmodial activity against the 010 chloroquine-sensitive 
strain of malaria parasite. 2- And 4-aminoquinoline were found to be unique in their ability to 
form strong complexes with Fe{III)PPIX (log K = 4.23 ± 0.02 and 4.49 ± 0.01 respectively) 
whilst quinoline, 3-, 5-, 6- and 8-aminoquinoline fail to fonn any detectible complexes with 
Fe(III)PPIX. The association with Fe(III)PPIX was found to be a necessary, but not sufficient 
requirement for inhibition of J3-haematin fonnation. The presence of a chloro-group at the 7-
position on the quinoline ring was found to be a requirement for this inhibition. In tum, 
inhibition of J3-haematin fonnation was found to be a necessary but not sufficient requirement 
for antiplasmodial activity. A basic side-chain was found to be the additional component 
needed for this activity. In a further series of eleven N2-(7-X-4-quinolinyl)-N1,N1-diethyl-1,2-
ethanediamines where X = NH2 , OH, OCHs, H, CHs, F, I, 8r, CI, CFs and N02 that were / 
synthesised, it was found that the pKa of the quinoline ring nitrogen and the tertiary amino 
nitrogen are both lowered by electron withdrawing sustituents at the 7-posiiton. The 
quinoline nitrogen pKa ranges from 6.28 in the nitro derivative to 8.36 in the amino derivative, 
whilst the tertiary amino nitrogen has a pKa ranging between 7.65 in the trifluoromethyl 
derivative and 10.02 in the amino derivative. Calculation suggests that the resulting pH 
trapping of these compounds in the paraSite food vacuole ranges between about 9% of that 
observed in chloroquine for the nitro derivative and 97% in the amino derivative. It was found 
that the critical structural feature in chloroquine and related 4-aminoquinolines responsible 
for strong J3-haematin inhibition is the chloro-group at the 7-position on the 4-aminoquinoline 
ring. In the series. of eleven 7-substituted 4-aminoquinolines a direct correlation was 
observed between anti plasmodial activity which had been nonnalised for the extent of pH 
trapping and J3-haematin inhibitory activity (rZ = 0.83, p = 0.004). The J3-haematin inhibitory 
activity was found to correlate with the Fe(III)PPIX-quinoline association constant and the 
Hammett constant of the substituent at the 7-posiiton. The aSSOciation constant was found 
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Chapter 1: Introduction 1 
INTRODUCTION 
1.1. HISTORICAL OUTLINE 
The antiquity of malaria, which is caused by protozoan parasites of the genus Plasmodium, 
is demonstrated by the host specificity of over 100 parasite species found in reptiles, birds 
and mammals. The four species of plasmodia that infect man are P. vivax, P. malariae, P. 
ovale and P. falciparum; of which P. falciparum is the most deadly (Bruce-Chwatt 1981 ). 
It is thought that malaria was prevalent in ancient Egypt, India, China and Greece where its' 
symptoms were described and documented. The Romans named the disease "mal' aria" as 
at that time, the disease was attributed to the "bad air" surrounding stagnant waters. 
Association of the disease with swamps, led to various methods of drainage practiced by the 
Greeks and Romans from the sixth century BC and continued in Europe throughout the 
middle ages (Bruce-Chwatt 1985, Sherman 1998). 
1.2. CURRENT GLOBAL MALARIA SITUATION 
1.2.1. The Global Malaria Eradication Campaign 
Huge progress was made in reduCing the number of malaria cases in the 1950's following 
the discovery of the insecticide dichlorodiphenyltrichloroethalle (DDT), chloroquine 
chemotherapy and the establishment of the World Health Organisation (WHO) who 
embarked on a Global Malaria Eradication Campaign. The strategy was to interrupt malaria 
transmission from vector to host by attacking the mosquitoes likely to have contact with 
humans, namely inside homes. This was done by employing a very large taskforce of people 
to spray DDT in eighty percent of houses in infected areas. With dramatic results, malaria 
was eliminated completely from Taiwan, the Caribbean, the Balkans, parts of North Africa, in 
most parts of Europe, Northern Australia and a large portion of the South Pacific. Also a 
significant decrease in malaria cases was observed in Sri Lanka and India (Russel et al. 
1963, WHO Health Report 1999, Gladwell 2001). 
By the mid-1960's resistance to DDT and chloroquine had emerged and the indiscriminate 
use of DDT as an insecticide for agriculture had impacted in the Western American 
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the WHO to drop the eradication program and put in place .control strategies which form the 
basis of their malaria policy today (Gladwell 200, WHO Health Report 1999). 
Contrary to the rest of the world, the Global Eradication Campaign had very little impact in 
the Amazon basin and Sub-Saharan Africa where social and economic conditions meant the 
program was either not implemented or not sustainable (WHO Health Report 1999). 
1.2.2. The Current Global Situation 
The downward trend in malaria-related mortality achieved during the 1950's has undergone 
a reversal since the late 1980's. This resurgence is confined mainly to underdeveloped 
countries where inadequate or deteriorating health systems are unable to provide rapid 
diagnosis and treatment. Areas of civil conflict and large scale human migrations have 
resulted in malaria epidemics due to increased vector-human contact or movement of 
unprotected and non immune populations into malariOUS areas. Epidemics have also broken 
out due to climatic and environmental changes which have caused an increase in the 
number of vectors. Of growing concern is the increasing antimalarial drug resistance which 
is rendering current antimalarial treatment ineffective (Pasvol 1995, Sherman 1998, WHO 
Health Report 1999). 
Today Malaria is the world's most important parasitic disease. Each year around 300 million 
people are infected with the disease and between 1.5 to 2.7 million people die. Almost 90% 
of the deaths occur in Sub-Saharan Africa where young children are the most affected. 
Malaria is directly responsible for one in five childhood deaths in Africa and indirectly 
contributes to illness and death from respiratory infections, diarrhoeal disease and 
malnutrition (WHO Health Report 1999). It is estimated that Malaria claims 100000 lives per 
year elsewhere in the world and these deaths occur in all age groups, mainly among 
individuals who lack immunity and are infected by P. falciparum in areas where appropriate 
diagnosis and treatment are not available (Sherman 1998). The current worldwide 
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Figure 1.1. Global malaria distribution in 1994 (Sherman 1998). 
1.3. THE LIFE CYCLE OF THE MALARIA PARASITE 
The life cycle of aU species of human malaria parasites are essentially the same (except that 
hypnozoites do not occur in P. fa/cipaum) and is represented in Figure 1.2. 
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Sporozoites, or infective stages are transmitted to a human host through the bite of around 
60 different species of the female Anopheles mosquito. These sporozoites rapidly pass to 
the liver and penetrate parenchymal cells where they multiply 30 000 fold and form liver 
schizonts which burst open to release merozoites after 5 days in the case of P. falciparum 
(Pasvol 1995). The merozoites invade red blood cells and develop into small, rounded 
bodies with a parasitophorous vacuole called rings, which develop into larger, more irregular 
shaped trophozoites. This stage of the life cycle is associated with host haemoglobin 
degradation and the formation of the black, granular malaria pigment within an acidic 
secondary lysosome known as the food vacuole (Bruce-Chwatt 1985) (Figure 1.3). 
Figure 1.3. P. falciparum trophozoite actively digesting haemoglobin. dv, digestive vacuole; c, cystome; v, 
transport vesicle (Goldberg and Slater 1992). 
The trophozoite divides asexually many times to form a blood schizont which, when mature, 
causes the red cell to burst open and release merozoites into the bloodstream. These 
merozoites then invade fresh red blood cells to produce another generation of parasites 
leading to a progressive increase in paraSitemia which continues until host response 
regulation or death of the patient (Pasvol 1985, Bruce-Chwatt 1985). This blood stage cycle 
takes 48 hours in P. falciparum, P.vivax and P. Ova/e and 72 hours in P. malariae, of which 
cell rupturing and freeing of merozoites into the blood stream is responsible for the periodic 
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schizonts cause the erythrocytes to become sticky and adherent to the capillary endothelium 
of deep organs which can result in coma, known as cerebral malaria, severe anaemia or 
multiple organ failure (Pasvol 1995, Ridley 1998). 
Some erythrocytic schizonts are intended to develop into male and female gametocytes 
which may then be taken up by an Anopholes mosquito through its bite. Once inside the gut 
of the mosquito, male and female gametes fuse to form a zygote which develops into an 
oocyst, and later into sporozoites. These sporozoites travel to the salivary glands where they 
wait to be discharged into the next human host when the mosquito takes another blood meal 
(Russell 1963, Bruce-Chwatt 1985). 
P. fa/ciparum is the most dangerous of the four human malarias because it can invade red 
blood cells of any age and produce overwhelming, potentially lethal parasitemias. There is 
virtually no risk of death from the other species that infect humans because they produce 
more limited parasitemias and can invade only young (P. vivax and P. ovale) or old (P. 
malariae) red blood cells with the latter being the mild est of the three (Pasvol 1995). P. vivax 
can complete its cycle inside the mosquito at lower temperatures than P. falciparum and was 
the malaria species transmitted in the UK and Netherlands in the 1800's (Pasvol 1995, 
Sherman 1998). liver stage P. vivax parasites tend to persist in the liver parenchymal cells 
as hypnozoites and may give rise to late relapses, even after several years. P. ovale is 
Similar to P. vivax and is found predominantly in West Africa (Pasvol 1995). 
1.4. CURRENT UTILISATION OF QUINOLINE ANTIMALARIALS 
1.4.1. The Discovery of Important Antimalarials 
The first effective treatment for malaria in Europe was brought from Peru by the Spanish 
priests in the mid-sixteen hundreds. Whether the curative properties ofthe bark of the "fever 
trees' growing on the mountainous slopes of the Peruvian Andes were known to the local 
inhabitants before the Spanish conquest remains uncertain and controversial. Demand for 
the powdered bark, known as "Jesuit's powder" became so great in the seventeen hundreds 
that accessible South American forests of "fever treesD were soon stripped. The Dutch 
successfully planted Cinchona ledgeriana trees from Bolivia in Java and by the 1930's were 
producing 97% of the world's production (Bruce-Chwatt 1981). "Jesuit's powder" contains 
four quinine related alkaloids which differ with respect to symmetry about the chiral centres 
at C-8 and C-9, namely quinine (1a, 9R, 8S), quinidine (1b, 9S, 8R), 9-epiquinine (ie, 9S, 
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Figure 1.4. The four quinine alkaloids present in the bark of the Cinchona tree. Quinine (1a), quinidine (1b), 9-
epiquinine (1c) and 9-epiquinidine (1d). 
During the First World War, the Germans, having found themselves cut off from the world's 
supply of natural quinine alkaloids, began synthesising synthetic antimalarials. These efforts 
resulted in the discovery of the fir t 8-aminoquinoline, pamaquine (2) in 1932 and quinacrine 
(3) in 1933. 3 was used as the first Malaria prophylactic by the allied forces during World 
War II (Coatney 1963, Bruce-Chwatt 1985). 
CH~y:J-:?" ~
I . 







In 1935, Germans chemists working at Bayer I.G. synthesised analogues based on 2 and 
discovered sontoquine (4) and resochin (later known as chloroquine (CQ» (Kenyon 1949, 
Coatney 1963). 4 was used as a prophylactic by the German troops and CQ was abandoned 
due to toxicity problems observed in preliminary trials (Coatney 1963). When a stock of 4 fell 
into US hands in 1941, CQ was rediscovered along with the development of amodiaquine 
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which limits their widespread use. CQ however turned out to be one of the most successful 
drugs ever developed and formed the mainstay treatment and prophylaxis for over five 
decades. 
H~C HN~C 








In the 1960's, CQ resistance to P. falciparum started to emerge simultaneously in Columbia, 
Brazil and Thailand. A very large program was launched with WHO sponsorship at the 
Walter Reed Army Institute of Research where 250 000 compounds were synthesised and 
screened for antimalarial activity. The result of this effort was the discovery of the 
phenanthrenemethanols of which halofantrine (6) is noteworthy and the qUinolinemethanols 







Antimalarials currently being developed by the WHO include pyronaridine (8) which is based 
on the template of (3) and artemesinin derivatives which are based on artemesinin (9), an 
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limited water solubility however the synthetic analogues artemether (10) and artesunate (11) 









10 Artemether CH3 
11 Sodium Artesunate COCH2CH2COONa 
1.4.2. Clinical Use 
The 4-aminoquinolines, acridines and quinolinemethanols, which include chloroquine, 
amodiaquine, quinacrine, quinine and mefloquine, all act solely on the blood stage of the 
infection and are termed blood schizonticides. They clear the malaria paraSites from the 
blood that give rise to the clinical symptoms of headaches, fevers and chills and therefore 
cure the disease. In cases of low toxicity, these blood schzonticides can be used 
prophylactically (Ridley 1998). 
In contrast, the 8-aminoquinolines primaquine and pamaquine act only on the early liver 
stage and are termed tissue schizonticides. Their clinical utility is for radical cure of certain 
species of the malaria parasite, such as P. vivax, by eliminating the residual hypnozoites 
that can lead to recurrent infections. These tissue schizontocides are too toxic for routine 
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Table 1.1. Clinical utility of quinoline antimalarial drugs currently in use. 
Drug Class of Compound Site of Action Clinical Utility 
Blood Stage Liver Stage 
Chloroquine 4-aminoquinoline + T, pa 
Amodiaquine 4-aminoquinoline + T 
Quinacrine 9-aminoacridine + T" 
Quinine quinoline methanol + T 
MefJoquine quinoline methanol + T,P 
Primaquine 8-aminoquinoline + T 
Pamaquine 8-aminoquinoline + T" 
T = treatment. P = prophylaxis, "limited by resistance, b no longer in cOnical use 
Chloroquine cross-resistance has been observed clinically in the structurally related 4-
aminoquinoline drug amodiaquine and experimentally in pyronaridine. To delay the spread 
..L 
of resistance and prolong the utility of drugs, they are now marketed as combination 
therapies. This has been done successfully for mefJoquine where resistance, which is now 
widespread in Thailand, has been successfully delayed by administration of Fansimef; a 
cocktail of mefJoquine and the antibacterial agents pyrimethamine and sulfadoxone (Ridley 
1998). When pyronaridine is marketed, it will probably be in combination with artesunate 
(Peters and Robinson 2000). Although quinine gives rise to serious toxic side effects, it is 
used along with mefloquine to treat chloroquine-resistant malaria (Egan 2001 b). 
1.5. MECHANISM OF ACTION OF QUINOLINE ANTIMALARIALS 
1.5.1. Evidence that the Food Vacuole is the Locus of Antimalarial Activity 
The utility of quinoline blood schizontocide drugs is limited to the stages actively involved in 
haemoglobin degradation, namely trophozoites and early schizonts (Yayon et al. 1983, 
Zhang et al. 1986). After exposure of these stage-specific parasites to CQ, the food vacuoles 
enlarge (Langareth et al. 1978) and according to some studies produce reduced amounts of 
haemozoin (Macomber and Sprinz 1967, Homewood et al. 1972, Zhang 1987, Zhang 1999) 
although it has been suggested that this may be secondary to parasite killing 
(Asawamahasakda et al. 1994). In addition, the parasite cytoplasm demonstrates ribosomal 
aggregation, mitochondrial swelling and swelling of the rough endoplasmic reticulum 
(Jacobs et al. 1988). Endocytosis and trafficking of erythrocytiC haemoglobin to the central 
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the food vacuole without further digestion (Yayon et a/. 1984). CQ accumulates (Aikawa 
1972, Geary and Ginsburg 1989) in the damaged food vacuole of malaria trophozoites, and 
has been shown to associate with haemozoin (Sullivan et a/. 1996b). Given the 
morphological changes and locus of accumulation upon CQ administration, it would appear 
that the primary drug target of CQ and related quinoline antimalarials is located within the 
food vacuole. 
1.5.2. Biochemical Processes Occurring in the Food Vacuole 
1.5.2.1. Haemoglobin Degradation 
Malaria paraSites obtain most of their amino acids required for protein synthesis from 
degrading 25 to 75% of host haemoglobin in the occupied erythrocyte (Goldberg et a/. 1990, 
Loria et a/. 1999). In this process, large quantities of erythrocyte cytoplasm are ingested by 
fluid phase endocytosis and transported in vesicles to a secondary lysosome known as the 
food vacuole (Sherman 1998) . 
. 1.5.2.1.1. The pH of the Food Vacuole 
The pH of the food vacuole (pHvac) was originally thought to range between pH 5.2 and 5.4 
based on cuvette measurements of pH-sensitive fluorescent probes that had been 
endocytosed into the food vacuole of intra- (Krogstad et a/. 1985) and extra-erythrocytic 
paraSites (Yayon et a/. 1984). Recently Dzekunov et a/. found the pHvac of the CQ-sensitive 
HB3 strain is 5.6 based on single-cell fluorescence measurements of parasitised 
erythrocytes stained with the fluorescent weak base, acridine orange (AO) (Dzekunov et al. 
2000). Their experimental methods have since been called into question by Bray et a/. who 
claim that the fluorescence pattem observed by Dzekunov et al. arises wholly from the 
paraSites cytosol and not from the food vacuole (Bray et al. 2002a). Technical aspects of the 
microscopy techniques used to monitor AO· fluorescence between the two laboratories, 
interpretation of the fluorescence patterns and hence the reported pHvac of 5.6 is still a 
matter of intense debate (Dzekunov et a/. 2002,Bray et a/. 2002b). 
1.5.2.1.2. Proteases Involved in Haemoglobin Degradation 
The food vacuole contains multiple proteases that degrade haemoglobin to peptide 
fragments in an ordered process (Goldberg et a/. 1990). Two aspartic proteases 
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a highly conserved hinge region, have been identified and extensively characterised 
(Goldberg et al. 1990, Goldberg et al. 1991, Tyas et al. 1999, Moon et al. 1997). Recently 
two additional proteases, namely a histidine-aspartic protease (HAP) containing an active 
site histidine, and plasmepsin IV (PM IV) have also been identified and implicated in the 
metabolism of haemoglobin (Bane~ee et al. 2002). Two cysteine proteases falcipain 2 
(Gluzman et al. 1994) and falcipain 3 (Sijwali et al. 2001) and a metallopeptidase falcilysin 
(Eggleson et al. 1999) are thought to act by degrading haemoglobin into smaller peptide 
fragments further downstream (Rosenthal and Meshnick 1996, Goldberg 1990). This 
degradation process is complicated by the release of ferrous haem which is rapidly oxidised 
to the ferric form known as haematin (aquaferriprotoporphyrin IX or H20-Fe(III)PPIX) (Figure 
1.5). Solubilised haematin is cytotoxic and has been shown to damage biological 
membranes (Tappe11953, O~ih et al. 1981, Ginsburg and Demel 1983, Van Der Zee et al. 
1996) and inhibit a variety of enzymes (Yasuhara et al. 1991) including vacuolar proteases 





Figure 1.5. Structure of aqua-ferriprotoporphyrin IX (H20-Fe(III)PPIX) 
1.5.2.1.3. The Haem Detoxification Pathway 
The malaria parasite has evolved a pathway to detoxify haematin by conversion~ at least in 
part, to the highly insoluble, black, granular substance known as malaria pigment or 
haemozoin. This substance is responsible for organ discolouration in malaria patients and 
was first described by Lancisi in 1716 and later by Bright in 1831 (Sherman 1998). 
Haemozoin formation is not unique to erythrocytiC stage malaria parasites, but has also 
been identified in other animals that degrade haemoglobin where it presumably serves the 
same purpose. These organisms are a blood sucking insect Rhodinus prolixus, which is an 
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al. 1999, Oliviera et al. 2000a); Shistosoma mansoni, a worm in humans causing 
schistosomiasis (Oliveira et a/. 2000b, Chen et a/. 2000) and Haemoproteus columbae, a 
protozoan parasite common in birds (Chen et al. 2001). 
1.5.2.2. The Structure of Malaria Pigment 
Malaria pigment can be synthesised in vitro by precipitation of haematin under acid 
conditions (Slater et a/. 1991, Egan et al. 1994) to form the synthetic equivalent known as [j-
haematin. The native and synthetic forms of haemozoin are chemically and structurally 
equivalent as shown spectroscopically by infra-red, EXAFS and ESR spectroscopy as well 
as X-ray powder diffraction (Slater et aJ. 1991, Scott Bohle et a/. 1998, Egan et al. 1999a). 
For many years f3-haematin was believed to be a polymer of haematin, however publication 
of the recently solved X-ray diffraction pattern (Pagola et a/. 2000) has shown that [j-
haematin is composed of crystalline dimers linked together through a Fe(lII)-carboxylate 
bond (Figure 1.6). These dimeric units interact in the crystal through hydrogen bonding 
between the remaining propionic acid group on each Fe(III)PPIX. 
Figure 1.6. Structure of the /3-haematin dimer (Pagola at al. 2000). 
1.5.2.3. Mechanism of [j-Haematin and Haemozoin Formation 
1.5.2.3.1. Mechanism of f3-Haematin Formation 
[j-Haematin can be precipitated from aqueous 0.1 - 4.5M acetate solution between pH 2.6 
and 5, at temperatures ranging from 6 to 70°C and reaction times between 30mins and 
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for this process is a vigorously stirred solution of haematin in 4.5M acetate, pH 4.5 at 60"C 
for 1 h (Egan et a/. 2001 c). In this observed pH window, one of the deprotonated carboxylate 
groups is available for coordination to the Fe(llI) centre of a second haematin molecule, with 
the remaining protonated carboxylate group available for intermolecular hydrogen bonding 
between two dimers. Formation of the product can be monitored by the appearance of two 
peaks in the infrared spectrum around 1660cm-1 and 121Ocm-1 which are believed to arise 
from C=O and C-O stretching of the Fe(lII)-coordinated propionate groups respectively 





2000 1200 1000 2000 1200 1000 
Wavelengthl nm Wavelengthl nm 
Figure 1.7. Infrared spectra of haematin after 0 (A) and 30m in incubation (8) 4.5M acetate, pH 4.5, 60"C. The 
definitive peaks for l3-haematin around 166Ocm-1 and 121Ocm-1 are marked by arrows (Egan et aI. 1994). 
Conversion of haematin to ~-haematin is spontaneous under the range of conditions 
mentioned although the reaction is markedly slower in acetate solutions below 4.5M and at 
pHs and temperatures below 3.0 and 60"C respectively (Egan et a/. 1994, Egan et a/. 
2001c). The process of ~-haematin formation occurs via rapid precipitation of noncrystalline 
haematin followed by slow conversion to the crystalline product. The acetate is thought to 
facilitate the dimerisation reaction by solubilising haematin through formation of a 
Fe(III)PPIX-acetate complex (Egan et al. 1994, Egan et a/. 2001c). The reaction kinetics 
follow a sigmoidal relationship which has been explained in terms of a biomineralisation 
process in which a rapidly precipitated, noncrystalline solid slowly converts to a more 
thermodynamically stable, crystalline product through an ordered process involving 
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1.5.2.3.2. Mechanism of Haemozoin Formation 
There is still much uncertainty regarding the mechanism of haemozoin formation in vivo. [3-
Haematin can form spontaneously from haematin under physiological conditions (37°C and 
pH 4.8) but the reaction only goes to completion after 12 days (Dom et al. 1998a). Slater 
and Cerami suggested that haemozoin formation is enzyme catalysed in vivo and 
demonstrated the catalytic activity of this putative enzyme present in P. fa/ciparum 
trophozoites extracts (Slater and Cerami 1992). That the reaction is enzyme mediated was 
questioned by Dom et a/. who noted that heat treatment of the extracts had little effect on 
the reaction and suggested the initiator is haemozoin itself (Dom et al. 1995). Bend rat et a/. 
suggested that this reaction promoting material is a lipid contaminating the haemozoin 
extracts (Bend rat et a/. 1995, Ridley et al. 1995). This has been supported by subsequent 
work in which acetonitrile extracts of malarial trophozoites and uninfected erythrocytes 
promote ~-haematin formation (Dom et a/. 1998a). It has been suggested that the active 
promoters in these extracts are lipids which themselves can catalyse the reaction (Dom et 
al. 1998, Fitch et al. 1999, Fitch et al. 2000). This is further supported by the ability of 
peri microvillar membranes from the midgut of the haemozoin producing insect R. pro/ixus to 
promote p-haematin formation (Oliveira et al. 1999, Oliveira et al. 2000a). 
Sullivan et al. managed to identify and clone two histidine-rich proteins (HRP II and HRP III) 
in purified digestive vacuoles which promote [3-haematin formation in vitro. (Sullivan et a/. 
1996a). This protein, which bears a similarity to human histidine-rich glycoprotein (HRG), 
can bind around 50 haem units which all share a similar environment as indicated by 
electronic absorption, resonance Raman and EPR spectroscopy (ChOi et al. 1999). These 
authors claim all the ferrihaems in the HRP II-Fe(III)PPIX complex are low spin, six 
coordinate with two histidine ligands and that this complex is stable between pH 5.5 and 7.0. 
These results are at odds with the findings of Lynn et a/., who observed two types of pH-
dependent Fe(III)PPIX binding in HRP-II. Below pH 6, Fe(1I1) is supposedly coordinated to 
aspartate through a weak carboxylate-metal interaction which is capable of promoting 
haemozoin formation. Above pH 6, it is thought that formation of a strong Fe(llI)-histidine 
complex correlates to the lack of haemozoin formation in this pH range (Lynn et al. 1999). 
Since recent findings on the mechanism of p-haematin formation in vitro have compared this 
process to biomineralisation, it is possible that the role of HRP in vivo may be to provide a 
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1.5.3. Hypotheses on the Mode-of·Action of Quinoline Antimalarials 
1.5.3.1. Extravacuolar Hypotheses 
From the morphological changes and specific accumulation associated with the food 
vacuole upon CQ administration, it would appear that this is the primary locus of drug 
activity. Various extravacuolar hypotheses have however been proposed over the last four 
decades but none have found widespread acceptance. 
1.5.3.1.1. DNA Binding 
CQ was originally thought to exert its antimalarial activity through DNA intercalation and 
hence inhibition of DNA replication and RNA synthesis. In vitro CQ binds to DNA (O'Brien et 
al. 1966) but at concentrations significantly higher (100J.l.M) than the in vitro concentration 
(typically 10nM) (Slater 1993). This theory has been further rejected on the basis that the 
quinoline antimalarial, mefloquine, does not bind to DNA (Davidson et al. 1975), and that 
there is no selectivity between the CQ - DNA interactions of host and parasite DNA 
(Angennan et al. 1972). 
1.5.3.1.2. Inhibition of Polyamine Synthesis 
CQ inhibits ornithine decarboxylase activity present in trophozoite extracts (Konigk et al. 
1981). Since inhibition of this enzyme would block polyamine synthesis, it has been 
suggested that CQ may exert its antiplasmodial activity through this effect. There have been 
no further follow-up experiments to lend weight to this hypothesis which does not account for 
the erythrocytic stage specificity of this drug, as liver stage paraSites also presumably have 
orthinine decarboxylase (Slater 1993). 
1.5.3.2. Intravacuolar Hypotheses 
1.5.3.2.1. Inhibition of Haemoglobin Degradation 
One of the morphological changes observed in malaria paraSites upon CQ administration is 
an accumulation of undigested haemoglobin-containing endocytic vesicles in the food 
vacuole (yayon et al. 1984b). This observation has led to hypotheses that CQ may interfere 
with the paraSites feeding mechanism by inhibiting haemoglobin degradation. In support of 
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containing antimalarial drugs and the parasite's ability to produce amino acids (Zarchin et a/. 
1986). Several proposals as to how this inhibition occurs have been made. 
1.5.3.2.1.1. Inhibition of Phospholipase Activity 
Vacular phospholipases have been identified within the food vacuole which are responsible 
for degrading endocytic vesicle membranes in order to release their haemoglobin content 
into the food vacuole. CQ has been shown to inhibit phospholipase activity in vitro (Ginsburg 
and Krugliak 1992), but at concentrations substantially higher than those likely to occur in 
the vacuole (Slater 1993). 
1.5.3.2.1.2. Inhibition of Protease Activity 
CQ has also been shown to inhibit the activity of partially purified aspartic protease from P. 
fa/ciparum extracts (Gyang et a/. 1982) but again only at concentrations above the clinical 
range. Furthermore, haematin itself is a very good inhibitor of acid proteases (roughly 10J.l.M) 
and this activity is unchanged in the presence of CQ (Vander Jagt et a/. 1987). 
Hypotheses that CQ interferes with the parasite's feeding mechanism have further been 
questioned by Ginsburg and Krugliak who noted that treatment of CQ-treated parasites with 
membrane permeable amino-acids, is unable to alleviate inhibition of parasite growth 
(Ginsburg and Krugliak 1992). 
1.5.3.2.2. Increased Vacuolar pH 
CQ has been shown to accumulate in the food vacuole, at least in part, through it's ability to 
act as a weak base (Section 1.5.3.3.1.). Homewood et a/. originally postulated that a rapid 
influx of CQ into the food vacuole through this weak base effect could deplete the vacuole of 
protons and thereby cause an increase in vacuolar pH (Homewood et a/. 1972). This 
hypothesis was supported by Goldberg et a/. who showed that proteases operating in the 
food vacuole showed reduced activity above pH 6 (Goldberg et a/. 1990). The strongest 
evidence in support of this hypothesis came from Krogstad et a/. who showed temporary 
alkalinisation of the parasite's food vacuole following CQ treatment (Krogstad et a/. 1992) 
which correlated to antiplasmodial activity (Krogstad et a/. 1985). These results have since 
been questioned by Ginsburg and colleagues who claim that the pH measurements of 
Krogstad et a/. were probably complicated by physiological alterations to the parasite during 
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dextrans to monitor the vacuolar pH have shown that vacuolar alkalinisation is only observed 
at levels above the clinical concentration ofthe antimalarial drugs (Yayon et a/. 1984, Yayon 
et al. 1985, Geary and Ginsburg 1986, Ginsburg et al. 1989). 
This theory further fails to explain the inactivity of the stereo isomers of quinine which 
presumably have Similar pKa's and hence alkalinising abilities, but exhibit very different 
anti plasmodial activities. 
1.5.3.2.3. Binding to Haematin 
Fitch originally observed that CQ uptake into parasitised red blood cells is saturable (Fitch 
1970) and dependent on haemoglobin degradation (Fitch et al. 1974). This has been 
supported by several recent findings that antiplasmodial activity of the blood stage 
antimalarial drugs CQ, AQ, quinine and mefloquine, are dependent on haemoglobin 
degradation (Mungthin et a/. 1998, Bray et al. 1998, Bray et al. 1999). These observations 
support the existence of a haemoglobin-clerived or related drug receptor within the food 
vacuole (Fitch et al. 1974). In theory, this receptor could be a protease responsible for 
haemoglobin degradation, a haemoglobin-clerived peptide, orthe haematin end product. It is 
unlikely that CQ inhibits proteases (Section 1.5.3.2.1.2.) and there is no evidence to suggest 
that CQ and related antimalarials act by interacting with haemoglobin-derived peptide 
fragments (Egan 2001 a). CQ does however, form a non-covalent complex with haematin 
(Cohen et al. 1964). This complex has also been shown to exist in the paraSite 
(Balasubramanian and Mohan Rao 1984) and has been isolated from parasitised 
erythrocytes (Fitch et al. 1980). There is therefore strong evidence that CQ acts by binding to 
a haematin target. 
1.5.3.3. Accumulation of Chloroquine in the Food Vacuole 
Food vacuoles have an incredible ability to accumulate CQ where it is estimated to reach 
millimolar concentrations at clinical doses (Yayon et al. 1985, Geary et al. 1986, Ginsburg 
and Geary 1987). This ability has been explained in terms of non-saturable weak-base 
properties and saturable binding to a drug target. 
1.5.3.3.1. Non-Saturable Uptake via Weak-Base Properties (Intravacuolar) 
CQ accumulation is sensitive to the proton gradient between the acidic food vacuole and the 
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gradients with specific inhibitors of vacuolar proton pumps (Bray et al. 1992b, Hawley et al. 
1996), or by lowering the external pH or alkalinising the intravacuolar pH (e.g. with NH4CI) 
results in less CQ accumulation in mammalian Iysosomes (Macintyre and Cutler 1993) and 
parasitised red cells (Yayon 1984, Krogstad et al. 1985). This pH-dependent accumulation 
has been explained in terms of CQ's ability to accumulate as a weak base (Homewood et al. 
1972). 
CQ has two sites that are capable of being protonated under physiological conditions, 
namely, the quinoline ring nitrogen (pKa1 = 8.3) and the diethylamino group on the side chain 
(pKa2 = 10.2) (Irvin and Irvin 1947, Schlesinger et al. 1988). These two protonatable sites 
can give rise to three pH-dependent species B, Bd and BHP (Figure 1.8). The relative 
percentages of these three species as a function of pH can be calculated from knowledge of 
the pKa'S and are plotted in Figure 1.8 below. 
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Speciation Dependence of CQ on pH 
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Figure 1.8. (top) the three pH dependent species of CQ. (bottom) a speciation plot of the relative percentages of 
(-) BHP, (-) BH' and (-) B as a function of pH. 
In the food vacuole (pH 5.2 to 5.6 (see Section 1.2.2.1.1», CQ exists in the form of BHP, 
whereas in the serum (pH 7.4), CQ exists 0.02% in the form of B, and between 11.2% and 
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Table 1.2. Calculated percentages of the three pH-dependent CQ species present in the food vacuole (between 
pH 5.2 and 5.6) and in the serum (pH 7.4) based on PKal (8.3) and pKa2 (1 0.2) 
Location pH %B %Bf( %BH2~' 
5.2 7.9 x 10-1 0.08 99.9 
5.3 1.3 x 10~ 0.10 99.9 
Food vacuole 5.4 2.0 x 10~ 0.13 99.9 
5.5 3.2 x 1~ 0.16 99.8 
5.6 5.0 x 1~ 0.20 99.8 
Serum 7.4 0.02 11.2 88.8 
Since the lipophilicity of charged CQ species is greatly reduced (Hansch and Leo 1979), 
predominantly B will pass by passive diffusion into the acidic food vacuole where it will be 
converted to the charged BF and BHP species which cannot pass back out across the 
membrane. This depletion of intravacuolar B will cause more of this species to diffuse into 
the food vacuole until the B equilibrium concentrations on both sides of the membrane are 
equal. Since both BF and BHP contribute to the total CQ concentration, the intravacuolar 
concentration will become substantially higher than the external concentration. 
Krogstad et al. observed that CQ accumulation into mammalian vesicles is Virtually identical 
to that predicted through pH trapping but that CQ accumulation in the vesicles of susceptible 
parasites is substantially more than predicted by pH trapping (Krogstad et a/. 1992). This 
observation has been confirmed by Bray et a/. who showed that CQ accumulates roughly 
1700 fold into red cells infected with the CQ-sensitive strain HB3 (expressed as the cellular 
accumulation ratio (CAR), Bray et a/. 1996, Bray et a/. 1996). Assumuing that the food 
vacuole occupies roughtly 2% of the volume of a red cell (Dzekunov et al. 2000), CQ is 
predicted to accumulate 65 000 fold into the food vacuole (expressed as the vacuolar 
accumulation ratio (VAR». The predicted CAR for CQ based on pH trapping alone lies 
between 71 and 446 (presuming the pH of the food vacuole to be between pH 5.2 and 5.6, 
Equation 1 and Table 1.3). Since these predicted CAR values can only account for 4-26% of 
















In equation 1, [CQ] v refers to the total vacuolar concentration of CQ and [CQ] e refers to its 
total extravacuolar concentration. The tenns [F]" and [F] e refer to the vacuolar and 
extravacuolar hydrogen ion concentrations respectively and KaJ = 5.01 x 10-9 M (pKa = 8.3) 
and Ka2 = 6.31 X 10-11 M (pKa = 10.2) 
In contrast, Hawley et al. found that the CAR of CQ could be accounted for based on pH-
trapping alone by assuming a vacuolar pH of 5.0 and a fractional vacuolar volume that is 
3.5% of that of the parasitised red blood cell (Hawley et al. 1996). This pH value for the 
vacuole would however appear to be too low, lying well below those that have been 
reported on the basis of experimental data. 
Table 1.3. Predicted and observed CQ accumulation ratio in the red cell (pH 7.4) and food vacuole (between 
pH 5.2 and 5.6) 
Predicted Observed 
pHv pH .. VAR CAR VAR CAR 
5.2 7.4 22324 446 85000 1700a 
5.3 14088 282 
5.4 8891 178 
5.5 5612 112 
5.6 3542 71 
VAR = vacuolar accumulation ratio between pH 5.2-5.6 and an external pH of 7.4, CAR = cellular accumulation 
ratio (for the paritisised red cel~, a Bray at 131. 1996. 
1.5.3.3.2. Saturable Uptake via Haematin Binding 
Fitch originally noted that CQ uptake is saturable and competitively inhibited by structurally 
related quinolines. This observation prompted him to propose the existence of a structurally 
defined drug receptor within the food vacuole (Fitch 1970, Fitch et al. 1974). Binding of CQ 
to this receptor will deplete the free CQ concentration inside the food vacuole, thereby 
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Although accumulation of CQ through pH trapping can only account for 4-26% of the total 
accumuation, it's importance in driving the total accumulation must not be underestimated 
(Egan 2001 a). If one considers formation of a 1:1 haematin-quinoline complex, an 
appropriate equilibrium expression can be formulated (Equation 2): 
K 
H + COr ==:::::: (2) 
K = [CQ]b [CQ] = K[H] [CQ] 
[H][CQ]! ' b ! 
Here, [H] represents the free haematin concentration, [CQ]r represents the free CQ 
concentration, [CQ]b represents the concentration of bound CQ and CQtot is the total CQ 
concentration. The free haematin concentration is unknown although it has recently been 
estimated at about 20llM (Dzekunov et a/. 2000) and the K value for CQ in 40% aqueous 
DMSO is 3.3x105 M·1 (Egan et a/. 1997, discussed in Section 1.5.3.5.). In the presence of pH 
trapping, CQ is predicted to accumulate between 3542 and 22324 fold (Table 1.3) which 
equates to a vacuolar CQ concentration of 3.5x10·5 - 2.2x10-4 M at the ICso (10nM) (Table 
1.4). The bound CQ is predicted to be roughly2.3x10-4 -1.5x10-3M (Equation 2) which gives 
a total CQ concentration in the food vacuole of roughly 2.7x 1 0-4 -1.7x10-4M (26900 -169700 
fold VAR accumulation). Since the food vacuole only occupies 2% of the total volume of the 
red cell, this amounts to a CAR of roughly 538-3394 fold (which is in general agreement with 
the experimentally reported value of 1700 (Bray et al. 1996). 
Table 1.4. Calculated CAR of CQ based on pH trapping and haematin binding 
pHv Predicted [CQ), [CQ]b [CQ]tot Predicted Predicted Found 
VARe VARb CAR CAR 
5.2 22324 2.2 x 104 1.5 X 10.3 1.7 X 104 169700 3394 1700" 
5.3 14088 1.4 x 10-4 9.3 X 10-4 1.1 X 10-4 107050 2141 
5.4 8891 8.9 x 10-0 5.9 X 10-4 6.8 X 10-4 67550 1351 
5.5 5612 5.6 x 10-0 3.7 x 10-4 4.3 X 10-4 42650 853 
5.6 3542 3.5 x 10-5 2.3 x 10-4 2.7 X 10-4 26900 538 
• Calculated from pH trapping alone (Table 1.3) 
b Calculated from pH trapping and complex formation with Fe(III)PPIX 
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In the absence of pH trapping, the free CQ concentration in the food vacuole will be roughly 
the same as the external clinical concentration of 10nM. The concentration of bound CQ will 
be roughly 6.6x10-8 M (Equation 2, Table 1.5.) which amounts to a total CQ concentration of 
7 .6x 1 0-8 M which gives a CAR of approximately 8 (compared to the observed CAR of 1700). 
Table 1.5. Calculated CAR of CQ based on haematin binding alone 
[CQ], [CQ]tot Predicted Predicted Found CAR 
VAR CAR 
6.6 x 10'" 7.6 X 10'" 400 8 
C Bray et al. 1996 
Therefore, even though accumulation via pH trapping only contributes to approximately 4~ 
26% of the total accumulation, it is essential to drive the saturable accumulation component 
through Le Chatelier's principle (Egan et a/. 2001 a). 
1.5.3.4. The Nature of Fe(III)PPIX~Quinoline Interactions 
Fe(III)PPIX~Quinoline interactions are difficult to study in aqueous solution as Fe(III)PPIX 
tends to aggregate (Davies 1940, Shack and Clarke 1947) and undergoes slow autoxidation 
(Brown et a/. 1968, Shack and Clarke 1947). Furthermore, this molecule precipitates out of 
solution below pH 6 (Dzekunov et a/. 2000) and has been observed to adhere to surfaces 
(Brown et a/. 1968). The most extensive study on the state of Fe(III)PPIX in aqueous 
solution was carried out by Brown et a/. in 1970 (Brown et a/. 1970) who found that 
Fe(III)PPIX is extensively dimerised in aqueous solution (log K = 0.65) and claimed it to be a 
Il-~XO dimer (Equation 3 and Figure 1.9). 
N N 
K= 4.5 
2M D +H+ (3) 
Figure 1.9. Dimerisation equilibrium of Fe(III)PPIX in aqueous solution proposed by Brown et al. 1970 where M 
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Because of the problems associated with studying haematin in aqueous solution, alternative 
binding models have been used. Studies have been performed either in non-aqueous 
systems (Warhurst 1981. Warhurst 1987) or in aqueous detergent systems (Bachhawat et 
al. 2000) where haematin is reported to be monomeric (Simplicio et al. 1975). Also the iron 
porphyrins that have a lesser tendency to aggregate have been used in studies 
(Constantinidis and Satterlee 1988a. Constantinidis and Satterlee 1988b. Marques et al. 
1996). 
Initial studies showed that the blood stage antimalarial drugs CQ. AQ, quinacrine. quinine 
and mefloquine are all capable of binding to Fe(III)PPIX in aqueous solution at pH 7.4 (Fitch 
et al. 1980). Qualitative experiments later questioned the ability of AQ to form a complex in 
benzene (Warhurst 1987). although subsequent studies using electronic and Mossbauer 
spectroscopies showed that a complex can be formed in aqueous solution (Blauer 1988. 
Blauer et al. 1993). There were also early studies showing that 9-epiquinine. the inactive 
enantiomer of quinine. could not form a complex with Fe(III)PPIX in benzene (Warhurst 
1987. Warhurst 1981). This is not the case in aqueous solution as quinine. quinidine, 9-
epiquinine and 9-epiquinidine all form complexes with Fe(III)PPIX (Egan et al. 1997. Egan et 
al. 1999a. Mavuso. PhD thesis 2001, Bachhawat et al. 2000). 
The binding interactions in CQ are thought to be coplanar 1t-1t interactions between the 
aromatic ring system of CQ and the porphyrin (Constantinidis and Satterlee 1988b. Moreau 
et al. 1982. Adams et al. 1996. Marques et al. 1996. Egan et al. 1997). Evidence that 
complexation does not involve metal-coordination is shown by the ability of CQ to form 
complexes with the metal free porphyrins. protoporphyrin IX (Moreau et al. 1985) and 
uroporphyrin I (Constantinidis and Satterlee 1988b) which are almost as strong as the 
corresponding metal porphyrin complexes. Furthermore. the strength of the complex is 
virtually unchanged between pH 5.6 and 7.4 (Egan et. al. 1997) which implies that the 
protonation state of the drug and hence metal-coordination is not important. 
The term 1t-1t complex does not necessarily imply that complex stability arises solely from 
overlap of 1t-orbitals. hydrophobic interactions are also important (Hunter and Sanders 
1990). The strength of the complex and hence hydrophobic interactions have been found to 
depend on the nature of the surrounding solvent. This is observed by a weakening in the 
association constant between CQ and Fe(III)PPIX with increasing concentrations of 
acetonitrile in water (Egan et al. 1997). The importance of the solvent in complex stability 
may also explain why early researchers failed to observe complex formation between 
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Since haematin is predominantly dimeric in aqueous solution, the current view is that CQ 
binds to haematin jl-Qxo dimers in a cofacial 1t-1t sandwich type complex (Figure 1.10) 
(Moreau et al. 1982, Dom et al. 1998a, Vippagunta et al. 1999). 
Figure 1.10. Model of the interaction between CQ and Fe(III)PPIX in aqueous solution (Moreau et al. 1982) 
Interactions between quinine and haematin also have a large 1t-1t component (Moreau et al. 
1985, Constantinidis and Satterlee 1988a), but NMR spectra of the urohemin I complex 
(Constantinidis and Satterlee 1988a) and the uv-vis spectrum of a haem-peptide complex 
(Marques et al. 1996) indicates that additional coordination of the 9-0H group to the iron 
centre is likely to occur. 
Further evidence that CQ-haematin and quinine-haematin complexes are different is 
supported by Mossbauer spectroscopy (Adams et al. 1996). Also thermodynamic 
parameters obtained for CQ-haematin complex formation indicates the process to be largely 
entropically driven whereas the quinine-haematin complex formation is enthalpically driven 
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1.5.3.5. Association Constants for Fe(III)PPIX-Quinoline Complexes 
Fitch et a/. originally reported association constants in aqueous medium based on an 
equilibrium dialysis method (Fitch et a/. 1980). Association constants have subsequently 
been measured in an aqueous environment using titration calorimetry where large 
haematin:drug stoichiometries are observed (Dom et a/. 1998a) (Table 1.6). This is 
supposedly because the drug is sandwiched between two or more haematin J.I.-oXO dimers. 
Since these large stoichiometries render the results difficult to interpret, efforts have been 
made to obtain association constants in strictly monomeric Fe(III)PPIX. Bachhawat et a/. 
obtained a similar value for CQ using titration calOrimetry in a detergent system in which 
haematin is likely to be monomerised into micelles (Bachhawat et a/. 2000). Similar 
association constants for the various drugs with haematin have also been obtained in our 
laboratories in 40% DMSO (aq) systems in which haematin is strictly monomeric (Egan et a/. 
1997, Egan etal. 1999a) (Table 1.6). 
Table 1.6. Association constants for interaction of quinoline antimalarials with Fe{III)PPIX (haematin:drug 













5.60 ± 0.2 (4:1) 
4.97 ± 0.1 (4:1) 
5.70 ± 0.04 (4:1) 
5.48 ± 0.03 (7:1) 
4.32 ± 0.04 (5:1 ) 
4.08 ± 0.1 (3:1) 
4.66 (1:1)* 
logK 
Bachhawat et al. 
5.64 (2:1), 2.90 
Egan et aI. 
5.52 ± 0.03 (1:1) 
5.39 ± 0.04 (1:1) 
4.10±0.02(1:1) 
5.02 ± 0.03 (1:1) 
4.04 ± 0.03 (1:1) 
4.37 ± 0.02 (1:1) 
3.90 ± 0.08 (1:1) 
5.29 ± 0.02 (1:1) 
,. In 80010 ethanol; Dam at a/. haematin 0.25M phosphate buffer, pH 6.5, 37°C (Dom at a/. 1998a); Bachhawat et 
a/. Haematin in 0.2% Triton X-100, pH 7.4, 5mM phosphate buffer. 27.5°C (Bachhawat et a/. 2000); Egan et al. 
haematin in 40% DMSO (aq). pH 7.4, 0.02M HEPES, 25°C (Egan et aI. 1997. Mavuso, PhD thesis 2001) 
Little is known about the structural features in CQ and related 4-aminoquinolines responsible 
for complex formation with Fe(III)PPIX. O'Neill et a/. used molecular mechaniCS to model the 
interaction between Fe(III)PPIX and theAQ analogue tebuquine (O'Neill et a/. 1997). These 
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between the quinoline nucleus and the porphyrin ring, and an apparent hydrogen bonding 
interaction between the side chain terminal amine of the drug and the Fe(III)PPIX propionate 
groups. A subsequent study has found that the hydrogen bonding interaction is not critical as 
CQ analogues lacking a basic terminal amino group in the side chain (14) or lacking a side 
chain (15) still form complexes with Fe(III)PPIX (Vippagunta et a/. 1999) (Figure 1.11A). 
These authors claim that the 7-chloro substituent on the quinoline ring of CQ is a critical 
structural determinant for binding as the 6-chloro analogue (17) of CQ failed to bind to 
Fe(III)PPIX (Figure 1.11 B). This is supported by Egan et a/. who found that quinoline, 5-, 6-
and 8-aminoquinoline (5AQ, 6AQ and 8AQ respectively) also failed to bind to Fe(III)PPIX 
(Figure 1.11 B)(Egan et a/. 1997). 
A: Compounds that associate 
strongly with Fe(III}PPIX 
~ 
HN~C 
m CI ::::..... I Nh Log K=5.60 
CQI 
H<~C ~~ N~ 
ex) m ill CI ::::..... I ~ CI ::::..... I Nh ::::..... Nh 
138 148 158 
LogK=4.93 LogK=4.90 LogK =4.72 
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B: Compounds that do not associate I. 
strongly with Fe(III)PPIX 
27 
Figure 1.11B. Reported analogues of CQ that fail to bind to Fe(III)PPIX. 8 Vippagunta et aJ. 1999, bEgan et 8/. 
1997. 
There is no evidence that the strength of haematin binding is quantitatively related to 
anti plasmodial activity (Vippagunta et a/. 1999, O'Neill et a/. 1997, Egan et a/. 1997, Dom et 
a/. 1998a) although all the CQ and related quinoline antimalarials form strong complexes 
with haematin. 
1.5.4. Hypotheses on how Complex Formation is Related to Antiplasmodial Activity 
1.5.4.1. Inhibition of Protein Synthesis 
Suriola and Padmanaban found that Fe(III)PPIX stimulates protein synthesis and proposed 
that CQ inhibits this process by formi ng a CQ-Fe(lll )PP IX complex (Suriola and Pad manaban 
1991). This hypothesis has not found widespread acceptance as the CQ concentrations 
required to inhibit protein syntheSiS are substantially higher (micro molar) than those required 
for antiplasmodial activity (nanomolar). Furthermore, there is no evidence that malaria 
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1.5.4.2. Inhibition of f3-Haematin Fonnation 
1.5.4.2.1. Inhibition of Haem Polymerase Activity 
Slater and Cerami originally suggested that CQ and related antimalarial drugs may act by 
inhibiting the haem detoxification pathway (i.e. haemozoin formation) in malaria parasites 
(Slater and Cerami 1992). At that time, haemozoin was thought to be a polymer that 
required a "haem polymerase" enzyme to fonn. This enzyme was supposedly present in 
extracts from P. falciparum trophozoites and CQ was shown to inhibit this process 
presumably by inhibiting the enzyme. Other researchers have supported the existence of a 
haem polymerase enzyme (Fitch and Chou 1996, Coy and Fitch 1997) even though no such 
enzyme has ever been isolated. Furthennore, under conditions where f3-haematin has been 
shown to fonn spontaneously in the absence of biological material, its fonnation is still 
inhibited by CQ (Egan et al. 1994). 
1.5.4.2.2. Inhibition of Crystallisation Activity 
In the absence of a haem polymerase enzyme, it has been suggested that CQ inhibits 13-
haematin formation directly (Egan et al. 1994, Sullivan et al. 1996, Sullivan et al. 1998). It 
was proposed that the CQ-Fe(III)PPIX complex prevents the incorporation of haematin into 
l3-haematin (Dom et al. 1995) by capping the grOwing polymer chain (Sullivan et al. 1996). 
This was supported by observations that [3H] CQ associates with haemozoin in vivo and that 
aSSOCiation in vitro is dependent on the presence of free haematin (Sullivan et al. 1996, 
Sullivan et a/. 1998). Recently Pagola et al. have shown that l3-haematin is not a polymer 
but a crystalline haematin dimer (Pagola et al. 2000) which has led to the suggestion that CQ 
may instead inhibit l3-haematin fonnation by blocking the fastest growing crystal face 
(Pagola et al. 2000) or inhibiting crystal nucleation (Egan et al. 2001a, Egan et al. 2001c). 
That f3-haematin inhibition is responsible for the antiplasmodial activity of CQ is supported by 
independent findings in the haemozoin-producing insect, R. prolixus. Following the feeding 
of the insect on blood supplemented with CQ; midgut swelling is observed, haemozoin 
production is inhibited and free Fe(III)PPIX is seen to appear in the insect's haemolymph 
(Oliveira et al. 2000a). Furthermore, evidence of lipid peroxidation is seen (although the 
insects do not die). 
CQ and related 4-aminoquinolines, quinolinemethanols. a wide range of 
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shown to strongly inhibit J3-haematin fonnation (Table 1.7 A) (Egan et at. 1994, Raynes et at. 
1996, Egan et a/. 1999a, Dom et at. 1998, Hawley et at. 1998, Vennerstroom et at. 1998, 
Vippagunta et at. 1999). In these classes of compounds, complex fonnation with haematin 
appears to be a prerequisite but not a sufficient requirement for J3-haematin inhibition (Table 
1.7B). This distinction is highlighted by the inability of the inactive stereoisomers of quinine, 
namely 9-epiquinine and 9-epiquinidine, to inhibit J3-haematin fonnation even though they 
fonn complexes of similar strength to quinine and quinidine with haematin (Egan et a/. 1997, 
Egan et at. 1999a, Mavuso PhD thesis 2001). In agreement with these observations, 
quinoline and related compounds that do not bind to Fe(III)PPIX or inhibit J3-haematin 
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Table 1.7 A Compounds that form strong complexes with Fe(III)PPIX, inhibit !1-haematin formation and have 













R = CH2CH3 
R = CH(CH3)CH2NEt2 
R = CH(CH3)CH2CH2NEt2 
R =CH(CH3)CH2CH2CH~H2NEt2 












































a Egan at al. 1994, Egan at at. 1997 and Egan at at. 1999a, b Dorn at at. 1998, "Hawley at al. 1998, d Dam et at. 
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Table 1.7B. Compounds that form strong complexes with Fe(III)PPIX, do not strongly inhibit }3-haematin 




I NEt" HN~ 










_9 - 9 
Q Egan et al. 1994, Egan at al. 1997, Egan at al. 1999a and Mavuso PhD thesis 2001, 9 Vippagunta at al. 1999. 
Table 1.7C. Compounds that do not form a strong complexe with Fe(III)PPIX, do not inhibit jl-haematin 

























Strong evidence that ~-haematin inhibition is primarily responsible for antiplasmodial activity 
is demonstrated in a wide variety of quinoline antimalarial (Dorn et a/. 1996b) and 
antiplasmodials (Hawley et al. 1996. Vippagunta et a/. 1999). Dorn et a/. found a correlation 
between ~-haematin inhibition and antiplasmodial activity for the blood stage antimalarial 
drugs: CQ, AQ. halofantrine, pyronaridine, quinine, quinacrine, mefloquine and Ro 46-6910 
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between the haematin binding constant and the ability of these compounds to inhibit /3-
haematin fonnation. This is in line with the hypothesis that CQ-haematin binding is important 
for antiplasmodial activity through /3-haematin inhibition. Similar observations have also been 
found in a series of AQ analogues and CQ where anti plasmodial activity was strongly 
correlated to /3-haematin inhibition when activity was nonnalised for the extent of cellular 
drug accumulation (Figure 1.12B) (Hawley et a/. 1998). Vippagunta et a/. also observed a 
modest correlation between anti plasmodial activity and /3-haematin inhibition for eleven CQ 
analogues when /3-haematin inhibition was nonnalised for jJ.-oxo dimer binding affinities 
(Figure 1.12C). In this case, no direct correlation was found between the strength of 
haematin association and the ability to inhibit /3-haematin fonnation although it was 
suggested that variable accumulation may have accounted for the lack of correlation 
(Vippagunta et al. 1999). Finally, a correlation has been observed between the 
antiplasmodial activity of a series of bis-quinolines and their ability to inhibit /3-haematin 
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Figure 1.12. Correlation between J3-haematin inhibition and antiplasmodial actMty in: (A) the CQ sensitive strain 
NF54 for eight antimalarial drugs (Dom et aJ. 1998b); (8) the CQ-sensitive strain 307 for seven AQ analogues in 
which antiplasmodial actMty was normalised for extent of cellular accumulation (CAR) (Hawley et al. 1998); (C) 
the CQ-sensitive strain NF54 for eleven CQ analogues in which rs-haematin inhibition was normalised for 
haematin fl-oXO dimer binding affinities (Vippagunta at aJ. 1999) and (D) the CQ-sensitive strain D1O-for nine bis-
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From the currently available literature, it is not obvious what structural features in CQ are 
responsible for j3-haematin inhibition. It would appear that the chloro-group at the 7 -position 
in CQ may playa role as replacement with hydrogen or amino (Table 1.7B) renders the 
compounds inactive and unable to inhibit j3-haematin formation, whereas replacement with 
nitro or bromo (Table 1.7 A) does not. 
1.5.4.3. Interaction of Haematin with Biological Membranes 
If formation of a CQ-haematin complex interferes with the parasite mechanism to sequester 
haematin, vacuolar haematin concentrations would be expected to increase following CQ 
administration. It has been proposed that haematin or the CQ-haematin complex exerts a 
toxic effect on the parasite by compromising the integrity of the vacuolar membrane (Chou 
and Fitch 1981, O~ih et al. 1981). This is in agreement with the observed morphological 
changes upon CQ administration which include a loss of internal detail and swelling of the 
food vacuole (Fitch et al. 1982). In vitro studies on erythrocytic membranes in P. berghei 
(Orjih et al. 1981) and P. fa/ciparum (Fitch et al. 1982) have shown that both haematin and 
the CQ-haematin complex cause membrane lysis. Being hydrophobic, haematin has a 
strong affinity to intercalate within erythrocytic membranes (Atamna and Ginsburg 1995) and 
lipid bilayers (Tipping et al. 1979, Ginsburg and Demel 1983, Cannon et al. 1984) which is 
likely to upset membrane order and increase permeability (Chou and Fitch 1981). In vitro, 
haematin has been demonstrated to impair the ability of erythrocytic membranes to maintain 
cationic gradients (Chou and Fitch 1981) and causes leakage of solutes trapped in inner 
vesicles and liposomes in a concentration-dependent manner (Schmitt et al. 1993). 
Another mechanism through which haematin may cause membrane damage is by promoting 
lipid peroxidation (Tappel 1953, Tappel 1955). This has been shown to occur in vitro where 
haematin-catalysed lipid peroxidation displays a bell-shaped dependence on haematin 
concentration as measured by thiobarbituric acid reactive substances (TBARS) (Schmitt et 
al. 1993, Omodeo-Sale et al. 2001). The extent of lipid peroxidation appears to be 
dependent on the pre-existence of hydroperoxides in the membrane (Omodeo-Sale 2001) 
which is in agreement with a proposed mechanism in which haematin reacts with membrane 
hydroperoxides to generate alkoxyl and peroxyl radicals (Van der Zee et al. 1996) which 
subsequently degrade the membrane (Dahle et al. 1962). Furthermore, complex formation 
between CQ and haematin has an increased ability to promote lipid peroxidation relative to 
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1.5.4.4. Alternative Hypotheses for the Fate of Intravacuolar Haematin 
Despite considerable evidence that quinoline antimalarials act by inhibiting haemozoin 
formation, unequivocal evidence for this hypothesis has not been provided in vivo. Recently 
two independent research groups have provided evidence suggesting that only less than . 
30% of haemoglobin derived hae~ is converted to haemozoin in P. fa/ciparum infected 
erythrocytes (Ginsburg et al. 1998, Loria et al. 1999). These observations have led to the 
recent advancement of two alternative hypotheses on haematin detoxification. 
Ginsburg et al. suggested that at least 70% of the haematin is not converted to haemozoin, 
but exits the food vacuole into the cytoSol where it is subsequently degraded by glutathione 
and that CQ and related 4-aminoquinoline antimalarials inhibit this process (Ginsburg et al. 
1998). Non-degraded haematin then exerts a toxic effect on the parasite by associating with 
the membranes. Glutathione has been shown to degrade haematin in vitro (Atamna and 
Ginsburg 1995) and CQ inhibits this process (Ginsburg et a/. 1998). Furthermore, a 
correlation has been observed between increased membrane-associated haematin following 
CQ administration and antiplasmodial activity (Ginsburg et a/. 1998). A problem with this 
hypotheSiS is that it assumes the existence of a CQ-haematin complex in the parasite's 
cytosol where no pH trapping is expected to occur. Here the free CQ concentration is 
expected to be similar to the clinical concentration (10nM) which would result in the 
existence of almost no CQ-haematin complex (discussed in Section 1.5.3.3.2). 
In an alternative hypothesis by LOria et al., it is proposed that haematin is degraded in the 
food vacuole by reaction with hydrogen peroxide (Loria et al. 1999). Hydrogen peroxide may 
arise from the oxidation of ferrohaem, released from haemoglobin, to ferrihaem (haematin) 




Haematin is known to display catalase-like and peroxidase-like activities with hydrogen 
peroxide in vitro (Orjih et al. 1988, de Almeida Ribeiro et al. 1995, de Almeida Ribeiro et al. 
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related antimalarials have been shown to inhibit this degradation process in vitro (de 
Almeida Ribeiro et a/. 1995, de Almeida Ribeiro et a/. 1997, Loria et a/. 1999). 
A potential problem with both these hypotheses is that the experimental methods used to 
assay for haematin do not unequivocally identify the putative non-haem iron species in the 
parasite-infected erythrocytes. The hypotheses rest on the accuracy of the haematin assay 
alone. In a recent study in which the total iron content in infected erythrocyes isolated from 
trophozoites, food vacuoles and haemozoin, was assayed using a ferrocene calorimetric 
assay (Jill Combrink, Hons Project, Department of Pharmacology, University of Cape Town. 
2001), 92% of the iron present in an infected erythrocyte was found to be located in the 
trophozoite food vacuole and 88% of this was in the form of haemozoin. Furthermore, a 
Mossbauer spectrum of the iron in trophozoites is identical to that of j3-haematin with no 
additional peaks observed. which implies that virtually all the iron in the parasite is 
haemozoin-iron (Egan. unpublished results). This calls into question the existence of a 
haematin detoxification route apart from conversion to j3-haematin. 
1.6. RESISTANCE MECHANISMS 
Resistance to CQ was slow to develop suggesting that multiple mutations were required to 
produce the resistance phenotype. Two resistance foci appeared simultaneously in South 
East Asia and South America in the 1960's, and these have since spread to every country 
where malaria is endemiC (Foote and Cowman 1994, Foley and Tilley 1997). Once 
established, the CQ-resistance phenotype appears to be stable and persists even in the 
absence of drug pressure (Le Bras et a/. 1983). 
1.6.1. Reduced Uptake vs Enhanced Efflux 
A common feature of CQ resistance is that CQ-resistant paraSites accumulate less drug than 
their sensitive counterparts (Macomber et a/. 1966. Fitch 1969, Krogstad et a/. 1987). Much 
debate has centred around whether this reduced accumulation is due to reduced drug 
uptake or enhanced drug efflux from the parasitised cell (Bray and Ward 1993). CQ 
resistance can be reversed by its co-administration with compounds such as verapamil 
(Martin et a/. 1987). desipramine and chlorpromazine (Bitonti et a/. 1988) which are known to 
reverse multi-drug resistance (MDR) in cancer cells. MDR is thought to arise from the 
presence of an ATP-dependent. membrane bound drug effluxer protein known as P-
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the anticancer drugs for P-glycoprotein binding and hence prevent their active efflux from the 
cell. The similarities between MDR and CQ resistance in malaria parasites has suggested 
that a similar energy dependent efflux protein may be present in CQ-resistant parasites 
(Krogstad et al. 1987, Warhurst 1988, Krogstad et al. 1992). Two MDR genes have been 
found in P. fa/ciparum (Wilson et al. 1989). one of which, pfmdr1, has a high degree of 
homology to mammalian MDR genes (Foote et al. 1990). However the level of CQ 
resistance in a number of strains of P. falciparum do not correlate with the level of pfmdr1 
expression arguing against a direct role for this protein in CQ resistance (Foote et al. 1990, 
Cowman et a/. 1994). In addition, offspring from a genetic cross of CQ-resistant and CQ-
sensitive cloned isolates could establish no linkage between the pfmdr1 gene and the rapid 
efflux phenotype (Wellems 1990, Wellems 1991). 
Chloroquine reSistance has also been mapped to complex polymorphisms related to two 
genes (cg1 and cg2) on chromosome 7 of the malaria parasite (Wellems et al. 1991). A 
recent study in which the cg1 and cg2 sequences in resistant parasites were replaced with 
the cg1 and cg2 sequences from sensitive parasites, however showed no subsequent 
change in the degree of CQ resistance thereby arguing against this hypothesis (Fidock et al. 
2000a). These authors instead suggested that a gene located close to cg1 and cg2, namely 
pfclf, is probably responsible for CQ resistance (Fidock et al. 2000b). There is an increasing 
body of evidence implicating the PfCRT protein in CQ resistance (Fidock et al. 2000b, Ward 
and Bray 2000, Warhurst 2001). This protein is located in the vacuolar membrane and 
resembles other 10 transmembrane domain proteins that facilitate transport of organic 
cations (Zhang et al. 1997). Although 10 codon changes were found in the pfclf sequance in 
CQ resistant isolates from South America, Africa and Asia, only the point mutation from 
lysine to threonine in codon 76 appears to be common to all CQ resistant strains (Warhurst 
2001). Furthermore, the CQ-resistant phenotype has been expressed from a CQ-sensitive 
strain by transfection with a plasmid containing the 'resistance" pfclf sequence (Fidock et al. 
2000b). 
There is various evidence that reduced CQ accumulation in reSistant paraSites is due to 
reduced drug uptake and not enhanced drug efflux (Geary et al. 1986, Ferrari and Cutler 
1991, Bray et al. 1992a and b, Martiney et al. 1995) which is supported by a number of 
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1.6.2. Other Hypotheses on Reduced Chloroquine Accumulation 
1.6.2.1. Reduced NHE activity 
Since the initial rate of CQ uptake into CQ-sensitive parasites is rapid, it has been proposed 
that CQ is actively transported into the parasite (Ferrari and Cutler 1991. Sanchez et al. 
1997). This is supported by evidence that specific inhibitors of a Na+/H'" exchanger (NHE) 
inhibit CQ uptake. It has therefore been proposed that CQ resistance is the result of an 
impaired NHE pump and that verapamil reverses this effect (Sanchez 1997. Wunsch et a/. 
1998). This hypothesis has recently been discredited by Bray et a/. who showed that CQ 
uptake is unchanged in the absence of sodium ions and that inhibition of CQ uptake by NHE 
inhibitors (amiloride derivatives) occurs via inhibition of CQ-haematin binding as opposed to 
inhibition of NHE (Bray et a/. 1999. Bray et a/. 1998). 
1.6.2.2. Increased Vacuolar pH 
Reduced CQ accumulation into resistant paraSites has also been attributed to an increased 
vacuolar pH in reSistant paraSites due to a weakened proton pump (Geary et a/. 1986. 
Ginsburg and Stein 1991). This was further supported by Bray et a/. who found that inhibition 
of the vacuolar ATPase system with bafilomycin A 1 caused a greater reduction of [3H] CQ 
uptake into CQ-sensitive as opposed to CQ-resistant parasites (Bray et a/. 1992). Krogstad 
et a/. however found no significant differences in vacuolar pH between resistant and 
sensitive paraSites (Krogstad et al. 1985). Recently Dzenukov et a/. found that the vacuolar 
pH in resistant paraSites is actually lower. and not higher. than their sensitive counterparts 
(Dzenukov et a/. 2000), although their experimental methods have recently been called into 
question (Bray et al. 2002a. Dzekunov et al. 2002, Bray et al. 2002b). 
1.6.2.3. Reduced Access to Haematin 
A recent study by Bray et al. found that saturable CQ uptake is due solely to the binding of 
CQ to haematin and that the number of binding sites in both resistant and sensitive paraSites 
are the same. The difference in CQ accumulation is accounted for by a reduction in CQ 
binding affinity which can be reversed in the presence of verapamil (Bray et a/1998, Bray et~ 
al. 1999). It has been suggested that the CQ-resistance mechanism probably regulates the 
access of CQ to haematin which is consistent with the resistance hypotheses arguing that 
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1.6.3. Concluding Remarks 
The mechanism of CQ drug resistance appears to be multifaceted and is still the subject of 
much debate. It appears that alteration in pfmdr1 and/or pfcrt gene sequences may playa 
role, however the search for a genetiC event capable of explaining resistance in all isolates is 
probably too simplistic (Ward et al. 1997). In highly CQ-resistant parasites, it has been 
proposed that at least two mechanisms are present; a verapamil-sensitive component which 
is responsible for the shift in ICso from moderate resistance to high resistance, and a 
verapamil-insensitive component responsible for the initial loss in sensitivity compared to the 
truly sensitive isolates (Ward et al. 1995). This is demonstrated by AQ resistance, which 
shows a degree of cross-resistance to CQ but lacks the verapamil-sensitive resistance 
component (Bray et al. 1996). It has been suggested that the existence of more than one 
resistance mechanism in highly CQ-resistant malaria has contributed to many of the 
controversies that surround the subject (Ward et al. 1995). 
1.6.4. Structural Modifications that Circumvent Resistance 
1.6.4.1. Changes to the Aminoalkyl Side-Chain of CQ 
Although the CQ-resistance mechanism is still the subject of much debate, it appears to 
arise from reduced drug accumulation and not modification of the target. The resistance 
mechanism is extremely structure specific and seems to recognise the aminoalkyl side-chain 
of CQ. This was demonstrated elegantly by Krogstad et al. who showed that close 
analogues of CQ with either shortened (2-3C long) or lengthened (10-12C long) side-chains 
maintain full activity against CQ resistant strains whereas those with chain lengths closer to 
that of CQ have intermediate activities (Figure 1.13) (De et al. 1996). 
R = ethyl, propyl, isopropyl, butyl, pentyl, 
isopentyl, hexyl, octyl, decyl and dodecyl 
100rr~====~--.--------. I:::.;:] 
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Figure 1.13. Relationship between length of the aminoalkyl side-chain and activity against chloroquine-sensitive 
(Haiti 135) and chloroquine-resistant P. falciparum (De at al. 1996). 
It appears that a high degree of variability can be tolerated in the side-chain as can be seen 
from the introduction of a short side-chain similar to that of CQ in 18 and Ro 47-0543, or the 
introduction of an organometallic substituent in 19 (Figure 1.14). Ro 47 -0543 and three other 
short chain analogues of CQ were selected for in depth scrutiny as potential replacements of 
CQ. They exhibited comparable activity to CQ in the mouse model but showed partial cross 
resistance with CQ. In addition, the metabolites of these compounds, which contribute to in 
vivo activity, are inactive against CQ-resistant strains bringing into question the ultimate 
efficacy of these compounds as CQ replacements in the clinic (Ridley et al. 1996, Ridley et 







IC50 I nM (18) ::: 8 (Haiti 135(5»,11 (Dd2 (RJ) 
1C50 I nM (Ro 47-0543)::: 18 (NF54 (5», 59 (K1 (R) 
8 ::: Ferroeene 
19 
1Cso I p.g.mr1 (19) = 0.057 (FG4 (S», 0.067(FG1(R) 
Figure 1.14. Analogues of CQ with different side chains that retain activity against CQ-resistant P. falciparum. 18 
(De et al. 1996), Ro 47-<)543 (Ridley at al. 1996), 19 (Biot at al. 1997). S represents a CQ-sensitive strain and R 
represents a CQ-resistant strain of P. falciparum. 
Many bis-quinolines with varying side chains also have good activity against CQ-resistant P. 
fa/ciparum (Figure 1.15) (Chen 1991, Vennerstrom et al. 1992, Raynes et al. 1995, Raynes 
et al. 1996, Ridley et al. 1997. Vennerstrom et al. 1998). In particular 22 underwent 
extensive preclinical evaluation at Hoffmann-LaRoche Ltd. but was rejected on toxicological 
















Figure 1.15. Bis-quinoline analogues of CQ with different side chains that retain activity against CQ resistant 
strains of P. falciparum. 20 (Chen 1991, 21 (Vennerstroom et al. 1992), 22 (Ridley et al. 1997, Vennerstroom et 
a/1998) and 23 (Raynes et al. 1995). 
1.6.4.2. Changes to the Quinoline Ring 
Structural changes to the quinoline ring system appear to have little effect on antiplasmodial 
activity of CQ against both CQ-sensitive and CQ-resistant parasites if the 7-chloro group is 
substituted with iodo, bromo or nitro groups (Table 1.8). Substitution with f1uoro or 
trifluoromethyl groups at the 7-position significantly reduces CQ's activity against both the 
CQ-resistant and CQ-sensitive parasites, and substitution with methoxy, hydro or amino 
groups substantially reduces CQ's activity against both CQ-resistant and CQ-sensitive 
parasites. From these observations, It appears that changes to the quinoline ring system 
have little effect on the CQ-resistance mechanism but are essential for CQ's antimalarial 
activity. From these 7 -substituted CQ analogues it would appear that antiplasmodial activitiy 
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Table 1.8. Effect of changing quinoline-ring substituents on the antiplasmodial activity of CQ 
Compound ICsol nM 
CQ-sensitive CQ-resistant 
~NEt2 
ill x ::::,... I N~ 
X Haiti 135 Indochina I 
CI (CQt 8 95 
I" 4 35 
Bf' 5 90 
Fa 20 500 
CFsa 16 45 
OMea 55 3000 
Hb 90 5000 
NF54 KI 
CI (CQ)C 13 350 
N02
c 15 68 
NH2
c 2600 4300 
~NEt2 30 {Haiti 135t 250 (Indochina 1)b 
~ 170 (NF54)C 4900 (Kit ::::,... ~
~NEI2 
1000 (Haiti 135)b 1050 (Indochina 1t 
y) ::::,... ~ N 
CI 
ODe et al. 1998, b De et aI. 1996, C Vippagunta et al. 1999. 
In summary, since close analogues of CQ maintain activity against CQ-resistant parasite 
strains it appears that the resistance mechanism does not involve any change to the target 
of this class of drug, but rather involves a compound-specific resistance. As a result, it 
remains of considerable importance to understand the mode-of-action of CQ with a view to 
rational design of new antimalarials based on the same mechanism of action. This is 
especially true given that the. putative haemozoin inhibition process occurs only in the 
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1.7. AIMS AND OBJECTIVES 
1.7.1. Aims 
The aims of the project are to investigate the nature of the ferriprotoporphyrin IX 
(Fe(III)PPIX) target and to determine the critical structural features in 4-aminoquinoline 
antiplasmodials responsible for their complexation with Fe(III)PPIX and the relationship to 
anti plasmodial activity. An attempt will also be made to identify the structural features in 4-
aminoquinolines responsible for f3-haematin inhibition with an aim to probing whether these 
compounds act by inhibiting f3-haematin formation. In addition, it will be investigated if 
accumulation of the 4-aminoquinoline antiplasmodials in the food vacuole is dependent on 
pH trapping and whether pH trapping is important for antiplasmodial activity. 
1.7.2. Objectives 
1.7.2.1. Investigation ofthe Target 
1.7.2.1.1. The Nature of Fe(III)PPIX in Aqueous Solution 
There is considerable evidence that ferriprotoporphyrin IX (Fe(III)PPIX), released from 
haemoglobin into an acidic aqueous environment is the target of CQ and related 4-
aminoquinoline antimalarials and antiplasmodials. Fe(lIl)PPIX in aqueous solution is 
generally thought to consist of monomers and fJ.-oXO dimers with a dimerisation constant 
strongly in favour of the dimer (K = 4.5) (Brown et al. 1970). Since behaviour of Fe(III)PPIX 
in aqueous solution is central to understanding the mechanism of action of quinoline 
antimalarials, and there have been no follow-up investigations since the study by Brown et 
al., the nature of the Fe(III)PPIX target in aqueous solution will be investigated. 
1.7.2.1.2. Structural Features of CQ critical for Fe(III)PPIX- CQ Binding 
Little is known about the structural features in CQ responsible for Fe(1II )PPIX binding. In this 
study, the following structural features in CQ will be probed to ascertain the effect they have 
on Fe(III)PPIX- CQ binding: (i) the position of the amino-group on the quinoline ring, (ii) the 
presence of a 7 -chloro group and (iii) the presence of a side chain with terminal amino 
functionality. The existence of a quantitative relationship between strength of Fe(III)PPIX 
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1.7.2.2. Mechanism of Antiplasmodial Action of4-Aminoquinolines 
1.7.2.2.1. Accumulation Through pH Trapping 
Since CQ accumulates roughly 10 000 fold in the food vacuole at the ICoo, it would appear 
that these enhanced intemal concentrations are necessary for antiplasmodial activity. It has 
recently been suggested that this vacuolar accumulation is driven predominantly by 
Fe(III)PPIX complex formation and that pH trapping plays a lesser role. In this study, the 
structural significance of the terminal amino-group will be probed to ascertain if pH trapping 
is important in antiplasmodial activity. Furthermore, the extent of pH trapping will be 
predicted for a series of structurally related compounds in order to ascertain if accumulation 
through pH trapping is quantitatively related to antiplasmodial activity. 
1.7.2.2.1. Inhibition of (3-Haematin Formation 
Although there is considerable evidence that CQ and related 4-aminoquinolines bind to 
Fe(III)PPIX, the resulting toxicity of this complex is still the subject of much debate. In this 
study, the hypotheSiS that CQ-type antimalarials act by inhibiting (3-haematin formation will 
be investigated. An attempt will be made to identify the critical structural features in CQ and 
related 4-aminoquinolines responsible for (3-haematin inhibition in order to probe whether 
























For more than 40 years, chloroquine (CQ) has been the drug most widely used in the 
prophylaxis and treatment of malaria. The recent spread of CQ resistance has compromised 
its utility and spurred on the need to develop new antimalarials. Instead of searching for a 
completely new motif, there has been a trend towards understanding the structure-activity 
relations in CQ with a view to rationally designing superior quinoline antimalarials. In this 
project, it was decided to dismantle the CQ molecule to probe how the following three 
structural features are related to antiplasmodial activity (Figure 2.1.): 
1. Position of the amino-group on the quinoline ring 
2. Functionality of the group at the terminal position on the side-chain, Y 
3. Functionality of the group at the 7-position on the quinoline ring, X. 
0.. x ...... t----y 
Hr(\ ~)n 
Figure 2.1. Schematic representation of the three structural features of interest in chloroquine (GQ). NH: pOsition 
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2.1.1 Synthetic Targets Chosen for the Study 
The following four classes (1-4 below) of aminoquinolines were obtained or synthesised in 
order to probe the following structural features in CQ. 
1. Position of the amino-group on the quinoline ring: 
Quinoline, 3-, 5-, 6- and 8-aminoquinoline are commercially available, whilst 2- and 4-
aminoquinoline were synthesised (Figure 2.2.). 
NH2 
* Commercially avaliable 
Figure 2.2. Aminoquinorrnes required for the study 
2. Influence of the group at the 7-position of 4-aminoquinoline (Figure 2.3.). 
Figure 2.3. 7-X-4-aminoquinolines required for the study 
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Figure 2.5. (left) derivatives of 4-amino-7-chloroquinoline with different terminal side chain groups and, (right) 
derivatives of N2-(7-X-4-quinolinyi)-N1,N1-diethyl-1,2-ethanediamine where X = NH2, OH, OCH3, CH3, F, Br, I, 
CF3 and N02. 
2.2. OVERVIEW OF QUINOLINE REACTIVITY 
2.2.1. Reactivity Towards Nucleophiles 
If quinoline is considered as benzo[b]pyridine, much of its chemistry can be rationalised in 
terms of benzene and pyridine. Like pyridine, the quinoline pyridine ring is 1t-deficient due to 
the electron-withdrawing inductive and mesomeric effects of the nitrogen atom. These 
effects are pronounced at positions 2 and 4 (Figure 2.6.), which are the preferred 
nucleophilic sites of attack. A halogen group at positions 2 or 4 on the quinoline pyridine ring 
further activates these positions towards nucleophilic attack. Quinoline is more reactive 
towards nucleophiles than pyridine as a result of stabilisation of the reaction intermediate by 
the presence of a second aromatic ring . 
5 • 
6~J _. ___ .
7~~1-:J 2 
8 N 
00 ...... ;-----,.- CO 
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2.2.2. Reactivity Towards Electrophiles 
Quinoline is more n-deficient than benzene and hence not very susceptible towards 
electrophiles. Electrophiles will first attack the electron-rich nitrogen atom of the quinoline 
pyridine ring but once this is protonated or quatemised, substitution will occur at positions 5 
and 8 on the quinoline benzene ring . These positions are favoured as the resulting 
intermediates can be represented by two canonical structures while preserving the aromatic 
character of the heterocyclic ring as opposed to only one resulting from electrophilic attack 
at positions 6 and 7 (Figure 2.7.) . 
00- . 6]) ro Q? ~ I ~(~ .. .. 
H C-5 H X HH C-8 X H H 
X 
Q {X) + I "N...0 H I ::::::..... i{~ 
H C-7 H C-6 H 
Figure 2.7. Mesomeric effects in quinoline providing a rational for the preferred sites of electrophilic attack 
2.2.3. Reactivity of Quinoline-1-oxide 
The quinoline ring can be activated towards electrophilic attack by transformation to its N-
oxide, quinoline-1-oxide. The N-oxide can act as an electron donor into the ring, thereby 
making it more n-rich. (Katritzkyand Lagowski 1971) (Figure 2.8.). Electrophilic substitution 
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2.3. GENERAL ROUTES TO 2-AND 7-X-4-AMINOQUINOLINES 
The 2-aminoquinolines (2AQ) and 7-X-4-aminoquinolines (7X4AQ) were synthesised by 
nucleophilic attack of the appropriate amine, in an addition-elimination pathway, with 2-
chloroquinoline 24 and 7X4AQ respectively (Scheme 2.1.). Since nucleophilic substitution of 
a halogen occurs more readily at positions 2 and 4 than in the quinoline benzene ring 
(Comprehensive Heterocyclic Chemistry II 1996), no unwanted 7-substituted side products 








Scheme 2.1 . General routes to 2- and 7-X-4-aminoquinolines from 2- and 7-X-4-chloroquinoline respectively. 
In order to make all the CQ analogues, both 24 and the various 7X4AQ were synthesised. 
The routes to these chloroquinolines are outlined below. 
2.3.1. Routes to 2-Chloroquinoline 
2-Chloroquinoline was synthesised using two methods. Firstly (Riegel et al. 1946) (Scheme 
2.2.) by treatment of commercially available 2-hydroxyquinoline 2Sa , with phosphorus 





Scheme 2.2. Preparation of 2-chloroquinoline. Reagents and Conditions: i. POCb. 1 aaoc . 
• 2- and 4-hydroxyquinoline exist in tautomeric equilibrium with their quinolone forms (shown for 2-quinolone (25». For 
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In a second route, quinoline-1-oxide, whose synthesis is described in Section 2.3.2.1. was 
treated with phosphorus oxychloride (Bachman 1944, Badger 1961) at 65°C for 1 h. The 
products were isolated by chromatogrphy to give a mixture of 2- and 4-chloroquinolines in a 
3.3:1 ratio (Scheme 2.3.). In this Meisenheimer type reaction (Meisenheimer 1929), it is 
proposed (Comprehensive Heterocyclic Chemistry II 1996) that the electrophilic phosphorus 
reagent first reacts with the N-oxide thus promoting chloride attack at positions 2 or 4 on the 





~A 24 N CI 
69% 
Scheme 2.3. Formation of a mixture of 2- and 4-chloroquinoline. Reagents and Conditions: i. POCb, 65°C . 
2.3.2. Route to 7-X-4-Chloroquinolines 
The 7-X-4-chloroquinolines were synthesied by two methods (Table 2.1 .). For compounds X 
= H and X = CH3 , Method 1 was used. Compounds X = CI and CF3 were obtained 
commercially and X = F, Br, I, OCH3 and N02 were synthesised according to Method 2. 
CI 
x 
Table 2.1. Routes used to 7-X-4-chloroquinolines 
x H CI F Br 
Method 1 1 ca ca 2 2 2 2 2 
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Treatment of 27a-b with peracetic acid at 65 - 70°C for 26 - 40h (Ochiai 1953) gave 28a-b in 
89 - 93% yield. Selective nitration at the 4-position was achieved using potassium nitrate in 
trifluoroacetic acid (Yokoyama et al. 1997) to give 29a-b in a 77 - 79% yield (Scheme 2.5.). 
co ---'---l"_ cO 
28a I 29a L 
0" 77% 0 
Scheme 2.5. Selective 4-nitration of 28a. Reagents and Conditions: i. CF3COOH. KN03. 60°C. 
Chlorination of 29a-b. using PCh in dry dichloromethane for 6 - 20h at room temperature 
followed by a further 40 - 50h at 60°C. resulted in formation of three products which were 
isolated by chromatography to give 30a and 30b as the major products in 78% and 75% 
yields respectively. The other two products in the "a" reaction were isolated and 
characterised as 2,4-dichloroquinoline 32 and 2-chloro-4-nitroquinoline 33 in 7% and 3% 
yields respectively (Scheme 2.6 .). In the "b" reaction the two side products were observed 
by TLC, but were not isolated. Attempts to scale-up the "a" reaction from 19 to 2.69 resulted 
in a lower yield of 30a (56%) and hence the reaction was only carried out on 19 quantities. 
cO 
CI CI N02 
cO cO cO :::,... I i!(~ • + I + I :::,... ~ :::,... N~ CI :::,... ~ N N CI 
29a L 30a 32 33 
0 78% 7% 3% 
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2.3.2.2. Method 2: Price and Roberts 
The 7-X-4-chloroquinolines, X = F, Sr, I, OCH3 and N02 were synthesised according to 
methodology developed to synthesise and derivatise CQ. These routes will be discussed 
brieflly as they give the background to Method 2. 
Surrey and Hammer developed a route to 7-X-4-aminoquinolines for X = CI, Sr and I, that 
was used for the production of CQ in the United States (Surrey and Hammer 1946, Kenyon 













~NEt2 ivl OH a 
~,~o) ,;;0) 
39 40 co 
100% 91% 40-90% 
Scheme 2.7. Commercial route to CQ developed by Surrey and Hammer in 1946. Reagents and Conditions: i. 
CH3COOH (aq), 40 - 50"C, 15 - 18h; ii. mineral oil, 250°C, 2Omin; iii. 35% NaOH, reflux. 2h; iv. mineral oil, 
270°C, 5min; v. POCb. reflux, 2h; vi. 4-amino-1-diethylaminopentane, 160 - 180°C, 7h (Surrey and Hammer 
1946). 
In the case of CQ, m-chloroaniline 34 was condensed with diethyl2-oxo-succinate 35 to form 
36. Thermal cyclisation of 36 gave a 1:1 mixture of 2-(ethoxycarbonyl)-4-hydroxy-7-
chloroquinoline 37a and its 5-chloroisomer 37b from which the desired 37a was isolated by 
selective crystallisation. Hydrolysis to the acid followed by decarboxylation and chlorination 
of the resultant 7-chloro-4-hydroxyquinoline 39 gave 4,7-dichloroquinoline 40, which 
underwent 4-substitution with excess 4-amino-1-diethylaminopentane (novol diamine, NDA) 
for 3 - 5h at 160 - 170°C to afford CQ as the free base which was isolated as the 
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Some interesting adaptations from Surrey and Hammer's laboratory synthesis to plant 
production of CQ were reviewed by Kenyon in 1949. One improvement was the use of 
Dowtherm instead of mineral oil for the cyclisation and decarboxylation steps ii and iv 
respectively as mineral oil is difficult to remove due to it's high viscosity and tendency to 
carbonise. Another improvement was addition of phenol to 40 prior to coupling with NDA 
(step vi). Phenol reacts with 40 to form 7 -chloro-4-phenoxyquinoline 41 (Surrey 1951) 
(Scheme 2.8.) which then couples more readily with NDA enabling the use of stochiometric 
amounts of NDA and lower reaction temperatures. This then eliminated the need to isolate 





Scheme 2.8. Improved preparation of CQ from 40. 
Subsequently, Johnson and Buell provided another route that gave, upon cyclisation, only 
the desired 7 -chloroisomer. In this route, methyl acrylate and m-chloroaniline were 
condensed to give 42 (Johnson and Buell 1952) (Scheme 2.9.). Tosylation and 
saponification then gave the acid 43 which was cyclised and detosylated to give 44. 
Condensation with NDA in the presence of an oxidising agent then gave CQ. The authors 
claim that an overall 25% yield from m-chloroaniline can be obtained which compares 
favourably to the Surrey and Hammer process. 
o 




,..~ 0 . CIAJlN) ~ co 
44 H 
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A superior route to 4,7-dichloroquinoline was developed by Price and Roberts 1946 that 
involved condensation of diethyl ethoxymethylenemalonate 45 with m-chloroaniline 34 
(Scheme 2.10.). In this method, cyclisation of 46 formed predominantly the 7-chloroisomer . 
47 (80 - 90%) with only traces of the unwanted 5-chloroisomer. Both the cyclisation and 



























80 - 90% 
Scheme 2.10. Improved route to 2,4-dichloroquinoline (Price and Roberts 1946). Reagents and Conditions: i. 
100°C, 1h; ii. Dowtherm A, reflux, 45min; iii. 10% NaOH (aq), reflux, 1h; iv. 240-270°C; v. POCIJ , reflux, 2h. 
The method of Price and Roberts was used to synthesise the 7-X-4-chloroquinolines 

























No. a b c d e F 
x F Br OH 
Scheme 2.11. Route to 7-X-4-chloroquinolines, X == F, Br, I, OCH3 and NOz. Reagents and Conditions. i. 60 -
110°C, O.S - 2h; ii. phenyl ether, reflux, 20min - Sh; iii. 10% NaOH (aq), reflux, 1 - 3h; iva. 2S% NH3 (aq), HzO, 
reflux, 10min ~ AgN~, reflux, 16h; iv and ivb. phenyl ether, reflux, 30 - SOmin; v. POCI3 , 11SoC, 1 h. 
The appropriate m-substituted aniline 49a-f and diethyl ethoxymethylenemalonate 50 were 
heated at 60 - 110°C for 0.5 - 2h to afford the acrylates 51 a-f which were crystallised from 
ethanol in 83 - 96% yield. Each purified 51a-e was then added, slowly, over 10 - 20min to 
vigorously stirred, refluxing phenyl ether and the mixture refluxed for a further 20 - 40min to 
give the desired 7-substituted quinoline products 52a-d regioselectively in 30 - 77% yields. 
Owing to the difficulty in removing all the phenyl ether from 52a-d, the regioselectivity of 
these derivatives was confirmed by nmr in the next step. By comparison , the nitro and 
hydroxy derivatives 51e-f, required longer, 5h, reaction times and both the 7- and 5-
substituted regioisomers formed. In this case, the remaining phenyl ether was removed by 
extensive washing with cold acetone. The 7- and 5-nitro regioisomers had different Rf's on 
TLC (methanol: ethyl acetate (10 : 90)) of 0.48 and 0.33 respectively, but were both too 
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separated by hot extraction into methanol and crystallised out of this solvent upon cooling to 
room temperature. The 7-nitroisomer 52e was then selectively crystallised from large 
volumes of DMSO in an optimised 23% yield. 
The hydroxy derivatives appeared separable on TLC using a mixture of methanol : 
dichloromethane (10 : 90). Chromatography however proved difficult as the products were 
insoluble in dichloromethane and only sparingly soluble in methanol. Hence, an alternative 
route to synthesising the 7-hydroxy derivative was used (described in Scheme 2.17. later in 
this chapter). 
Saponification of 52a-e by refluxing in 10% NaOH (aq) for 1 - 3h gave the sodium salts of 
54a-e which were precipitated out of solution as their acids by addition of 10% HCI (aq). In 
the case of the nitro derivative, the precipitate was a yellow sludge from which 54e was 
selectively extracted into large volumes of boiling ethyl acetate. The 7-substituted 
regioselectivity of compounds 54a-e was confirmed by the 1H nmr splitting patterns and 
coupling constants of the protons in the quinoline benzene ring. H-5 and H-8 appeared as 
doublets and H-6 as a doublet of doublets with ortho and meta coupling constants of 8.8 and 
2Hz respectively (Figure 2.10.). The analogous arrangement of hydrogens in the 1H nmr 
spectrum for the 5-regioisomers revealed a completely different pattern. 
8.~ 
f ~-5 OH 
C3=' H-8 2.0Hz 
Figure 2.10. Characteristic 1 H nmr coupling constants of the quinoline benzene protons in the 7 -substituted 
quinolines. 
54a-d were decarboxylated in refluxing phenyl ether for 30 - 50min to give the respective 7-
X-4-hydroxyquinolines 56a-d in quantitative yields. 54e was decarboxylated via the silver 
salt, 55 (Baker et al. 1946) to give 31e in an optimised 13% yield. The 7-X-4-
hycfroxyquinolines 56a-e showed the characteristic ortho and meta couplings between the 
protons in the quinoline benzene ring as well as a pair of AB doublets (J = 7.3Hz) 
corresponding to H-2 and H-3 in the quinoline pyridine ring (Figure 2.11.). This large 
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quinolone form. H-2 resonated at a higher chemical shift owing to the deshielding effect of 













81 ppm Multiplicity JI Hz 
5.9-6.0 d 7.3 
7.8- 7.9 d 7.3 
variable d 8.8 
variable dd 8.8 and 2.2 
variable d 2.2 
Figure 2.11. Characteristic 1H nmr muHiplicities and coupling constants for 7-X-4-hydroxyquinolines 56a-e. 
Chlorination of 56a-e in phosphorus oxychloride at 110 - 120°C for 20min - 1 h gave 7 -X-4-
chloroquinolines 57a-e in yields of 73 - 91 %. The 1 H nmr spectra of these compounds again 
showed the characteristic ortho and meta couplings between the protons in the quinoline 
benzene ring. H-2 and H-3 had characteristic chemical shifts of 7.5 - 7.7ppm and 8.7 -
8.9ppm respectively and their common coupling constant was lowered to 4.7Hz (Figure 
2.12.). 




H-2 8.7 - 8.9 d 4.7 
H-3 7.5- 7.7 d 4.7 
H-5 variable d 9.0 
H-6 variable dd 9.0 and 2.0 
H-8 variable d 2.0 
Figure 2.12. Characteristic 1H nmr multiplicities and coupling constants for 7-X-4-chloroquinolines 57a-e 
2.3.2.2.1. Mechanistic Comments 
Although the route to 7 -X-4-chloroquinoline developed by Price and Roberts in 1946 has 
been widely used to make 4-aminoquinoline antimalarials, there has been no comment on 
the thermal cyclisation mechanism. The current study has not attempted to study this 
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The first possibility involves a polar intramolecular nucleophilic substitution pathway (ionic 
mechanism) (Scheme 2.12.). In this case, attack of the aromatic ring on the carbonyl group 
would produce the polar intermediate (A) in the rate determining step (rds) . Subsequent 








Scheme 2.12. Proposed c'tdisation mechanism 1 via a polar intermediate A 
OEI 
B H 
Another possibility is that the reaction proceeds via a 67t-electrocyclic mechanism (Scheme 
2.13.). In this case, a reactive ketene intermediate C would need to form by an entropically-
driven (favoured by high temperature) expulsion of ethanol. A subsequent 67t-electrocyclic 
rearrangement followed by tautomerism would give the products 52a-f. 
CASE 2 
o o 
xUk: -EtcH. ~crOEl_---l.~ x~, x OEI 





Scheme 2.13. Proposed 67t-electrocyclic cyclisation mechanism 2 via the ketene intermediate C. 
If the cyclisation reaction proceeds via a polar mechanism, then strongly electron-releasing 
substituents (eg OH which has a strongly negative Hammett constant, Table 2.2) would 
favour the formation of A, via the resonance contribution of E promoting a fast rate of 
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which has a strongly positive Hammett constant, Table 2.2) would disfavour the formation of 
A thereby leading to a reduced rate (Scheme 2.14.). 
The progress of the cyclisation reactions were monitored approximately every 20 mins by 
viewing the disappearance of the starting material (51a-f) by TLC. In the reactions involving 
the N02 and OH-substituted aromatic rings (51e and 51f respectively), it was found that 
longer reaction times (approximately 5h vs 20 - 60mins for the other derivatives) were 
required to produce the cyclised products which formed in lower yields (approximately < 
30% vs > 90% for the other derivatives) (Table 2.2.). Since these results are not consistent 
with the predicted outcome for a polar mechanism, it is likely that the cyclisation reaction 
does not proceed via this mechanism. 
Table 2.2. Experimental and reported observations on the cyclisation reaction 
-x (Jp Reaction Times Yield Regioselectivity 
(viewed by TLC) 
-OH -0.37 5h <20% 5 and 7 
-OMe -0.27 30 ± 20 min >90% 7 
-F 0.06 40 ± 20 min >90% 7 
-I 0.18 60±20 min >90% 7 
-CI 0.23 20-40 mina >90%8 7 
-Br 0.23 45 ± 20 min >90% 7 
-CF3 0.54 20-40 minb >90%b 7 
-N02 0.78 5h 34% 5 and 7 
O"p = para constant (Hansch and Leo 1979). • Price and Roberts 1946. b Snyder et at. 1947. 
o 
AhOEI ?" ~ OEI P N 0 
H 
0) 














x = electron wi thdrawing 
Scheme 2.14. Resonance forms resulting from the presence of (top) an electron donating and (bottom) an 
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From the available experimental data, it is not possible to ascertain if the reaction proceeds 
via a 61t-electrocyclic mechanism (CASE 2) since it is not evident which step is rate 
determining. According to Frontier Molecular Orbital Theory (FMO theory), one would need 
to have information on the effect of the aromatic ring substituents on the HOMO and LUMO 
energies of the electrocyclic system as well as on the coefficients of the ketene carbon and 
C-4 of the aromatic ring (Scheme 2.13., intermediate C). Calculation of these parameters in 
addition to rate experiments would be required to ascertain if this reaction proceeds via a 
pericyclic mechanism. 
It is also not obvious what controls the observed 5- and 7 -substitution regioselectivity. 
Presumably the 7 -isomer is sterically preferred and the 5-isomer may thus form as a result 




x = OH, OMe, F, I, 
CI, Br, CF3 , NOz 
P: I ~ X NH \, O,Ety 
COzEt 5-Substituted regioisomer 
x = NOz, OH 
Scheme 2.15. Proposed formation of 5- and 7-substituted regioisomers 
2.3.3. Synthesis of the 2- and 4-Aminoquinoline Analogues 
The 2- and 4-aminoquinoline analogues were synthesised from their respective 2- and 4-
chloroquinolines by nucleophilic substitution with the appropriate amine. In the literature (J. 
Am. Chern. Soc 1946), the 2- and 4-aminoquinoline analogues were often synthesised from 
carefully prepared diamine side chains and hence stoichiometric amounts of reagents were 
desired. This could be achieved using careful temperature control in the presence of phenol. 
The reaction mixture was heated until a sudden rise in temperature was noted . Thereafter 
the temperature was maintained a few degrees below this pOint for one to two hours (Drake 
et al. 1946). This method was not used in this study as our coupling amines were all 
commercially available. Instead, the chloroquinolines were heated with excess amine in a 
sealed tube at 105 - 140°C for 20 - 65h to give the 2-aminoquinolines 58-60 (Scheme 2.12.) 
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the 2-substitutions were slower than the 4-susbstitutions and took longer reaction times. 
Substitutions with 25% ammonia (aq) were slower as a result of the lower nucleophilicity of 
ammonia relative to a primary amine. The heat sensitivity of N2-(7-nitro-4-quinolinylrN1,N1-
diethyl-1 ,2-ethanediamine 79, resulted in thes coupling reaction (iv)e being carried out under 
the milder refluxing conditions of 85°C for 5h. 
In general, most of the excess amine was removed under reduced pressure and then hot 
benzene was used to selectively extract out the product. The compounds were then 
chromatographed or crystallised directly to give analytica"y pure hydrochloride salts of 60 
and 64, and the free bases of 58,59, 61-63, 65-80. 
~ ~ I H2NR :::::.... I ~ NHR • :::::.... h (i)a-c N CI 
24 58·60 
Rxn No R Yield I % 
(i)a 33 H 78 
(i)b 34 CH3
8 81 
(i)c 35 CH2CH2NH2 82 
• (Ashley Misplon, honours project, Department of Chemistry. University of Cape Town. 1998) 
Scheme 2.12. General route to 2-substituted aminoquinolines. Reagents and Conditions: (i)a. 25% NH3(aq). 











































































Scheme 2.13. Synthesis of 7-X-4-aminoquinolines. Reagents and Conditions: (i)a. 25% NH3(aq), ZnCI2, 150"C, 
35h; (i)b. 33% CH3NH2 (methanol), 154°C, 20h; (I}c. NH2CH2CH20H, 120"C, 4.5h; (i}d . 90% NH2CH2CH2NH2 
(aq), 120°C, 5h; (i)e. NH2CH2CH2NEh, 150°C, 8h; (ii)a. 25% NH3 (aq), ZnCb, 145°C, 18h ~ 160°C, 24h; (ii)b. 
NH2CH2CH2NEh, 130°C, 18h ~ 150"C, 6h; (iii)c. NH2CH2CH2CH3, 95°C, 2Oh; (iii)f. NH2CH2CH2NMe2, 140°C, 
3.5h; (iii)g. NH2CH2CH2NEh, 150", 5h; (iv)a. NH2CH2CH2NEt2, 1600C, 6h; (iv)b. NH2CH2CH2NEh, 135°C, 6h; 
(iv)c. NH2CH2CH2NEh, 1200C, 8h; (iv)d . NH2CH2CH2NEh, 1400C, 5h; (iv)e. NH2CH2CH2NEt2, 85°C, 5h (iv)f. 
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2.3.4. Characterisation of 2-Aminoquinolines 
1 H nmr spectra of 60 
The 2-aminoquinolines all showed characteristic 1H nmr splitting patterns (Figure 2.13) and 
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Figure 2.13. 1H nmr spectrum of 60 in d6 DMSO. Inset: expanded aromatic region between 6.7 and B.Oppm . 
The CH2 peak at 3.61 ppm was assigned to CHru on the basis of a strong interaction with 
NH identified in the COSY spectrum. The remaining CH2 peak at 3.06ppm was thus 
assigned to CH2-~' The two doublets at 6.80ppm and 7.88ppm share a common coupling 
constant of 9.0Hz and were aSSigned to H-3 and H-4, the former being shielded by 
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the four quinoline benzene ring protons gave rise to two types of splitting patterns; a dd at 
7.63 and 7.56 for H-5 and H-8, and a td at 7.48 and 7.16 for H-6 and H-7. These protons 
could not be individually assigned from the HMBC spectrum although it was evident from the 
COSY that the dd Signal at 7.63ppm is ortho to the td signal at 7.16ppm. 
13C nmr spectra of 60 
From the HSQC spectrum of 60, the 13C nmr signals could be assigned collectively (Table 
2.3). C-2 could be assigned from the HMBC spectrum owing to an interaction with CHz-a,. 
Since all the 2-aminoquinoline analogues had similar 13C nmr spectra, the chemical shifts for 
58 and 59 were assigned from 60 (Table 2.3). 
Table2.3. 13C nmr peaks of 60 (-) assigned from HSQC and HMBC spectra, and 58 and 59 (- ) 
assigned from 60 
C 58 59 60 
C-2 156.9 157.6 157.2 
C-3, C-4 111 .6, 138.0 111 .1, 137.2 113.7,136.9 
C-5, C-8 126.0, 127.5 126.1, 127.4 125.9,127.9 
C-6, C-7 122.7, 129.7 121 .9, 129.5 122.0,129.6 
C-4a, C-8a 123.6, 147.7 123.3, 148.1 123.4, 147.8 
Melting Points and Microanalysis of 2-Aminoquinolines 
The melting points were compared to literature values where appropriate, and combustion 
analysis was obtained to ensure analytical purity of the compounds (Table 2.4). 
Table 2.4. Characterisation 2-Aminoquinolines 58-60 
No. Observed Literature Microanalysis 
mp/DC mpl DC Calcuated I % Found I % 
C H N C H N 
33 129 128 -129, Brown and Plasz 1970. 75.0 5.6 19.4 75.3 5.6 19.5 
34 70-72 69 - 71, Watanabe et al. 1980. 75.9 6.4 17.7 76.1 6.5 17.4 
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2.3.5. Characterisation of 4-Aminoquinolines and 7-X-4-Aminoquinolines 
Both the 4-aminoquinoline and 7-X-4-aminoquinoline series showed characteristic 1H nmr 
splitting patterns and 13C nmr chemical shifts which will be discussed for the representative 
analogues 64 and 74 respectively. 
1 H nmr spectra of 64 and 74 
The 1H nmr spectra for analogues 64 and 74 (Figures 2.13 and 2.14 respectively) revealed 
the characteristic pair of AB doublets corresponding to H-2 and H-3 sharing a common 
coupling constant of 5.4Hz. In this case, H-3 is assigned the lower chemical shift due to a 
shielding effect by mesomeric release from the 4-amino substituent. The aromatic 
multiplicities in the quinoline benzene ring for 64 were the same as observed for the 2-series 
but with the signals further apart and hence better defined. In the case of 64, H-6 was 
assigned from a HMBC interaction with CH3 which enabled absolute assignments of the 
remaining quinoline benzene protons. 
8.0Hz n-5 
7.5HZf.( ~ I 
~ H-7 ~ 
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Ii II I II i I I' I II I II II I I I I I I II I I I I I I I I I I II I II II Iii iii II iii ( Iii Iii iii I I I I I 1 
8.~ 8.0 7.~ 7.0 6.~ 6.0 5.S !I.O 4.S 4.0 3.S 3.0 2.S 2.0 











Chapter 2: Synthesis 66 
The 1H nmr spectrum for analogue 74 (Figure 2.15) showed the characteristic 7 -substitution 
in the quinoline benzene ring which allowed for unambiguous assigment of all the aromatic 
protons. 




2xCH3 H-8 H-3 H-2 H-5 
H-6 
'--__ ----J'--_,.'-_--'.'-~ ______ ...... '--
2xCH2 
I I I I I I I I I I I I' I I I I I I I I I I I I I I' i " I I I I I I I I r I I " i I I i I I I I I I " I I I I I 
U &.. 1.2 1..0 7& 7.6 7.4 U. 7.0 6.& 6.6 6.4 
I' II , I' II I I' II , II I I I II I I I II II I II I I I II I I I II I I 1)1 I II I" II II I II II I II II I II I" I I I" I I I" I I 
9.0 85 8.0 7.S 7.0 6.5 6.0 55 5.0 4.S 4.0 3.S 3.0 2.5 2.0 I.S 1.0 
Figure 2.15. IH nmr spectrum for 74 in CDCb. Inset: expanded aromatic region between 6.3 and 8.6ppm. 
13 c nmr assignments of the 4-aminoquinolines and 7-X-4aminoquinolines 
In all cases, the HSaC spectrum of each compound in both series enabled assignment of 
the CH carbon signals, C-2, C-3, C-5, C-6 and C-8, in the 13C spectrum (Table 2.7 and Table 
2.8). The quarternary carbons, C-4, C-4a, C-7 and C-8a, for both the 4-aminoquinolines and 
the 7-X-4-aminoquinolines were similar and were solved from the long range HMBC 
interactions for compound 78 (Table 2.5). In this case, C-7 was unambiguously assigned 
from its strong interaction with the methyl protons of the methoxy group at position-7. C-4 
revealed a strong interaction with CHz-a" and the ring junction carbons (C-4a and C-8a) from 
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4a -.....:::::: 3 
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CHra and H-5 




Further support for all the ring carbon assignments comes from the C-F coupling constants 
identified from the 13C nmr spectra for all the 7-f1uoroquinoline compounds (Table 2.6). 




F N m,: :::::..... ~ F N F 
548 568 578 75 
No 54a 56a 57a 75 
01 ppm J/Jfz 01 ppm J/Jfz 01 ppm J/Jfz 01 ppm J /'){z 
C-2 146.8 140.6 151.8 152.2 
C-3 108.6 109.7 121.1 98.7 
C-4 178.5 177.0 141.3 150.0 
C-4a 122.2 2 123.6 122.8 115.9 
C-5 129.3 11 129.0 11 126.6 10 121.8 10 
C-6 115.9 24 112.6 24 118.3 15 114.3 25 
C-7 165.5 253 164.4 248 162.8 250 162.9 249 
C-8 105.8 25 104.0 25 113.0 21 113.3 20 
C-8a 141.8 13 142.1 13 149.5 13 149.9 12 
The C-7 assignment was confirmed from the large coupling constant of 250Hz to F. The 
assignments for the C-6 and C-8 carbons was confirmed by their similar coupling constants 
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value of 12 Hz. Finally, in the case of 54a (Figure 2.15), C-4a shows a weak 4J coupling 
constant of 2Hz to F, further supporting the HMBC assignment for 78 at C-4a. 
'J J C-f" J I Hz 
OH 0 IJ 253 
OH 2J 25 
JJ 12 
4J 2 
Figure 2.15. Observed coupling constants between -C and -F in the 13C nmr spectrum for 54a. 
The quarternary carbon signals for all the 4-aminoquinolines and 7-X-4-aminoquinolines 
could therefore be assigned on the basis of the HMBC assignments for 78, and the C-F 
coupling constants identified from the 13C nmr of the 7-fluoroquinoline compounds. The 13C 
nmr peaks for C-4 and C-8a were not individually assigned as both had similar chemical 
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Table 2.7 (top) 13C nmr assignments of the 7-X-4-aminoquinolines differing only with respect to the group at the 
7-position, quarternary carbons assigned from 74, 75 and 78 (- ) and, Table 2.7 (bottom) 13C nmr assignments 
of the 4-aminoquinolines . Quarternary carbons assigned from trends noted in the 7-X-4-aminoquinolines (- ). 
( 
HN~~ 
65, 67,74-80, 82-83 
C H CH3 CI F Br I OCH3 N~ CF3 OH NH2 
65 67 74 75 76 77 78 79 80 82 83 
2xCH3 12.1 12.1 12.0 12.1 12.1 12.1 12.1 12.1 12.1 12.5 12.0 
CHr~ 50.8 50.8 50.6 50.7 50.7 50.7 50.8 50.5 50.6 51 .4 50.9 
2xCH2 46.6 46.5 46.5 46.5 46.5 46.5 46.6 46.5 46.6 47.4 46.5 
CHra 39.8 39.8 39.7 39.7 39.8 39.8 39.8 39.8 39.8 41.5 39.8 
C-2 151.1 151.1 152.1 152.2 152.1 151.8 151.3 153.2 152.3 148.5 151.3 
C-3 99.0 98.5 99.3 98.7 99.4 99.5 98.1 101.1 100.3 97.3 97.1 
C-4a 119.6 116.9 117.4 115.9 117.8 118.2 113.5 122.5 120.1 112.3 112.3 
C-5 119.1 119.3 121.1 121.8 121.2 121.1 120.9 121.5 121.0 124.0 120.9 
C-6 124.5 126.6 125.2 114.3 127.8 133.0 116.9 117.7 120.1 117.3 116.0 
C-7 128.9 139.0 134.7 162.9 123.0 94.8 160.3 147.9 127.6 159.9 147.2 
C-8 129.8 128.9 128.7 113.3 132.1 138.7 108.1 125.9 127.6 108.5 110.4 
C-4. 148.4 148.6 149.1 150.0 149.9 150.0 150.2 147.9 147.7 147.6 150.0 
C-Ba 149.9 149.9 149.8 149.9 149.4 149.5 150.1 149.6 149.7 152.3 150.0 
61-65,81 
C 61 62 63 64 65 81 
C-2 151.6 151.2 151.1 150.7 151.1 151 .1 
Col 103.6 98.3 98.6 98.8 99.0 98.5 
C-4a 118.8 119.2 119.2 119.3 119.6 119.2 
C-5 120.3 121.8 122.0 122.6 119.1 121.8 
C-6 124.7 124.2 124.2 124.4 124.5 124.3 
C-7 129.3 129.1 129.1 129.4 128.9 129.1 
C-8 129.7 129.4 129.4 129.0 129.8 129.4 
C-4 148.8 148.5 148.7 148.2 148.4 148.7 
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Melting Points and Microanalysis of 4-Aminoquinolines and 7-X-4-Aminoquinolines 
The melting pOints of all the crystalline compounds were compared to literature values 
where appropriate and combustion analysis was obtained to ensure analytical purity (Table 
2.8). 
Table 2.8. Characterisation of 4-Aminoquinolines and 7-X-4-Aminoquinolines 
No. Observed Literature Microanalysis 
mp/oC mp/oC Calcuated I % Found I % 
C H N C H 
61 151 - 153 151 - 152, Den Hertog et al. 1967; 149- 75.0 5.6 19.4 74.8 5.7 
150, Tondys et al. 1985. 
62 233 dec. 227 - 227.5, Luthy et al. 1949; 231 - 232, 75.9 6.4 17.7 75.8 6.6 
Watanabe et al. 1980. 
63 139 Novel 70.2 6.4 14.9 69.6 6.7 
64 211-212 Novel 59.1 6.3 18.8 59.0 6.5 
65 82 Novel 74.0 8.7 17.3 74.0 8.8 
66 164 -165 Novel 75.9 6.4 17.7 75.7 6.5 
67 102 - 105 99 - 103.6, Patent US2940974 1960. 74.7 9.0 16.3 74.6 9.4 
68 134 105 - 110, Price et al. 1946, 152 - 154.4, 
Roseman et al. 1970, 146 - 147, Lin and 8 8 
Loo 1978. 
69 245 245 - 246, Craig and Pearson 1968. 62.3 4.7 14.5 62.5 4.6 
70 146 - 148 Novel 
71 217-218 214, Elderfield et al. 1946. 59.3 5.0 12.6 59.2 5.0 
72 137-139 137 - 139, Pearson et al. 1946. 59.6 5.5 19.0 59.6 5.6 
73 122 - 124 121 - 122.8, Surrey et a/1959. 62.5 6.5 16.8 61 .7 6.6 
74 106 - 108 92, De et al. 1997. 64.9 7.3 15.1 64.7 7.3 
75 81 - 82 72 - 73, De et al. 1998. 68.9 7.7 16.1 69.1 7.8 
76 120 -121 111-112, De etal. 1998. 55.9 6.3 13.0 56.0 6.4 
77 133 -136 131 -132, De et al. 1998. LUI. 8 5.5 11.4 48.8 5.7 
78 98-99 94 - 95, De et al. 1998. 70.3 8.5 15.4 70.4 8.8 
79 110-113 Novel 62.5 7.0 19.4 62.8 6.7 
80 121 - 123 122 - 123, De et al. 1998. 61.7 6.5 13.5 61 .9 6.4 
"The melting point is strongly dependent on the degree of hydration of the compound . When hydrated the melting 
point is 105 - 110°C, but rises substantially after extensive drying (Price et al. 1946). Due to this phenomenon, 
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2.3.6. Alternative Routes to 4.Aminoquinoline 
4-Aminoquinoline was also synthesised in this project by the Chichibabin reaction 
(Chichibabin and Seide 1914) in which treatment of a heterocyclic base, such as quinoline, 
with a metal amide in the presence of a hydride ion acceptor gives predominantly the 2-
substituted amino-product. The amination procedure of Tondys et al. was followed in which 
thermodynamic control results in production of 4-aminoquinoline as the main product 
(Scheme 2.14) (Tondys et al. 1985). The immediate product of the reaction is 61a, the metal 
salt of 61 (McGill and Rappa 1988). Protonation of this metal salt during aqueous work-up 
then generates 4-aminoquinoline 61. Prior to aqueous work-up, the reaction mixture was 
warmed to DOC, resulting in rapid evaporation of the ammonia which caused spluttering of 




001 ---~ _rIio... N 
N~ 61 618 
Scheme 2.14. Synthetic route to 4-aminoquinoline where T represents thermodynamic and K represents kinetic 
control. Reagents and Conditions: i. NH~KNH2. ii. KMN04 , aq work-up. 
A third route to 4-aminoquinoline was achieved by reducing 4-nitroquinoline-1-oxide in a 
solution of H2, 1 D% Pd-C, acetic acid, acetic anhydride and ethanol at room temperature for 
7.5h (Ochiai 1953) to give 61 in a 65% yield (Scheme 2.15). Longer reaction times resulted 
in unwanted side products due to over reduction . 
... 
Scheme 2.15. Reduction of 298 to 4-aminoquinoline. Reagents and Conditions: i. H2, 10% Pd-C, CH3COOH, 
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2.3.7. Synthesis of the Remaining Analogues 
The remaining analogues 81, 82 and 83 were synthesised according to Schemes 2.16., 
2.17. and 2.18. respectively and are characterised in Table 2.9. 
The terminal amino group of 64 was acetylated using acetic anhydride and triethylamine to 
give analogue 81 in a 78% yield (Scheme 2.16). 
/'... ~NH.2 
HN' "'-..,/ 




cOl ~ 0 :::::-... h-N 
81 
78% 
Scheme 2.16. Acetylation of 64. Reagents and Conditions: i. Acetic anhydride. EllN. ll-lF. OOC. 
Since difficulties were experienced in synthesising 7-hydroxy-4-chloroquinoline via the 
cyclisation route of Price and Roberts, 82 was synthesised by treatment of the methoxy-
analogue 78 with boron tribromide at -13°C for 40h to form the hydroxy product (Scheme 
2 .17). 
Scheme 2.17. Preparation of 82. Reagents and Conditions: i. BBr3. CH2CIz. -78°C 
Analogue 83 was synthesised by room temperature reduction of 79 in a hydrogen 
atmosphere over 10% Pd-C for 22h (Vippagunta et al. 1999). The product was then isolated 
and purified using neutral alumina chromatography to give 83 in a 78% yield (Scheme 2.18) . 
.. 
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Compound 81 was purified by crystallisation and characterised by a sharp melting point 
combustion analysis (Table 2.9). Compounds 82 and 83 were oils were 
by High Resolution Spectroscopy (HRMS). 
Table 2.9. Characterisation of 81-83 
No. Observed literature Microanalysis 
mp/oC mp/oC Calculated I 0/_ Found I % 
C H N C H N 
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THE BEHAVIOUR OF Fe(III)PPIX IN AQUEOUS SOLUTION 
3.1. BACKGROUND 
As described in Chapter 1, there is considerable evidence that haem (Fe(III)PPIX), released 
from haemoglobin into an aqueous environment (pH 5.4) is the target of chloroquine and 
related antimalarial drugs. Chloroquine interacts with the aqua- or hydroxy- form of haem 
known as haematin (H20-Fe(III)PPIX or HO-Fe(III)PPIX) to form a 1[-1[ Fe(III)PPIX-
chloroquine complex which then ultimately leads to a toxic effect on the parasite. In order to 
probe which structural features of chloroquine are important in complex formation, we 
needed to understand the behaviour of Fe(III)PPIX in aqueous solution. 
3.1.1. The Behaviour of Fe(III)PPIX in Haemoglobin 
Haemoglobin (Hb) acts as an oxygen-transport protein by reversibly binding oxygen to haem 
iron (Figure 3.1.). There are four haem groups per protein and they are situated in 
hydrophobic pockets within the globin structure. Haem in deoxy-Hb (84) (Figure 3.1.) 
consists of high-spin ferrous iron (HS Fe(lI)) situated out of the plane of a tetrapyrrole 
protoporphyrin ring with a proximal histidine ligand occupying the fifth coordination site. 
Owing to the ~teric positioning of a nearby distal histidine residue, oxygen binds weakly to 
the sixth coordination site through a bent bond. This weak interaction causes only partial 
oxidation of HS Fe(lI) to the smaller low-spin ferric iron (LS Fe(III)), which then moves into 
the plane of the porphyrin ring 85 (Rawn 1989, Buchler 1978). 
84 
HS Fe2+ 
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Figure 3.1. (left) structure of haemoglobin containing four haem units (Campbell 1991). (right) reversible binding 
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The large globin protein provides a sterically hindered, hydrophobic cage that protects the 
porphyrin ring and the haem iron from irreversible oxidation. When haem is released from 
haemoglobin into an aqueous environment, the ferrous iron rapidly binds oxygen in a strong 
linear bond (Figure 3.2.) (Hoard 1971) and is irreversibly oxidised to HS ferric iron with the 
production of superoxide (Gutteridge 1989). In water, the vacant fifth coordination site is 
occupied by OH- or H20 ligands forming hydroxo- or aquaferriprotoporphyrin IX (86 or 87 


















o II _ 
c-o 
87 
Figure 3.2. Irreversible oxidation of haem iron in water to form hydroxoferriprotoporphyrin IX (86) and 
aquaferriprotoporphyrin IX (87). 
Crystal structures and Mossbauer spectra of chloroferriprotoporphyrin IX (haemin) and 
related HS ferric porphyrins have confirmed that the geometry of these complexes are 5-
coordinate, square pyramidal (C4V) with the ferric ion displaced out-of-the-plane of the 
porphyrin ring (Figure 3.3.) (Koenig 1965, Hoard et al. 1965, Hoffman et al 1972, Hoard 
1971, Fleischer and Srivastava 1969, Moss at al. 1969). 




















Chapter 3: The Behaviour of Fe(III)PPIX in Aqueous Solution 76 
3.1.2. Characterisation of the J.L-oXO dimer 
Aqueous haematin solutions are difficult to work with as haematin is known to adhere to 
surfaces (Brown 1968) and precipitate below pH 6 (Dzekunov et al. 2000). Furthermore, 
aged solutions undergo slow spectroscopic changes indicative of either higher aggregation 
(Davies 1940, Shack and Clarke 1947) or molecular modification (Brown et al. 1968, Shack 
and Clarke 1947). This behaviour of haematin is attributed to the strongly polar carboxyl 
groups and the labile vinyl groups on the protoporphyrin IX ring . To overcome these 
limitations, synthetic derivatives of haematin are often used. Removal of the vinyl groups 
gives ferrideuteroporphyrin IX (88) or conversion of the carboxyl groups to the less polar 
dimethyl ester derivatives gives ferriprotoporphyrin IX dimethyl ester (89), 
ferrimesoporphyrin IX dimethyl ester (90) and ferrideuteroporohyrin IX dimethyl ester (91) 
(Figure 3.4.). Ferritetraphenylporphyrin IX (92), which can be prepared from pyrrole in one 




No R R Abbreviation 
87 CH=CH2 H Fe(III)PPIX 
88 H H Fe(III)DP 
89 CH=CH2 CH3 Fe(III)PPIX~DME 
90 CH2CH3 CH3 Fe(III)MESO~DME 
91 H CH3 Fe(III)DP~DME 
Figure 3.4. Synthetic modification of haematin 87 to the more stable porphyrin derivatives 88-91 . 
It has long been known that fresh aqueous solutions of haematin consist of monomers and 
dimers (Davies 1940, Shack and Clarke 1947). In water-dimethyl sulphoxide (DMSO) 
mixtures, haematin is monomerised at acid or neutral pH, presumably by formation of a 
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Since precipitation haematin from aqueous alkaline solution solid sodium hydroxide 
gives a I-l-OXO dimer (i2) (Brown et al. 1969) (Figure 3.5.), it has long been thought that this 
is dimeric ::;lJt~GIt:::s present in aqueous solution (Brown et al. 1970). 
12 
Figure 3.5. ,..--axo dimer of haematin 12. 
This I-l-DXO dimer, can also be synthesised by (i) addition of water or alumina to the 
monomer in chloroform (Sadasivan al. 1969, and Srivastava 1969); (Ii) 
treatment of the monomer with pyridine followed by alumina chromatography (O'Keeffe and 
Barlow 1975) or (iii) autoxidation dipyridine Fe{II}OP-OME monomer in 
(Alben et a/. 1968). 
The crystal of the I-l-DXO dimer of 92 is consistent with the square-pyramidal five 
coordinate is typical ferric In this case, both the iron 
centres are displaced 0.5A from the plane of the porphyrin ring towards the oxo-ligand 
with the two iron centres antiferromagneticafly coupled through a near linear 174.5° oxo-
linkage (Hoffman et al. 1972, and Srivastava 1969). Magnetic susceptibilities and 
Mossbauer of the haematin j..l-DXO dimer (Lucas Silver 1983, et 1982) 
and various j..l-DXO Fe(III)OP-OME (O'Keeffe and Barlow 1975, Torrens et a/. 1972, 
Cohen 1969) are consistent with two spin (S ::: ions antiferromagnetically 
coupled to other. A distinctive infrared absorption band between 800cm·1 and 900cm-1 , 
assigned to a V3 asymmetric stretching vibration of the bond (Brown et al. 1969), 
has often for quick identification of the j..l-Dxo-<limer. The Uv-vis of the 
.... -L .... V.C dimer in chloroform shows a and a shoulder at 590nm j..l-DXO 
(Sadasivan et 1969) (Figure 3.6. left). The data in 3.6 (right) show that this peak 
and shoulder are largely substituent independent. Comparison of Figure 3.6 (left) with 
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Figure 3.S. (left). UV-vis spectrum of (-) Fe(I/I)DP J,l.-:'oxo dimer and ( .. ,) CI-Fe(1I1)DP monomer in chloroform 
:saaa~)lvGIn et al. 1969). (right). UV-vis of J,l.-<lXO Fe(III)DP-DME derivatives in benzene where the 
hydrogens at pOSitions 2- and 4- are substituted for: A, B, ethyl; C, i-(ethoxycarbonyl)cyclopropyl; D, 
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3.1 Evidence for the Existence of Higher Aggregates in Aqueous Solution 
Inada and and Srinivas and Rao, both nn'~j:Jof'\Je:>n tINO rate constants for the 
formation of dimers and higher aggregates in non-buffered haematin solutions (Inada 
and Shibata 1 Srinivas and Rao 1990). Kuzalova et al. further supported these 
in phosphate-buffered (pH 7.4) solutions by measuring binding of monomeric 
haematin to albumen. In fresh solutions rate of binding was dependent on the 
dissociation dimers to monomers (Kuzalova et al. 1997). This dissociation process was 
biphasic in aged solutions and thus suggested to provide support for the formation higher 
aggregates over time. 
Haematin has however been shown to undergo slow autoxidation in phosphate buffered 
solutions (pH 11) (Figure 3.7.) (Brown et 1968, Shack and Clarke 1947). This been 
attributed to the slow oxidation of the vinyl groups of haematin as Fe(III)DP (Brown a/. 
1968) and ferrihematoporphyrin (Marques 1992). in which the vinyl groups are replaced by 
hydrogens or hydroxyethyl groups respectively. show no such behaviour. Since authors 
studying the higher aggregation of haematin did not take precautions autoxidation, 
their spectral changes to aggregation may have been due to the appearance of an 
oxidised product. Definitive evidence of higher aggregation in aqueous solution is thus 
lacking. By contrast, it is well established that metal protoporphyrin undergoes extensive 
aggregation in aqueous solution (Brown and Shillcock 1976). 
Figure 3.7. Spe!ctr()SC()pic ~h.l'lfml"':; associated with ageing haemalin in nnn,SDI'1181f! buffer, pH 11 ; ( fresh 
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3.1.4. Existence of the JL-Gxo-dimer in Aqueous Solution 
Although there is unequivocal proof for the existence of the JL-oxo-dimer, it is clear that 
this is the Spt~CIE!S present in aqueous solution. Silver have provided 
indicating that Mossbauer spectra of frozen haematin solutions are composed of 
monomers at low pH JL-oxo-dimers at pH (Silver and 1983). The authors also 
recorded uv-vis of 50JLM in fresh aqueous solution and assigned the 
limiting spectrum at low pH to the monomer and at high pH to the JL-oxo-dimer 
suggesting that formation of the two species are pH-dependent (Figure ). These authors 











dimers in aqueous 
pH 5.9 13.0 
Figure 3.S. (left) UV-vls spectra of 50J.1M haematin in aqueous solution at pHs L...J 5.9, 7.6, L __ ) 8.2 
and ( ...... ) 13.0. Note the maximum at 610nm which does not to the distinctive peak and 
shoulder in the I-l-oxo-dimer at 590 and 567nm. pH dependent monomer and woxo-dimer haemalin 
species proposed to exist in aqueous solution (Silver and Lucas 1983). 
3.1.4.1. Spectrophotometric Study by Brown et al. 
The most extensive study of haematin dimerisation was out by Brown et in 1970. 
It has frequently cited as of JL-oxo dimer formation in aqueous solution 
(Brown et a/. 1 In this study, a pH dependent dimerisation 
constant in aqueous solution. Brown et al. collected spectra of the region of Fe(III)DP 
(384nm) and Fe(III)PPIX (394nm) in the range - 2x10-4M at pH 6.98, 
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coefficient and a flattening of the Soret band with increasing ferrihaem concentration. This 
was interpreted as evidence for the existence of monomers at low concentration and dimers 
at high concentration. In the case of Fe(III)PPIX, the Soret band is flattened even at the 
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Figure 3.9. Illustration of the drop in extinction coefficient of ferrihaems (pH 6.98) with increasing concentration 
for (--) Fe(III)DP and ( ......... ) Fe(III)PPIX. Concentrations: a, 2x10-7M; b, 7x10-7M; c. 7x10-9M; d, 2x10-4M; e, 
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This process was also shown to be apparently pH dependent with increased sharpening of 
the Soret bands at low pH. The extinction coefficient of the Soret band of Fe(III)PPIX and 
Fe(III)DP were recorded between concentrations of 2x 10-7 and 2x 10-4M in the pH range 6.5 
to 11 .0 and found to follow a sigmoidal relationship when plotted on a log scale (Figure 








80 x 50 -... 
OJ 
60 45 
1x10'7 1x10" 1x10·5 1x10-4 1x10-7 1x10'" 1x10·5 1x10" 
Concentration I M Concentration I M 
Figure 3.10. Concentration and pH dependence of £384 for (A) Fe(III)DP . • , pH 6.64; ll, pH 6.98; D, pH 7.38; ... , 
pH 8.04; 0, 11.0 and (B) Fe(III)PPIX ., pH 6.98; ll, pH 7.38; D, pH 8.04; ... , pH 11 .0 (Brown et al. 1970). 
The absence of intermediate steps in the curves was taken as evidence that aggregation 
beyond f.I.-oXO dimers does not occur and the following pH dependent relationship was 
envisaged: 
2M 
K (1 ) 
where M represents the Fe(III)PPIX and Fe(III)DP monomers and D their respective dimers. 
K is the dimerisation constant and n an integer corresponding to the number of protons 
released upon dimer formation . 
The equilibrium expression for (1) can be written as follows: 
(2) 
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K _ K = [D} 
obs - [HF [Mf (3) 
Taking the log of (3) gives a linear relationship between log Kobs and pH with a slope equal to 
the number of protons released in the dimerisation process and the y-intercept equal to log 
K. 
log Kobs = log K + npH (4) 
3.1.4.2.Determination of log Kobs 
The extinction coefficients of the monomers (I>M) and dimers (1)0) at the various pH's were 
read off or extrapolated from the curves in Figure 3.9 and used to obtain the respective KobS 
values by linearisation methods. This was done relatively easily for Fe(III)DP where the 
limiting values of I>M and 1>0 could be read off the curves directly. 
For Fe(III)PPIX, the extent of dimerisation is high even at the lowest pH and concentration 
and hence it was possible to obtain limiting extinction coefficients for the dimer but not for 
the monomer. Here the authors assumed that the values of I>M for Fe(III)PPIX are Similar to 
those of Fe(III)DP and used these values to calculate Kobs for Fe(III)PPIX. 
3.1.4.3. Determination of K and n 
Plots of log Kobs against pH for both Fe(III)DP and Fe(III)PPIX were fitted to straight lines 
with unit slopes and K was found to be 1.9 x10-2 for Fe(III)OP and 4.5 for Fe(III)PPIX by 










Chapter 3: The Behaviour of Fe(lIl)PPIX in Aqueous Solution 84 
9 
6 7 8 
pH 
Figure 3.11 . Dependence of Kobs on pH for a . • Fe(lIl)DP and b. 0 Fe(III)PPIX (Brown et al. 1970) 
In addition to Fe(III)PPIX and Fe(lIl)DP, a range of other iron porphyrins have been found 
undergo a pH dependent dimerisation with the release of a single proton (Brown et al. 1976). 
Fleischer et al. found that the water soluble tetrasulfonated tetraphenylporphyrin IX 
(Fe(lIl)TPPS), releases two protons upon dimer formation (Fleischer et al. 1971). 
The haematin dimerisation constant obtained by Brown et al. has been accepted and used 
in malaria related research to describe interactions between chloroquine and the drug target 
(Vippagunta et al. 1999, Dorn et al. 1998). 
3.1.4.4. Reasons for Repeating the Study of Brown et al. 
It was decided to repeat the study by Brown et al. for the following reasons: 
1. The authors did not have access to computerised non-linear least squares fitting 
procedures in the 1970's and therefore manipulated their data by linearisation methods 
which can introduce distortions into the analysis through unequal weighting of data pOints 
(Motulski 1995). Another advantage of non-linear regression is that parameters do not need 
to be fixed on the basis of extrapolated values, but all parameters can be refined 
simultaneously, removing further sources of error from the analysis. 
2. Since the authors were unable to obtain values of EM for Fe(III)PPIX, they made 
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true, considering the very different behaviour and solubilities of the two porphyrins in 
aqueous solution. Today we have access to more sensitive uv-vis spectrophotometers and 
better data fitting techniques which may enable us to obtain these limiting values for the 
Fe(III)PPIX monomer. 
3. The authors studied haematin in phosphate buffer and used sodium chloride to adjust the 
ionic strength. This may have introduced additional species into their systems as both 
phosphate (Parapini et a/. 2000) and chloride (Koenig 1965) can act as axial ligands to 
haematin. This can now be circumvented by using non-coordinating buffers (e.g. MES, 
HEPES and CHES) and by the judicious choice of salts (e.g. sodium perchlorate). 
4. Owing to the low solubility of Fe(III)PPIX below pH 6 and the inability to obtain an 
estimate of EM for Fe(III)OP above pH 8, the authors obtained only three log Kobs values for 
Fe(III)PPIX between pH 7 and 8. Their final determination of K is therefore dependent on a 
straight line fit through only three data points extrapolated from pH 7 to the origin at pH O. 
5. Finally, since today haematin and the haematin ~-oxo dimer are known to be five-
coordinate (Koenig 1965, Hoard 1971, Fleisher and Srivastava 1969, Hoffman et al. 1972), it 
is difficult to interpret the finding of Brown et al. that dimerisation involves a single 
deprotonation (Equation 5). 
2M 
K (1 ) 
In aqueous solution, haematin is likely to exist as two pH-dependent forms with either H20 or 
HO- as the axial ligands whereas the ~-oxo dimer likely exists as one species only, 
irrespective of pH. In theory, these three species should give rise to two pH-dependent and 
one pH-independent equilibria in aqueous solution (Figure 3.12.) with Equation 5 
predominating at low pH, Equation 6 around the pKa of the axial ligand and Equation 7 at 
high pH. The slope of log Kobs against pH is predicted to correspond to two deprotonations at 
low pH, one around the pKa and none at high pH. On the contrary, Brown et al. observed a 
slope of one over their entire pH range even though they covered a large enough range to 
observe non-linearity. By contrast to Fe(III)PPIX, Fe(III)TPPS dimerises with release of two 
protons, indicating that this iron porphyrin does indeed form a ~-oxo dimer (Fleischer et al. 
1971). This further demonstrates that extrapolation of the behaviour of one iron porphyrin to 
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(4) 
Figure 3.12. (A). Predicted equilibria between monomeric and ~oxo dimeric ferrihaem in aqueous solution 
(Equations 5, 6 and 7). (B) The expected relationship between logKobs and pH (Equation 4) should be a straight 
line with a limiting slope of 2 at low pH (n = 2), 1 around the pI<.. of the axial ligand (n = 1) and 0 at high pH (n = 
0). This predicted plot of logKobs vs pH is different from that observed by Brown et al. who found a slope of 1 over 
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3.2. RESULTS AND DISCUSSION 
3.2.1. Determination of ex, f3 and log Kobs by Non-Linear Least Squares Fitting 
3.2.1.1 . Spectra of Haematin in Aqueous solution 
Spectra were collected for haematin in 50mM HEPES buffer in the same pH range as Brown 
et al., namely between pH 6.9 to 8.0. The ionic strength was corrected to the physiological 
ionic strength of 154mM using sodium perchlorate (Figure 3.13.). 
[High haematin] 
1 4 1.4 
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Figure 3.13. Spectra of haematin in SOmM HEPES buffer, J.l = 154mM at pH 6.9 (left) and 7.7 (right) from 
2.0x10·7 t04.2x10·6M haematin showing the position of the (- ) N (0,0) band (361nm) and the (-) Soret B (1,0) 
band (395nm). 
As observed by Brown et al., a drop in intensity of the Soret band ( - ) relative to the N-
band ( - ), and broadening of the Soret band occurs with increasing haematin concentration 
and pH. This flattening of the Soret is further accompanied by a simultaneous relative 
increase in intensity of the N band. Furthermore the apparent position of the Soret band 
appears to shift from 398nm at low concentration to 387nm at higher concentrations. 
Spectra were collected under an argon atmosphere to prevent haematin from undergoing 
slow autoxidation (Brown and Shillcock 1976). We were prevented from obtaining data 
below the limiting haematin concentration of 2x10·7M used by Brown et al. due to excessive 
data scatter in this region. A plot of absorbance at 389nm against haematin concentration 























0.Ox10'CO 1.0x10·oo 2.0x10.oo 3.0x10.oo 4.0x10·oo 
[Haematin] I M 
Figure 3.14. A Beers law plot of A:Jag vs haematin concentration in aqueous buffer at pH 6.92 
88 
In principle, such deviations can be used to model dimerisation and aggregation behaviour 
in porphyrins (White 1978, Munro and Marques 1996). In the case of haematin, however, 
this approach could not be used as the limiting extinction coefficient for the monomer was 
too poorly defined due to significant aggregation at even the lowest concentration. An 
alternative approach, where the extinction coefficient was plotted as a function of 
concentration also gave unsatisfactory results because of excessive data scatter at low 
concentrations. For this reason absorbance ratios as opposed to absolute absorbances 
were plotted at the apparent positions f the Soret (8 (1,0» (395nm) and the N (0,0) 
(361 nm) bands (Mavuso pHD thesis 2001) in which the latter absorbance approximates to 
an isosbestic point (Figure 3.1 .5.) 
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Figure 3.15. Position of the wavelengths used in to obtain the absorbance ratios (~AJs1) for determination of 
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3.2.1 .2. Derivation of the Dimerisation Equation 
The following Beer's law relationship applies: 
At At + At = etca + etcb 







a and A/ are the absorbances of the monomer (a) and dimer (b) at 395nm 
(1) and 361 nm (2). Similarily, c1 a , c1 b, c2a and 8/ refer to the corresponding extinction 
coefficients of the monomer (a) and dimer (b) at 395nm (1) and 361 nm (2). Ca and Cb represent 
the concentrations of the monomer (a) and dimer (b) respectively. 
Dividing the top and bottom by (ca + Cb) leads to 
(6) 
In the special case where the absorbance at 361 nm (b) is an isosbestic point 82a ~82b. In this 
instance, 82a and 82b can be interchanged in the demononator of Equation 6 to give Equation 
7. 
(7) 
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Regrouping: 
= = and = = 
And --=-- fraction of haematin in fonn of the monomer if,,) and --"-- == the 
fraction of haematin in the fonn of the dimer (jd), Equation 8 can be written which is only true 
in case where the absorbance at 361 nm is an isosbestic point. 
(8) 
Equation 8 was therefore used to fit the absorbance ratios collected at 395nm and 361 nm to 
the dimerisation equation (See Section 7.2.2.2.5. for derivation of the model). 
3.2.1.3. Analysis of Data 
Absorbance ratios (A1/A2 ) were collected for haematin in the same pH range as Brown et 
namely between pH 6.9 to 8.0, and fitted to the dimerisation equation using non-linear least 
procedures Section for derivation of the model). In 
with Brown at a/., data gave excellent fits to the dimerisation equation with no 
evidence of higher aggregation (Figure 3.16.). 
As observed by Brown at al.. the limiting absorbance ratio of the monomer is never reached 
although this value appears to increase with decreaSing pH. At high haematin 
concentrations, the curves flatten off significantly to the limiting absorbance ratio of the d imer 
which to slightly with pH. describing this 
behaviour were extracted from the dimerisation equation namely: 0., the absorbance ratio of 
the pure monomer; 13. the absorbance ratio of the pure dimer and log Kobs, the log of the pH-
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Figure 3.16. Graphs of experimental data (e) fitted to the dimerisation equation (-) using non-linear least 
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Table 3.5. Mean ± SO for a, p and log Kat>; calculated by non-linear least squares fitting to the dimerisation 
equation. 
pH a p log Kobs 
6.92 2.7± 1 0.82 ±0.06 6.6±0.5 
7.19 2.6±0.3 0.87 ±0.03 7.0 ±0.4 
7.39 2.5 ±0.3 0.89 ±0.01 7.1 ±0.2 
7.69 1.9±0.5 0.91 ± 0.01 6.8 ± 0.5 
7.99 2.0 ± 0.1 0.91 ± 0.02 6.97 ± 0.04 
Mean 2.34 ±0.36 6.89± 0.20 
Since there is relatively little monomer present even at the lowest concentrations, scatter in 
the a. values is large. Furthermore, a strong cross-correlation exists between log Kobs and a. 
which further adds to the uncertainty in these a. values. Contrary to the findings of Brown et 
a/., no significant correlation was found to exist between log Kobs and pH even though a large 
enough pH range was covered, implying that K is pH-independent and dimerisation does not 













Figure 3.17. Plot of log Kots vs pH for fitted data obtained from the dimerisation equation allowing all three 
parameters ct, p and log Kat>; to refine freely. 
Considering the strong cross-correlation between a. and log Kobs, the possibility that this lack 
of dependence could be artifactual was then explored. If it is assumed that the decreasing 
value of ~ with pH is an artifact of its correlation with log Kobs, and a. is fixed at the mean a. 
value of 2.34, log Kobs and f3 can be recalculated from the dimerisation equation to obtain a 
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Table 3.6. Mean ±SD for 13 and log Koo.. calculated by fixing a = 2.34 in the dimerisation equation. 
pH P log Kobs 
6.92 0.8 ± 0.1 6.4 ± 0.3 
7.19 0.87 ± 0.03 6.9 ± 0.2 
7.39 0.88 ± 0.01 6.9 ± 0.1 
7.69 0.93 ± 0.02 7.4 ±0.2 
7.99 0.92 ± 0.02 7.3 ± 0.1 
A plot of log Kobs vs pH now gives a straight line with slope of 0.9 ± 0.2 which is similar to the 
slope of 1 obtained by Brown et al. (Figure 3.18.). If this slope is then fixed at 1, a 
dimerisation constant of K = 0.35 is obtained. This constant is more than an order of 
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Figure 3.18. Plot of log Koo.. vs pH for LogKobs calculated by fixing a = 2.34 in the dimerisation equation. 
3.2.2. Independent Determination of ex 
Since the values of log Kobs are only well defined when ex is fixed, use of the mean from fitted 
data is arbitrary and difficult to justify. A method was sought to measure 0. for the pure 
haematin monomer, independently. This is problematic as the limit of the monomer cannot 
be reached in aqueous solution and non-aqueous solvents may displace the axial H20 or 
OH- ligands of haematin. Dimethyl sulfoxide (DMSO) monomerises haematin presumably by 
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Figure 3.19. UV-vis spectrum of haematin in DMSO, a = 3.22. 
The detergent sodium dodecyl sulphate (SDS) has been shown spectrophotometrically to 
monomerise haematin by formation of a 1:1 haematin-micelle complex (Simplicio 1972, 
Simplicio and Schwenzer 1973, Figure 3.20.). It was therefore decidied to dissolve haematin 
in 2% SDS as a method to obtain monomeric haematin in an aqueous milieu. The nmr 
spectrum of 2% SDS in D20 shows smallest paramagnetic shifts in the peak positions of the 
methylene protons adjacent to the sulfonate group (ilD = 0.033ppm) upon addition of 
0.24mM haematin, with larger shifts in the terminal methyl (ilD = 0.038ppm) and methylene 
protons (ilD = 0.047ppm). This indicates that monomerisation is induced by haematin 
embedded within the micelle and not by axial coordination of a sulfonate group to Fe(III). 
Figure 3.20. (left). structure of SDS. (right). proposed monomerisation of haematin in SDS by formation of a 1: 1 
haematin-micelle complex (Simplicio 1972). 
Spectra of haematin in SDS and two other detergents, polyoxoethylene (10) isooctylpentyl 
ether (TRITON X-100) and polyoxoethylenesorbitan monolaurate (TWEEN-20) were 
recorded in HEPES buffer at pH 7.2 and 8.0. The soret region was not very informative as in 
all cases it remained flattened except in the case of SDS where it became sharpened 
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on the nature of the haematin species in aqueous solution, only this part of the spectrum 
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Figure 3.21. Visible spectra of haematin in (A) 3% TRITON X-100, (8) 2% TWEEN-20 and (C) 2% SDS at pH 
7.2 and pH 8. O. For comparison (D) visible spectrum of haematin in HEPES buffer (pH 6.5) and CHES buffer (pH 
10) (D). 
Spectra of haematin in 3% TRITON X-100 and 2% TWEEN-20 (Figure 3.21A. and 3.21B.) 
are characteristic of the j.l.-0XO dimer at both pH 7.2 and 8.0, indicating that these two 
detergents, in fact, induce j.l.-0XO dimer formation and not monomerisation. Spectra of 
haematin in 2% SOS at pH 7.2 and 8.0 (Figure 3.21 C.) appear to represent the proposed 
haematin-micelle complex as they are different from both the j.l.-0XO dimer and haematin in 
purely aqueous solution. In this case, ex. = 1.74 at both pHs, implying that the presence of 
this haematin monomer is pH-independent. In order to ensure that 2% SOS, pH 8.0 is the 
limiting spectrum of the monomer, ex. was recorded in varying percentages of SOS from 
0.25% to 3.0% in the pH range from 7.2 to 10.1. In all cases a ratio close to 1.74 was 
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1.74 ± 0.02 
for mixtures of 
monomer dimer in aqueous solution and hence cannot be a pH-independent value for 
monomeric in aqueous solution at pH 5. It was decided to in\l'es·tim3te 
another non-coordinating solvent, 
The of haematin in dry 
haematin in solution (Figure 
is again different 
and the value of C(. is 
the J..L-oXO dimer and 
1.74. In this system, 
C(. is very sensitive to the presence of with only a few percent a large increase 
in the of C(. at low pH. This effect is further dependent on with the largest increases 
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Figure 3.22. (B) Effect of percentage water and pH on a. in buffered water-methanol systems at pH ( - ) 10.03, 
( - )8.00, ( - ) 7.41 and (-) 5.99. 
At neutral and low pH, there is a sharp rise in the a. ratio from 1.74 in pure methanol to a 
value which plateaus in 10 - 30% water-methanol and then declines in higher water 
percentages indicative of the onset of dimerisation . This increase in the a. value is most 
pronounced at low pH and is completely absent at pH 10 where the ratio remains at 1.74 
until the dimer starts to form. The fact that the value of a. in non-aqueous environments 
(strictly dry methanol and the hydrophobic core of SDS micelles) is essentially identical to 
that in basic aqueous methanol solution (around 1.74) indicates that this a. value is solvent 
independent and corresponds to a haematin monomer in which hydroxide is the ligand. In 
hydrophobic environments, it is possible that the pKa of the propionate groups and axial 
water increase and decrease respectively to generate a formally neutral, non-polar haematin 
monomer 86 (Figure 3.23.). Upon addition of a few percent of acidic or neutral aqueous 
medium to methanol, the pH dependent zwitterionic and charged species 87a is likely to 
form. Upon the addition of alkaline aqueous medium to the dry methanol solution, it is likely 
that the carboxylic acid side chain deprotonates and hydroxide remains as the axial ligand to 
give species 87b which has the same a. value as the spectrum arises from the porphyrin 
core. The intermediate a. values (Table 3.B.) probably correspond to mixtures of the two 
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+ H+ !II> Dimerlsatlon 
86 87a 87b 
Melhanol 10-30% H20-Melhanol 30-100% H20-Melhanol 
0:=1,74 0: = 3,60, pH 6.0 0: = 1.74, pH 10,0 
Figure 3.23, The haematin monomers in methanol (86) and 10-30% H20-Methanol mixtures (87a and 
87b). Since Fe(lll) carries a +3 charge, the porphyrin nitrogens carry a -2 charge and the HO'ligand carries a-1 
charge, the overall on 86 and 87a is zero, since 87a Zwitterionic. ~im,jl",riI\J the overall on 87b is 
1- as the on the H20 ligand is zero, 
Table 3.8. Umiting \X values of haematin in 10 - 30% water-methanol mixtures as a function of pH 
6.51 3.25 ±0.08 
6.89 3.23 ±0.02 
7.19 2.96 ± 0.01 
7.41 2.82 ± 0.01 
7.73 2.48 ±0.01 
8.00 2.22 ± 0.Q1 
9.22 1.80 ± 0.01 
10.03 1.71 ± 0.01 
Relatively large errors are associated with the a. values at the two lowest pHs investigated. 
This is probably due to the onset of haematin precipitation in the low pH range. To check 
where the onset of precipitation begins, C:!:Ilmnlt3C: of 1.951J.M haematin in 
buffer between pH 5.1 and 8.0 were stirred for 30mins and then centrifuged. This haematin 
concentration was chosen as it is the same as that used in the Fe(III)PP1X-quinoline binding 
assays. In the low pH samples a black pellet formed on the bottom of the tube after 
centrifugation indicative of precipitation. A plot of the absorbance of the Soret band as a 
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Figure 3.24. Absorbance of the Soret band for 1. 95~M haematin as a function of pH. 
If the limiting ex. values reported in Table 3.8. represent average values for mixtures of 
protonated and deprotonated monomer species, (87a and 87b respectively), the equilibrium 
constant for this deprotonation process should give the pKa of the axial H20 ligand in the 10 




pKa OH I 
-Fe- + H+ (8) 
87a 87b 
When the absorbance ratios were fitted to an equilibrium equation (Derived in Chapter 7.2) 
for a single deprotonation using non-linear least squares fitting procedures an excellent fit 
was obtained with the pKa of the axial ligand being 7.56 ± 0.07 (Figure 3.24.). This is in good 
agreement with the pKa value of 7.6 reported by Shack and Clarke for ferriprotoporphyrin IX 
(Shack and Clarke 1947). Similar pKa values of the aqua ligand have been reported for the 
haematin analogues ferrimesoporphyrin (pKa = 7.01) (Cowgill and Clarke 1952 and 
ferricoprotoporphyrin (pKa = 7.44) (Clarke and Perkins 1940), and various haemproteins 
(pKa's = 8.05 - 8.99) (Baldwin 1986). Furthermore, the fitted ex. values reported in Table 3.5. 
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Figure 3.25. Umiting (J. values obtained in 20% water-methanol mixtures ( .... ) fitted to a pH titration curve for a 
single deprotonation (-) using non-linear least squares fitting. The fitted (J. values from Table 3.5. are shown for 
comparison (. ). 
Spectroscopic evidence for two protonatable states of haematin is provided by visible 
spectra of haematin in 20% water-methanol between pH 6.0 and 10.0 in which conversion of 
one species to another gives rise to two isosbestic pOints at 628nm and 653nm (Figure 
3.26.). The spectrum of the monomer when H20 is the axial ligand shows a peak maximum 
at 623nm which shifts to 599nm for axially coordinated HO'. This shift to shorter wavelength 
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Since the two monomelic species of haematin in 10 - 30 % water-methanol appear to be 
those expected in pure water, namely HO-Fe(III)PPIX and H20-Fe(III)PPIX, we can assume 
that the limiting 0. values for the monomer in the mixed water-methanol systems are good 
approximations of corresponding 0. values in aqueous solution. The 0. values at the pHs 
of our titrations can read off the pKa curve and fixed in the haematin dimerisation 
equation in order to recalculate log Kells using non-linear fitting. 
3.2.3. Determination of log Kulis and ~ by Fixing 0. 
vu.cnc:u values of log Kells and p obtained when 0. is at limiting values 
the monomer obtained in 10 - 30% water-methanol systems are presented in Table 3.9. 
Table 3.9. log Kobs and f3 obtained by non-linear least squares fitting with a fixed to the limiting water-methanol 
values 
a. 
6.92 7.00 ± 0.09 
7.19 3.00 0.89 ± 0.02 7.3 ±0.2 
7.39 2.81 0.89± 0.01 7.2 ± 0.1 
7.69 2.50 0.93 ± 0.02 7.5 ± 0.2 
7.99 2.22 0.92 ±0.02 7.2 ± 0.1 
A plot of log Kells vs pH confinns our original findings that there is no significant dependence 
of log Kells on pH (Table 3.10. and Figure and that dimerisation does not involve 
deprotonation. 
Table 3.10. Slope and statistical parameters obtained from a linear regression fit to log K"t.; vs pH for values of 
log K"t.; obtained by free fitting and methanol fitting procedures 
Parameters 
Pvalue 



































Figure 3.27. Plot of log Kot.. vs pH for free fitted data from Table 3.5. ( - ) and data fitted using the limiting u 
values from the water-methanol mixtures (-). 
3.2.4. Reanalysis of the Data of Brown et al. 
Since analysis of the data using both freely refined parameters and fixed a. values 
independently determined give a different result to Brown et a/., it was decided to reanalyse 
their data using non-linear least squares fitting. Data points of the extinction coefficient at 
varying haematin concentrations were extracted off their sigmoidal curves (Figure 3 .1 OA and 
3.10B) for Fe(III)DP and Fe(III)PPIX (Appendix 1) and were converted to absorbances. The 
absolute absorbances were then fitted to the dimerisation equation (See Section 7.2.2.2 .5 . 
for derivation of the model). The data for Fe(III)DP converged using the dimerisation 
equation and values for SM, So and log Kobs were obtained (Table 3.10.). For Fe(III)PPIX the 
same problems reported by Brown et a/. were encountered with the EM'S being too poorly 
defined to obtain corresponding values of log Kobs. These values were then fixed at the 
limiting monomer extinction coefficients of Fe(III)DP, as done by Brown et a/., to obtain the 
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Table 3.10. Values of ~M, ~D and log Kobs obtained for Fe(III)OP by i. linearisation methods (Brown et ai. 1970) 
and ii. non-linear least squares fitting. 
pH 8M/mM 8D/mM log Kobs 
Brown et al. 1970 
6.64 132500 35 000 4.83 
6.98 121500 37000 4.73 
7.38 110000 40000 4.46 
8.04 95000 44000 3.78 
11.0 89000 46400 nd 
Refitted by Non-linear Least Squares Fitting 
6.64 137 000 ± 5000 38300 ±5000 5.7 ±0.2 
6.98 127 000 ± 6000 38 000 ± 4000 5.8 ± 0.2 
7.38 115000 ± 12000 41 000 ± 6000 6.0±0.4 
8.04 96 000 ± 6000 44 200 ± 2000 6.6 ±0.2 
11.0 76000±4000 44 000 ± 1 000 6.9 ±0.2 
Table 3.11 . Values of ~D and log Kot>s obtained for Fe(III)PPIX by i. linearisation methods (Brown et a/1970) and 
ii. non-linear least squares fitting. 
pH eo/mM log Kobs 
Brown et al. 1970 
6.98 39300 6.33 
7.38 40800 5.98 
8.04 44600 5.41 
11.0 46600 nd 
Refitted by Non-linear Least Squares Fitting 
6.98 39200 ± 900 7.84 ± 0.08 
7.38 40700 ± 700 8.01 ± 0.08 
8.04 44400 ±500 8.3 ± 0.1 
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Although a plot of 10gKobs against pH for the refitted data of Fe(III)PPIX and Fe(lIl)DP does 
increase slightly with pH, the slopes are only 0.19 ± 0.04 and 0.27 ± 0.07 respectively which, 
contrary to the findings of Brown et al., is indicative of n = 0 and not n = 1 (Figure 3.28.). The 
discrepancy with the data analysis of Brown et al. is likely due to the errors involved in 
extrapolating the limiting monomer extinction coefficient for Fe(lIl)DP from their curves, and 
fixing this value as the limiting monomer extinction coefficient for Fe(III)PPIX. As can been 
seen from our data analysis (Tables 3.5. and 3.6.), the value of log Kobs and hence the 
overall slope of log Kobs against pH, is highly sensitive to this limiting value obtained for the 
monomer. 
We can therefore conclude that there are discrepancies in the data analysis of Brown et al. 
and that dimer formation is pH-independent and does not involve deprotonation. 
10 
9 
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Figure 3.27. Plot of log Kobo vs pH for reanalysed data of Brown et al. 1970. (- ) Fe(III)PPIX. (- ) Fe(III)DP. 




where log K is the pH-independent dimerisation constant of 6.9 ± 0.2 which compares 
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3.2.5. Spectral Evidence 
That haematin dimerisation is pH-independent is further supported by the changes observed 
by Egan et al. in the Soret band of aqueous haematin with pH (Egan et al. 1994). At low pH 
(pH = 5.0), this peak remains broad and does not have the characteristic sharpness of 
monomeric haematin such as is observed in SDS solution and in the monomerising solvents 
methanol and DMSO. 
Since formation of the haematin dimer does not involve deprotonation, this dimer must have 
a different structure to the ~-oxo dimer. This is supported by spectra of haematin in pure 
aqueous solution at pH 6.5 and pH 10.0 (Figure 3.29A) which are different to the spectrum 
of the synthesised ~-oxo dimer in benzene (Figure 3.29B) (O'Keeffe and Barlow 1975) or 
chloroform (Sadasivan et al. 1969). In the case of the aqueous haematin dimer, the band 
around 650nm shifts to about 610nm and increases in intensity with increased pH, whilst the 
band at 550nm decreases in intensity and is eventually obscured. This contrasts to the 
spectrum of the synthesised ~-oxo dimer which is characterised by a distinctive peaks 
around 567nm and a shoulder around 590nm (Figure 3.29B). 
0.6.,.------------------, 
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Figure 3.29. Uv-vis spectra of (A) haematin dimer in HEPES buffer at pH 6.5 (- ) and in CHES buffer at pH 10.0 
(-), (8) synthesised J.1-oxo dimer of Fe(III)DP-DME in benzene (O'Keeffe and Barlow 1975). 
Furthermore, a spectrum of the ~-oxo dimer can be obtained from the high pH spectrum of 
haematin in aqueous media if a small amount of pyridine is added (Figure 3.30C. and 
3.30D.} which is in agreement with earlier studies (O'Keeffe and Barlow 1975, Gallagher and 
Elliot 1973). Alternatively, saturating sodium chloride or sodium perchlorate can induce ~­
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pyridine at or below pH 7.4 gives spectra of a bis pyridyl low spin complex (White 1978) 
implying that in this pH range, pyridine coordinates to the iron. 
A B 
0.75 0 .75 
pH 6.51 pH 7.40 
Q) 
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Figure 3.30. Spectra of haematin in HEPES buffer (-) at pH 6.51 (A) and 7.40 (B.) and in CHES buffer at pH 
10.0 (C), haematin in the respective buffers with ( - ) 501ll pyridine, ( - ) saturating sodium chloride and ( - ) 
saturating sodium perchlorate. (D) Titration of 28).IM haematin in 0.02M NaOH with pyridine (Gallagher and Elliot 
1973). 
Further work in our laboratories have shown that no isosbestic pOints exist in the haematin 
dimer spectrum as a function of pH implying that more than two dimer species are present in 
aqueous solution (Egan, unpublished results). This is contrary to what is reported by Silver 
and Lucas (Silver and Lucas 1983), although close inspection of their spectra show the 
absence of an isosbestic point at 500nm (Figure 3.8). 
Given that the haematin dimer observed in aqueous solution is not a J.l.-oXO dimer, it is 
proposed that it is a coplanar 1t-1t dimer in which the faces of the ferriporphyrins lacking axial 
ligands interact with each other (Scheme 3.1.). Interestingly, the proposed stoichiometry of 
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ferrihematoporphyrin dimers appear to associate with one hydroxyl ion per iron atom in 
alkaline solution (Davies 1940). This dimeric structure is consistent with the lack of 
isosbestic pOints seen for the dimer in aqueous solution where presumably two pKas give 
rise to the three dimeric species 93a, 93b and 93c. Furthermore, this structure explains why 
in contrast to protoporohyrin IX, aggregates higher than dimers are not observed. In this 
case, the outwardly directed axial ligand would sterically hamper such aggregation (93a - c 
in Scheme 3.1), whereas there is no apparent reason why the j.l.-Qxo dimer should not form 
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Scheme 3.1. Proposed structures of the haematin dimer 93a, 93b and 93c present in aqueous solution between 
pH 6.9 and 8.0 where Ko is the pH independent dimerisation constant, PK.,M1 is the protonation constant of the 
























Scheme 3.2. Speculation on why aggregates higher than haematin dimers do not exist. If the haematin dimer is 
a J.1-DXO dimer, the outwardly pointing face of the porphyrin ring would be expected to form aggregates higher 
than dimers in aqueous solution (A). On the contrary, aggregates higher than dimers would not be expected for 
the proposed 7t-7t dimer (8) since the axial hydroxo- or aqua ligands are predicted to sterically hinder the outer 
porphyrin face. 
3.3. CONCLUSIONS 
Haematin in aqueous solution is extensively dimerised with a pH-independent equilibrium 
constant of log Ko = 7.2 ± 0.2 and the pKa of the monomer equal to 7.56 ± 0.07. This dimer 
is not a fJ.-oXO dimer as proposed by Brown et al. but is likely to be a pH-dependent mixture 
of three 1t-1t stacked dimers 93a, 93b and 93c, it is presumably the low pH form that is the 
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As mentioned in the introduction, CQ has the ability to accumulate to mM concentrations in 
the food vacuole at therapeutic levels (nM). It is thought that some of this accumulation can 
be attributed to the weak base properties of CQ, whilst the majority has recently been 
attributed to saturable binding to the Fe(III}PPIX target (Bray et a/. 1998). The resulting 
toxicitiy of this complex is still the subject of much debate. In this study, the hypothesis is 
investigated that the Fe(III}PPIX-quinoline complex inhibits haemozoin formation thereby 
causing a toxic build-up of Fe(III}PPIX or the Fe(III}PPIX-quinoline complex which ultimately 
leads to death of the parasite. 
Although a wide range of quinoline antimalarials and antiplasmodials have been shown to 
bind to Fe(IJI}PPIX, little is known about the critical structural features on the quinoline 
nucleus required for complex formation. It was originally suggested that the similar inter-
nitrogen (Nquinoline - Ndielhyl) atomic distance in the antimalarial drugs AQ (Yennawar and 
Viswamitra 1991, (Koh et a/. 1994) and CQ may be important structural features for binding 
to a similar acceptor site on the Fe(IJI)PPIX receptor (O'Neill et a/. 1997). No direct 
relationship was however found between the inter-nitrogen separation of isolated drug 
molecules and the antimalarial activity of CQ, 94 and a range of AQ analogues (Figure 4.1.) 
although the terminal amino group was suggested to be important for hydrogen bonding to 
the propionate groups of Fe(III)PPIX in the complex (O'Neill et a/. 1997). That hydrogen 
bonding is important is questionable when considering the recent finding that CQ analogues 
with shortened (2-3C long) and lengthened (10-12C long) side chains retain full activity 
against CQ-resistant and CQ-sensitive malaria parasites (De et a/. 1996). Furthermore, 
analogue 15 which lacks a side chain or a terminal amino group still forms a relatively strong 
complex with Fe(III)PPIX (Figure 1.4.) (Vippagunta et a/. 1999). The authors propose that 
the 7-chloro group in CQ is the critical structural feature for complex formation as 6-chloro-
chloroquine (13) failed to form a complex. Further support is shown by the inability of simple 
quinolines which lack a 7-chloro group to form a complex with Fe(IJI)PPIX (Figure 4.1 .) 
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Figure 4.1 . The relationship between some structural features on AQ, 94, CQ and some simple aminoquinolines, 
and the ability to form a complex with Fe(III)PPIX. • Vippagunta et al. 1999, bEgan et aI. 1997 and Mavuso PhD 
thesis 2001, C O'Neill et al. 1997. 
Less is known about the structural features in CQ responsible for f3-haematin inhibition 
although again, the group at the 7-postion appears to playa role. This is demonstrated by 
the 7-nitro and 7-bromo derivatives of CQ which retain f3-haematin inhibitory activity, 
whereas the 7-amino and 7-hydro derivatives of CQ do not (Vippagunta et al. 1999). 
In this chapter, the critical structural features in CQ responsible for complex formation with 
Fe(III)PPIX and f3-haematin inhibition will be probed. It will be investigated if (i) there is a 
quantitative relationship between the strength of Fe(III)PPIX-quinoline association and 
antiplasmodial activity if (ii) the strength of Fe(III)PPIX-quinoline association is related to the 
ability to inhibit f3-haematin formation, and (iii) if strong f3-haematin inhibition is related to 
strong antiplasmodial activity. 
The structural significance of the terminal amino group in the side chain will also be probed 
to ascertain if it plays a role in (i) stabiliSing the Fe(III)PPIX-quinoline complex, presumably 
through hydrogen bonding to the propionate groups in Fe(III)PPIX or (ii) contributing to 
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4.2. EXPERIMENTAL METHODS 
4.2.1. Synthesis ofthe Chloroquine Analogues 
Various simplified analogues of were obtained commercially or according to 
the procedures outlined in Chapter 2. To ensure analytical purity of all the compounds, 
microanalysis were obtained for the solids and HRMS for the oils. Details of 
experimental procedures are reported in Section 7.1.2. 
4.2.2. Spectrophotometric Titrations 
It is not possible to determine quinoline-Fe(III}PPIX association constants 
spectrophotometrically in aqueous solution as the spectrum of the haematin dimer is broad 
(Figure 3.12.) and little change upon complex formation. The association 
constants were obtained by the method of et in aqueous 40% 
dimethylsulfoxide (DMSO) at pH 7.4 (Egan et a/. 1997, Mavuso PhD thesis 2001) according 
to methods outlined in Section 7.2.3. 
Association constants were determined spectrophotometrically at pH 7.4 not at the pH 
of the food vacuole (5.2 and 5.5) as haematin has only 30% solubility in this lower pH range 
(see Figure 3.2.3). In 40% DMSO (aq) haematin is strictly monomeric (Collier et al 1979) 
with a coordinating DMSO molecule occupying axial position (Brown and Lantzke 1969). 
the trends observed for the association constants in 40% DMSO are the same as 
those nn.,c".IPr1 in pure aqueous media using titration (Dorn et 1998a) it 
appears the association constants in 40% DMSO at pH 7.4, provide a good 
reflection of the interactions occurring in the food vacuole. Furthermore, interpretation of the 
results is simplified under conditions where haernatin is strictly monomeric and either one or 
two quinoline molecules associate with each haematin molecule (Egan et a/. 1997) 
compared to large stoichiometries of between 1 and 19 haematin molecules per quinoline 
molecule obtained in a pure aqueous medium (Dorn et a/. 1998a, Vippagunta et a/. 1999). 
From Figure 4.2A, it can be seen that no changes in the spectrum of Fe(III}PPIX in 40 % 
DMSO are observed in the of compounds unable to form complexes with 
Fe(III)PPIX (for example 27b). Compounds do however, form such complexes (for 
example 68) cause a substantial decrease in intensity of the Soret band at 402nm with no 
shift in the peak maximum ). At longer wavelengths, the Q band (494nm and 
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and undergoes a substantial blue shift to 594nm. These changes are quite distinct from the 
spectrum of the haematin 7t-7t dimer in pure aqueous solution (Figure 4.2C.) or the spectrum 
of the ~-oxo dimer (Figure 4.2D.). Where the resulting quinoline-Fe(III)PPIX complex 
involves 1:1 stoichiometry, excellent isosbestic points are observed (Figure 4.2B.). 
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Figure 4.2. Visible spectra of Fe(lIl)PPIX in 40% DMSO, pH 7.5 (spectrum a) titrated with (A) a compound 
unable to form a complex with Fe(III)pPIX (27b) (spectrum b); (B) a compound that forms a complex with 
Fe(III)PPIX (68) (spectrum b). (C) Visible spectra of Fe(III)PPIX in 40% DMSO, pH 7.5 (spectrum a), and in water 
(spectrum b). (D) Visible spectra of Fe(lIl)PPIX in 40% DMSO, pH 7.5 (spectrum a), and under the same 
conditions but with the addition of saturating NaCI (spectrum b). The spectrum of the latter is identical to that of 
the ).!-oxo dimer reported by O'Keeffe and Barlow (O'Keeffe and Barlow 1975). Concentrations of Fe(lIl)PPIX are 
8x10-8M (left panels) and 2.4x10-5M (right panels). All spectra are corrected for dilution. 
The absorbance of the Soret band at 402nm was recorded as a function of quinoline 
concentration according to the methods outlined in Chapter 7.2. In all cases, the corrected 
absorbance of the Soret band at 402nm as a function of quinoline concentration fitted a 1:1 
or a 2:1 association model (quinoline:Fe(III)PPIX) (See Chapter 7.2 for the derivations). A 
typical example of an association curve is displayed in Figure 4.3 where the solid line 
represents a best fit of the data to the association model using non-linear least squares 
fitting procedures_ The titration curves for all the other compounds are displayed in Appendix 
2_ In most cases where the quinolines formed 2:1 complexes with haematin, the second 
association constant was small with large relative errors and was therefore not reported. In 
all instances the values of the first association constant have acceptably small errors and the 
data is well fitted in the low quinoline concentration region where strong binding occurs. The 
association constants are all quoted as an average of three separated determinations and 
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Figure 4.3. Typical spectrophotometric titration curve (in this case for 68). The solid line is a best frt to the data of 
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4.2.3. ~·Haematin Inhibition 
J3-Haematin inhibition was detennined by the infra-red method of Egan et al. 1994 which is 
outlined in Section 7.2.4. In this method. haematin is converted to j3-haematin in 4.5M 
acetate. pH 4.5 at 60°C for 30m ins. The infrared spectrum of J3-haematin (Figure 4.4B.) has 
two characteristic peaks around 1660cm-1 and 1210cm-1 which are absent in haematin 
(Figure 4.4A). This method unequivocally distinguishes between inhibitory and non inhibitory 
compounds as is shown by the typical examples (Compounds 61 and 68 in Figure 4.4C and 
4.40 respectively). These two characteristic peaks are absent in the product spectrum of an 
inhibitory compound (Figure 4.4C) and present in the product spectrum of a non inhibitory 
compound (Figure 4.40). Since CQ inhibits J3-haematin fonnation at 4eqivalents. all 
compounds were tested for inhibition at this mole ratio. A positive result therefore implies 
that the compound has comparable inhibitory activity to CQ. and a negative result implies 
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Figure 4.4. Infra red spectra of (A) haematin. (B) 13-haematin. (C) the product of the 13-haematin reaction in the 
presence of the inhibitory compound 68 and (D) the non inhibitory compound 61 . The arrows highlight the peaks 
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4.2.4. Antiplasmodial Testing 
All compounds were sent away to Mr Jason Walden, Dept of Pharmacology, UCT for in vitro 
antiplasmodial testing using a cultured CQ-sensitive strain of P. fa/ciparum, D1 O. No attempt 
was made to determine ICso values in excess of 1 O~M as it has been observed that CQ 
exhibits several effects at ~M and mM concentrations which probably play no role in its 
therapeutic activity (see Section 1.5.3.). 
4.3. RESULTS 
The results for all the quinolines tested for (i) aSSOCiation with Fe(III)PPIX, (ii) strong 
inhibition of 13-haematin fommation and (iii) in vitro antiplasmodial activity against the CQ-
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Table 4.1 . Results of quinolines tested for association with Fe(IJI)PPIX, inhibition of j3-haematin formation and 
antiplasmodial activity. 
NH R NH R 
C'Ct 06 m I ~ h ~ h ~ h N NH R N X N 
No. R No. R No. X R 
66 CH3 H 
58 H 61 H 68 CI H 
59 CH3 62 CH3 69 CI CH3 
60 CH2CH2NH2 63 CH2CH2OH 70 CI CH2CH2CH3 
81 CH2CH2NHCOCH3 71 CI CH2CH2OH 
64 CH2CH2NH2 72 CI CH2CH2NH2 
65 CH2CH2NEt2 73 CI CH2CH2NMe2 
74 CI CH2CH2NEt2 
No. log K±SEMa Stoichiometry" f3-Haematin IC!50 (nM) ± SEM 
Inhibition 
58 4.23 ± 0.02 1:1 > 10000 
59 4.26 ± 0.03 1: 1 > 10000 
60 4.34 ± 0.06 1:1 > 10000 
61 4.49 ± 0.01 2:1 c > 10000 
62 4.38 ± 0.03 1:1 > 10000 
63 4.18±0.03 1:1 > 10000 
81 4.28 ± 0.06 2:1 c >10000 
64 4.59± 0.04 1:1 4700 ± 800 
65 4.75 ± 0.03, (log K2 = 3.2 ± 0.01) 2:1 799 ±404 
66 4.52 ± 0.01 1:1 > 10000 
68 4.43 ± 0.01 1:1 + 3800 ±500 
69 4.48 ± 0.02 1:1 + 4000 ±2 200 
70 4.43 ± 0.05 1:1 + 954 ±2~ 
71 4.66 ± 0.02 2: 1c + 5070 ± 80 
72 4.928 ± 0.003 1:1 + 92 ± 12 
73 4.96 ± 0.01 2:1c + 81 ±6 
74 5.81 ± 0.01, (log K2 = 4.47 ± 0.02) 2:1 + 49± 14 
CQ 5.52 ± 0.03 1:1 + 38 ± 14 
• Standard error of the mean, three determinations, b Quinoline:Fe(III)PPIX, c Fitted to a 2:1 model but meaningful 
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4.4. DISCUSSION 
4.4.1. Structural Requirements for Haematin Binding 
It was found that the quinolines in Figure 4.SA all associate strongly with Fe(III)PPIX and the 
quinolines in Figure 4.SB do not associate with Fe(III)PPIX. 
em A: Strong association 
with 
Fe(III)PPIX 
I .. .. 







rol~ ~ h N NH2 
58 
log K = 4.23 ± 0.02 (1 :1) 
59 
log K = 4.26 ± 0.03 (1 :1) 
log K = 4 .34 ± 0.06 (1 :1) 
XTa 
061: ~ h N 
61 
log K = 4.49 ± 0.01 (2:1) 
62 
68 
log K = 4 .43 ± 0.01 (1 :1) 
Hm 
66 
log K = 4.52 ± 0.01 (1 :1) 
e~S 
69 
log K = 4 .48 ± 0.02 (1 :1) 
log K =4.18 ±0.03 (1 :1) 
./'.... ~~COCH3 ./'--.... / CH3 
o6
HN~ ~ ~ ~ 
~ I rr cMj 
81 70 
log K = 4.28 ± 0.06 (2:1) 







log K = 4.59 ± 0.04 (1 :1) log K = 4 .66 ± 0.02 (2:1) 
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Figure 4.5. Quinolines and analogues of CQ that exhibit (A) a strong assoclation with Fe(III)PPIX (log Ks 
between 4 and 5.5), and (B) no strong association with Fe(III)PPIX 
It is immediatedly evident from Figure 4.5 that all quinolines with an amino-group at the 2-or 
4-positions form strong complexes with Fe(III)PPIX. The ability of these compounds to form 
a complex with Fe(III)PPIX appears to be independent of the presence of a 7-chloro group 
as is elegantly demonstrated by comparing 40, 61 and 68 (Figure 4.6). Here, 40 which has a 
7-chloro group but lacks an amino group at the 4-position does not associate with 
Fe(lII)PPIX, whereas 61 and 68 which both have 4-amino groups, associate equally strongly 
with Fe(III)PPIX. 
CI 
05 m m I I ~ h ~ h ~ h CI N N CI N 
40 61 68 
No binding log K = 4.49 ± 0.01 (2:1) log K = 4.43 ± 0.01 (1 :1) 
Figure 4.6. Identification of the 4-aminoquinoline nucleus as critical for association with Fe(III)PPIX 
Introduction of a short chain on the nitrogen atom at the 2- or 4-positions appears to also 
have little effect on the association constant although a combination of both the 7-chloro 
group and the terminal diethylamino group (ie 74 and CQ) increase the association constant 
significantly (around 7 fold). It has been recently found that the quinolines in Figure 4.5A do 
in fact, form complexes with Fe(III)PPIX but with association constants 300-10 000 fold 
weaker (log K ~ 1.5) than those observed for the quinolines in Figure 4.58 (Smith, Egan and 
Marques, unpublished results). The 7-fold increase in the binding constant observed for 74 
and CQ is therefore small in comparison to the association constants observed for those 
quinolines that do not bind strongly. Furthermore, the Fe(III)PPIX association constants 
obtained for all the quinolines used in this study are within the range of known antimalarials 
and antiplasmodials (Figure 4.7 A). Since no significant correlation was found between the 
strength of Fe(III)PPIX association and antiplasmodial activity (Figure 4.78), it appears that 
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4.7. (A ) of K values for association between and the synthesised 
120 
Jcuuyut;,~ (58 - 66, 68 - 74, 81) (black circles). Triangles correspond to the K values obtained for known 
antimalarial drugs and refer to (a) (b) amodiaquine, (c) (d) and quinidine. The 
as~;ocllatir1Q compound (27b) is shown for comparison (f). (8 ) Piolof ICoo vs log K for the ",\",\!h.~",i"",rI 
anaiogues whose ICoo values are beiow 10 OOOnM (circles) and for the known antimalarial drugs which 










Chapter 2: structuf'lrActivlty Relationships in 4-Aminoquinolines 121 
The molecular basis for the specific interaction of 2AQ and 4AQ with haematin is not clear. 
These two molecules have however substantially higher pKas than the other 
aminoquinolines as a result of the unique resonance stabilised cations which retain the 
benzenoid structure of the carbocyclic ring (2AQa and 4AQa, Scheme 4.1. and Table 4.2) 
(Barton and Ollis 1979). At the pH of the binding experiment (pH 7.4), 4AQ is predominantly 
in the protonated fonn, whilst 2AQ is 47% protonated . By contrast, the other quinolines are 
almost exclusively deprotonated which seems to suggest that complex formation may 
involve a 1t-cation interaction. The association constant of 4AQ was however found to be 
pH-insensitive down to pH 5.5 (log K = 4.57 ± 0.02) and quinoline and 3AQ still failed to form 
a complex with haematin at this lower pH where these molecules are 22% protonated . 
Presumably the ability to associate thus stems from the electronic distribution in these 
molecules, rather from their protonation state although the exact nature of these interactions 
is still unknown. 
4AQ 4AQa 
Scheme 4.1. Unique resonance forms of 2-and 4-aminoquinoline 
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4.4.2. Structural Requirements for ~-Haematin Inhibition 
It was found that the 4-aminoquinolines in Figure 4.8A do not strongly inhibit ~-haematin 
formation and the quinolines in Figure 4.8B do strongly inhibit ~-haematin formation. 
A: No strong inhibition of 13-
haematin formation 
• NH2 
cO ~ h N 
61 
HNCH3 
cO ~ h N 
62 
H~OH 
cO ~ h N 
63 ~ 
~ COCH 3 
HN 








cO ~ h N 
65 
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Figure 4.8. Structures of 4-aminoquinolines that all associate strongly with Fe(III)PPIX and (A) do not to strongly 
inhibit ~-haematin formation and (B) strongly inhibit ~-haematin formation. 
It is immediately evident from Figure 4.8 that all the 4-aminoquinolines with a chloro-group at 
the 7-position, strongly inhibit f3-haematin formation. This effect appears to be independent 
of the presence of a side chain or a terminal amino group. The ability to strongly inhibit 13-
haematin formation also appears to be independent of the strength of association with 
Fe(III)PPIX which is clearly demonstrated by 61, 66 and 68 which all have virtually identical 
log K values yet only 68 which contains a chloro-group at the 7-position, strongly inhibits 13-
haematin formation (Figure 4.9.). 
cO JJ5 m I ~ h ~ h ~ h N N CI N 
61 66 68 
log K = 4.49 ± 0.01 (2: 1) logK=4.S2±0.01 (1 :1) log K = 4.43 ± 0.01 (1 :1) 
no Inhibition no inhibition inhibition 
Figure 4.9. Critical structural feature in CQ responsible for ~-haematin inhibition. The association model used is 
included in parenthesis. 
Although the strength of associa ion with Fe(III)PPIX does not distinguish between 
quinolines that do or do not inhibit f3-haematin formation, it was found that all compounds 
that strongly inhibit f3-haematin, also associate strongly with Fe(III)PPIX. Furthermore, not all 
quinolines that strongly inhibit f3-haematin formation exhibit strong antiplasmodial activity 
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4.4.3. Structural Requirements for Antiplasrnodial Activity 
All the 4-aminoquinolines can be divided into three catagories: those that are inactive (ICsa > 
10 OOOnM) (Figure 4.10A). those that are weakly active (lC50 in or around the j..LM range) 
(Figure 4.1 OB) and those that are strongly active (IC5o < 1 OOnM) (Figure 4.1 OC). 




/'... , OH 
HN" ~ 
061 ".:::: ~ ~ N 
63 H 
~NCOCHJ 
061"~ ~ ~ N 
81 
72 
IG50 = 92 ± 12 








cOl"N: ~ ~ ~ N 
69 65 




IG50 = 954 ± 28 
71 
IG50 = 5070 ± 80 
73 












Chapter 2: structure-Activity Relationships in 4--Aminoquinolines 125 
Figure 4.10. 4-Aminoquinolines that are (A) inactive (IC50 > 10 OOOnM) , (8) weakly active and (C) strongly active 
(IC50 < 100nM) against the CQ-sensitive D10 strain of P. fa/ciparum. ActMties and standard deviations shown 
below each compound in nM. 
It is immediately evident from Figure 4.10, that the strongly active 4-aminoquinolines (72, 73 
74 and CQ) are those that form strong complexes with Fe(III)PPIX, strongly inhibit (3-
haematin formation and contain a terminal amino side chain presumably for accumulation in 
the food vacuole via pH trapping. These observations are in line with our hypothesis that pH 
trapping of the diprotic base in the food vacuole contributes significantly towards the overall 
cellular accumulation (see section 1.5.3.3.2.), which in tum is important to drive formation of 
the quinoline-haematin complex through Le Chatelier's principle and to reach the 
concentrations required to inhibit (3-haematin formation. 
This hypothesis is further supported by the compounds (68, 69, 70 and 71) that strongly 
inhibit (3-haematin formation but do not have a terminal amino group to bring about strong 
accumulation, and in tum exhibit only weak antiplasmodial activity (between 25 and 125 
times less active than CQt Compounds 64 and 65 exhibit limited anti plasmodial activity 
(4700nM and 800nM respectively) despite showing no evidence of strong (3-haematin 
inhibition. This observation however is not contradictory to the SAR hypotheSiS as both 
compounds would be expected to accumulate to high concentrations in the food vacuole 
where they may act via an alternative mechanism. Furthermore, it is not known what effect 
replacement of the 7-chloro-group with hydro-group may have on the pKa of the quinoline 
ring nitrogen. Since chloro is electron withdrawing, it is possible that this group may lower 
the pKa of the quinoline ring nitrogen relative to hydro. The 7-hydro compounds may 
therefore accumulate more strongly in the food vacuole than the 7-chloro derivatives where 
at these higher concentrations they may inhibit (3-haematin formation. These ideas are 
expanded further in Chapter 5. 
Finally compounds which fail to inhibit (3-haematin formation (55 - 66) and are not expected 
to accumulate more than 100 fold in the food vacuole (except for 60) all show no significant 
anti plasmodial activity. 
It has been found (Vippagunta et al. 1999), that the CQ analogue lacking a terminal amino 
group (95) still retains strong antiplasmodial activity (Figure 4.11). This result is however at 
odds with our SAR hypotheSiS and with a previous result that the CQ analogue with a 
a The presence of the basic quinoline nitrogen will cause some accumulation, but in the absence of the terminal 
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terminal hydroxy group (96) exhibits much reduced activity (Gasquet al. 1987). 
of Vippagunta a/. is at odds with 












IC50 (nM) ::: 570 (FCC, 




ICsa (nM) 48 (010) 
~CH3 
mlH~ ~ h-C N 
70 
1Csa (nM) ::: 954 (010) 
result 
figure 4.11. The quinoUne analogue lacking a terminal amino group in the side chain 70 exhibits much reduced 
activity the Cg... sensistive strain 010 relative to 74. This result is at odds with the findings of Vippagunta 
et 131. who found 95 had only 4-fo(d reduced relative to against the strain NF54. 8 
et aI. 1999, b Gasquet et 131. 1987. The (Coo has been normalised relative to the value obtained for 
the FCC straln and scaled for comparison with the NF54 strain 
In line with the SAR hypothesis, all the 4-aminoquinolines in this study can be 
classified into one of the four catagones presented in Table 4.3. 4-Aminoquinolines that do 
not strongly inhibit i3-haematin formation and do not have a terminal amino-group for strong 
accumulation, have no activity against the paraSite >10 OOOnM) (Category A). 
4-Aminoquinolines that strongly inhibit i3-haematin formation but do not a terminal 
amino group are only active (ICoo - J.lM) (Category Those Ll_gnu".", that 
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exhibit weak activity (Category C) and fully active 4-aminoquinolines (Category D) are those 
that accumulate strongly in the food vacuole where they have the ability to strongly inhibit ~­
haematin formation. 
Table 4.3. Classification of 4-aminoquinolines in into four catagories based on the SAR study in this chapter 
Catagory Examples of 4- Strong 13- Accumulation of Activity 







H~~COCH3 - - none 
A 
00 ::::,... h N 
ill' + - weak ::::,... ~ 
CI N 
~OH + - weak 
B m ::::,... h-I N 
~NH2 - + weak HN 
e cO ::::,... h-N 
H~NEI2 - + weak 
06 ::::,... h N 
HN~NMe2 + + strong 
~ , ::::,... h CI N 
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~NEt2 + + strong 
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These results are all in line with the hypothesis that CQ and related 4-aminoquinolines act by 
accumulating to therapeutic levels in the food vacuole, at least in part through pH trapping 
and that these high concentrations are required to drive the formation of a Fe("I)PPIX-
quinoline complex which then inhibits haemozoin formation. 
Since calculation of the predicted pH trapping of CQ in the food vacuole can only account for 
roughly 4 - 26% of the observed accumulation, and it has been recently suggested that the 
activity of CQ and AQ is solely dependent on saturable binding to haematin (Bray et al. 1998) 
it would appear that the saturable accumulation component is of far greater importance than 
the contribution from pH trapping. In this study however, the strength of association with 
Fe(III)PPIX was not found to be correlated to antiplasmodial activity. Fully active 4-
aminoquinolines were only those that had a significant pH trapping component which 
suggests that the role of pH trapping in antiplasmodial activity is greater than recently 
suggested. That pH trapping is important is in line with the existence of a chemical 
equilibrium between free and the bound drug in the food vacuole of the malaria paraSite. As 
outlined in the introduction (Section 1.5.3.3.2.), even though pH trapping may only account 
for roughly 4 - 26% of the observed accumulation, in its absence, the free drug concentration 
in the food vacuole wi" be significantly lowered. This will result in substantially less complex 
formation as predicted by Le Chateliers principle. This is supported by calculation of the 
cellular accumulation, in the absence of pH trapping, to be only around 8 fold (compared to 
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4.5. CONCLUSIONS 
This chapter brings together some useful data on 4-aminoquinolines from which the SAR 
profile of CQ in Figure 4.12. is proposed. It appears that the 4-aminoquinoline nucleus alone 
provides a template for complexing to Fe(III)PPIX and that complexation is not a sufficient 
requirement for ~-haematin inhibition or antiplasmodial activity. The 7-chloro group is 
necessary for ~-haematin inhibition and this group has little influence on the strength of 
association with Fe(III)PPIX. In addition, ~-haematin inhibition is not a sufficient requirement 
for antiplasmodial activity in the absence of the terminal amino group which presumably 
allows the quinoline to accumulate in the food vacuole through pH trapping. A combination 
of the 7-chloro group and the terminal diethylamino group appears to further enhance the 
strength of association with Fe(III)PPIX although this effect does not appear to be critically 
related to antiplasmodial activity. 
,..-t-, ........ t---Weak base : assists in drug accumulation 
via pH trapping 
..... --Fe(III)PPIXcom plexing group 
I.-.J---- Weak base: assists in drug accumulation via pH trapping 
'--_ ...... _'--1 
t 
Required for Inhibition ofl3-haematin formation 
Figure 4.12. Proposed structure-activity relationships in CQ 
The results from this study reconcile much evidence from the literature that structurally 
diverse analogues of CQ which retain the 4-amino-7-chloroquinoline nucleus but have very 
different side chains and contain a terminal amino group, retain strong activity against 
malaria paraSites. This is shown in a wide range of 4-aminoquinolines (Figure 4.13) 
including CQ analogues with various straight or branched side chains (De et al. 1996, Ridley 
et al. 1996), analogues which have a bulky organometalliC ferrocene moiety in the side chain 
(Siot et al. 1997, Chibale et al. 2000), numerous analogues of AQ which also contain a 4-
amino-7-chloroquinoline nucleus and presumably act via the same mechanism (Hawley et 
al. 1996, O'Neill et al. 1997, Hawley et al. 1998), and a number a bis-quinolines (Chen 1991, 
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Raynes 1999) (Figure 4.14). Presumably these compounds are all fully active as they have a 
4-aminoquinoline nucleus for association with Fe(III)PPIX, a 7-chloro group for strong 
inhibition of ~-haematin formation, and contain a second weakly-basic quinoline ring nitrogen 
or basic piperazine nitrogen to assist with accumulation in the food vacuole. 
R1 R2 ~ ICsol nM ICso of cQ I nM 
CH2CH2 CH2CH2 CH2CH2 7 (Haiti 135)" 8 (Haiti 135)" 
CH2CH2CH2 CH2CH2 CH2CH2 5 (Haiti 135)" 
CH(CH3)CH2 CH2CH2 CH2CH2 8 (Haiti 135)" 
CH(CH3)(CH2)J CH2CH2 CH2CH2 7 (Haiti 135)8 
(CH2)1O CH2CH2 CH2CH2 6 (Haiti 135)8 
(CH2)12 CH2CH2 CH2CH2 13 (Haiti 135)" 
CH(CH3)CH2 CH3 CH3 22 (NF54t 16 (NF54t 
" De et aI. 1996. b Ridley et a/. 1996. 





1G50 I nM = 1.74 (HB3)C 
IG50 I nM = 2 .93 (HB3)C IG50 I nM = 2 .73 (HB3)C 
mHN,-,::: I :::,.... h C I N 
94 
1C50 I nM = 0.9 (HB3)d 
H 
e = Ferrocene 
19 
IC50 I mgIKg·l (19) = 75.5 (P. Berghei)" 










Chapter 2: structurrrActivity Relationships in 4-Aminoquinolines 131 
Figure 4.13. 4-Aminoquinolines that have a chloro-group at the 7-position with varying side chains and a terminal 
amino group for accumulation all retain strong activity against malarial parasites. a De et al. 1996, b Ridley et al. 
1996, e Hawley et at. 1996, d 0' Neill et al. 1997, e Biot et al. 1997. 
1\ 1\ 





Figure 4.14. Some bis-quinolines that retain actMty against malaria parasites are 20 (Chen 1991), 21 
(Vennerstrom et al. 1992) and 22 (Ridley et al. 1997, Vennerstrom et al. 1998). 
It is important to note that the SAR hypothesis proposed above only pertains to 4-
aminoquinolines and does not include the quinoline methanols (ie mefloquine and quinine) 
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QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS 
IN 4-AMINOQUINOLINE ANTIPLASMODIALS 
5.1 BACKGROUND 
The current debate regarding the mode of action of CQ-related 4-aminoquinoline 
antimalarials is centred around whether these compounds exert a toxic effect solely through 
haemozoin inhibition or whether an alternative haem detoxification mechanism exists and 
that these compounds act by inhibition thereof (see Section 1.5.4.4). In Chapter 4, 
qualitative evidence was found in support of the hypothesis that CQ-related 4-
aminoquinoline antimalarials and antiplasmodials act by accumulating to therapeutic levels 
in the food vacuole of the malaria parasite through a strong pH trapping component, where 
they exert a toxic effect by inhibiting haemozoin formation. In this study, the 7-chloro group 
on the 4-aminoquinoline nucleus alone was identified as the critical structural feature 
necessary for ~-haematin inhibition. Further evidence that the substituent at the 7-position in 
4-aminoquinoline antiplasmodials is of critical structural significance for ~-haemati n 
inhibition, and that ~-haematin inhibition is directly related to the anti plasmodial activity is 
shown in a SAR study in which the 7-chloro group in CQ was replaced with nitro-, bromo-, 
hydro- and amino-groups (Vippagunta et a/. 1999) (Table 5.1.). Here, the 7-nitro and 7-
bromo analogues of CQ were found to strongly inhibit ~-haematin formation and exhibit 
strong anti plasmodial activity against malaria parasites. Conversely, the 7-hydro and 7-
amino analogues of CQ were found not to inhibit J3-haematin formation and showed only 
weak activity against malaria parasites. In addition, De et al. showed that analogues of CQ in 
which the 7-chloro group had been replaced with iodo- or bromo- groups were fully active 
against malarial parasites whereas the 7-trifluoromethyl, 7-f1uoro and 7-methoxyanalogues 
were about 2 and 7 fold less active than CQ respectively (Table 5.1.). In support of the 
findings in Chapter 4, that the side chain in CQ and related 4-aminoquinolines serves only as 
a linker between the structurally significant features responsible for antiplasmodial activity, 
De et al. found that 7-substituted 4-aminoquinolines with a short, linear 2-C side chain or a 
short, isopropyl side chain had essentially the same antiplasmodial activity as the 
corresponding CQ analogues (De et al. 1998). Although none of these analogues were 
tested for ~-haematin inhibitory activity, their antiplasmiodial activities appeared to depend 
solely on the group at the 7-position which has been identified as the structural feature 
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differences in antiplasmodial activities observed between these analogues may reflect their 
varying abilities to inhibit ~-haematin formation. 
Table 5.1. Apparent relationship between the group at the 7 -position of CQ and two other short chain 4-
aminoquinolines, and antiplasmodial activity 
X R I3-Haematin Inhibition ICso I nM 
ICsol ~ 
CQ sensitive strain NF548 
CI (CQ) CH(CH3)(CH2~ 15 ±5 13 
Sr CH(CH3)(CH2~ 18±2 93 
N02 CH(CH3)(CH2~ 100 ± 10 15 
H CH(CH3)(CH2~ >2500 350 
NH2 CH(CH3)(CH2~ >2500 2600 
Haiti 135" a 
CI (CQ) CH(CH3)(CH2~ Nd
c 8u 
CH2CH2 Nd r 
CH(CH3)CH2 Nd 8
d 





Sr CH( CH3)( CH2h Nd 5° 
CH2CH2 Nd 7
b 
CH(CH3)CH2 Nd 11b 
F CH(CH3)(CH2h Nd 20u 
CH2CH2 Nd 35
b 
CH(CH3)CH2 Nd 30b 
CF3 CH(CH3)(CH2h Nd 16° 
CH2CH2 Nd 30
b 
CH(CH3)CH2 Nd 50b 
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Since the presence of the 7-chloro group on the 4-aminoquinoline nucleus appears to be 
directly responsible for f3-haematin inhibition, it was decided to synthesise a series of 4-
aminoquinolines which retain all of the structural features identified in Chapter 4 as required 
for strong antiplasmodial activity, and differ only with respect to the group at the 7-position. 
These 7-substituted analogues were then used as probes to ascertain if a quantitative 
relationship exists between f3-haematin inhibition and antiplasmodial activity. 
In this regard, it was decided to synthesise a series of quinolines (Figure 5.2.) with (i) an 
amino group at the 4-position to ensure strong association with Fe(III)PPIX, (ii) the simplest 
possible side chain with a terminal amino group to ensure strong accumulation at the site of 
action in the food vacuole and (iii) with variation in the substituent at the 7 -position to test the 
hypothesis that f3-haematin inhibition is directly responsible for antiplasmodial activity. Even 
though all these 4-aminoquinoline analogues contain a terminal amino group for strong 
accumulation, it is possible that variation of the group at the 7-position may influence the pKa 
of the quinoline ring nitrogen and therefore the relative extent of accumulation between 
analogues. It was therefore decided to measure the pKa's of the 4-aminoquinoline analogues 
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5.2. EXPERIMENTAL METHODS 
5.2.1. Synthesis of the" -(7-X-4-quinolinyl)-N',N1-diethyl-1 ,2-ethanediamine 
Analogues 
135 
The ~-(7-X-4-quinolinyl)-Nl,Nl-<iiethyl-1 ,2-ethanediamine analogues, where X = NH2, OH, 
OCH3 , H, CH3, F, I, Br, CI, CF3 and N02 were all synthesised according to the procedures 
outlined in Chapter 2 (see Section 7.1.2. for experimental details). To ensure analytical 
purity of all the compounds, microanalysis for all the solids and HRMS for the oils were 
obtained. 
5.2.2. Spectrophotometric Titrations 
The association constants between Fe(III)PPIX and the 4-aminoquinoline analogues were 
determined by spectrophotometric titration in aqueous 40% DMSO mixtures according to the 
procedures outlined in Section 4.2.2 (see section 7.2.3 for experimental details). The raw 
titration data and plots thereof fitted to either a 1: 1 or 2:1 (quinoline:haematin) association 
model (derived in Chapter 7.2.3.5) appear in Appendix 1 and 2. 
5.2.3. ~·Haernatin Inhibition 
5.2.3.1. IR Method (Egan et al. 1994) 
Qualitative data for ~-haematin inhibition were obtained for the 4-aminoquinoline analogues 
by the infrared method of Egan et al. which is described in Section 4.2.3. (see Section 7.2.4. 
for experimental details and Appendix 3 for the infra red spectra). In short, this method 
unequivocally distinguishes between inhibitory and non-inhibitory compounds by 
examination of the infrared spectrum of the product formed in the ~-haematin reaction. All 
compounds were tested at 4 equivalents relative to haematin, a mole ratio that is inhibitory in 
the case of CQ. A positive result therefore implies that the compound has comparable 
inhibitory activity to CQ, and a negative result implies that the compound is significantly less 
inhibitory than CQ. 
5.2.3.1. BHIA Method (Parapini et al. 2000) 
The 4-aminoquinoline analogues were sent to Prof. D. Taramelli (Institute of Microbiology, 
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(Parapini et al. 2001) in order to obtain quantitative ~-haematin inhibitory 
method is based on the differential solubilisation of the starting material (haematin) and the 
product (j3-haematin) in DMSO and NaOH solution respectively. In this method, the BHIAso 
value corresponds to the number of equivalents of 4-aminoquinoline required to obtain 50% 
percent inhibition of 
experimental conditions. 
relative to a control experiment under the same 
pK.. Determinations 
The pKa's of the 4-aminoquinolines were determined by 
titration according to the methods of Jackson et al. 1996 Section 
eCl:rocle potentiometric 
for experimental 
of Chemistry, details) and the data were by Thembalani E Nomkoko 
University of Cape Town) using the program ESTA (May et a/. 1 
each case two pKa values were obtained. 
May et al. 1988). In 
Antiplasmodial Testing 
All the were sent to Prof. D. 
University of Milan) for antiplasmodial testing against the 
paraSite. No attempt was made to investigate the activities 
in these 
inherent 
uptake or enhanced 
of action of the 4-aminoquinoline 
5.2.6. Statistical Correlations 
correlations were performed 
(Institute of Microbiology, 
D 10 strain of malaria 
a CQ-resistant strain as 
is likely to mask the 
programs EXCEL and The 
GPAPHPAD 
considered to 
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5.3. RESULTS 
All the physical constants and biological results obtained for the 4-aminoquinoline analogues 
are presented in Table 5.2. These include: association constants between Fe(III)PPIX and 
the 4-aminoquinoline, J3-haematin inhibitory activities from the infrared assay and the BHIA 
assay, two pKa's obtained for each compound and the anti plasmodial activity against the 
CQ-sensitive D10 strain of malaria parasite. Also listed in Table 5.3 are the meta- and para-
Hammett constants (am and a p respectively) and lipophilicity constants (n) for the 
substituents (-X) (Hansch 1979). The meta- and para-Hammettt constants give a relative 
empirical measure of the meta and para n-electron withd rawing abilities of the substituent on 
an aromatic ring. Positive values of a indicate electron withdrawal from the aromatic system 
and negative a values indicate electron release into the aromatic system. The lipophilicity 
values give an indication of the relative affinity of the group towards organic-like or aqueous-
like phases. Positive values indicate that the group is lipophilic (partitions preferably into an 
organic phase) and a negative value indicates that the group is hydrophilic (partitions 
preferably into an aqueous phase). 
Table 5.2. Experimentally determined Fe(III)pPIX-quinoline association constants, acid dissociation constants, ~­




u logKC I3Hld BHIAso" ICsol nM 
83 NHz 8.36 ± 0.02 10.02 ± 0.01 4.35 ± 0.02 - >20 >5000 
82 OH 6.82 ± 0.01 8.953 ± 0.007 4.48 ± 0.02 - >20 3071 ± 112 
78 OCH3 8.094 ± 0.002 9.495 ± 0.002 4.83 ± 0.01 - >20 448± 40 
65 H 7.964 ± 0.003 9.422 ± 0.002 4.75 ± 0.03 - >20 1060 ± 103 
67 CH 3 8.118 ± 0.006 9.508 ± 0.004 4.86 ± 0.01 - 17 ±4 82 ±6 
75 F 7.62 ± 0.01 9.241 ± 0.009 4.60 ± 0.02 - 9.7 ±0.8 138 ± 26 
77 I 7.48± 0.02 7.79 ± 0.06 5.02 ± 0.02 + 2.8 ±0.2 35± 3 
76 Br 7.93 ± 0.02 7.97 ± 0.04 4.99 ± 0.01 + 4.4 ± 0.7 36 ± 1 
74 CI 7.56 ± 0.02 8.83 ± 0.01 5.81 ± 0.01 + 2.2 ±0.2 37±3 
80 CF3 7.50 ± 0.02 7.65 ± 0.03 4.67 ± 0.02 + 8±2 99±29 
79 N02 6.28 ± 0.03 8.80± 0.02 4.65 ± 0.02 + 3.1 ± 0.6 325 ± 170 
CQ 8.55 ± 0.05 9.81 ± 0.04 5.52 ± 0.02 + 1.7 ± 0.89 30± 1 
• All data represents an average of three independent determinations, errors represent one SD for pI<.. 
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7.5, 20mM HEPES buffer, 40% DMSO (aq). Data fitted to a 1:1 assodation model, d Positive (+) or negative (-) 
result obtained for j3-haematin inhibition assayed by the infrared method at 4eq of 4-aminoquinoline relative to 
haematin, e j3-haematin inhibitory activity in equivalents of 4-aminoquinoline relative to haematin causing 50% 
inhibition, r Concentration required to kill 50% of the CQ-sensitive D10 strain of malaria parasite, 9 Parapini et al. 
2001 . 
Table 5.3. The para- and meta-Hammett constants and the lipophilicity constants 
-x a O"m D 'ICc O"p 
NH2 -0.66 -0.16 -1.23 
OH -0.37 0.12 -0.67 
OCH3 -0.27 0.12 -0.02 
H 0 0 0 
CH3 -0.17 -0.07 0.56 
F 0.06 0.34 0.14 
I 0.18 0.35 1.12 
Br 0.23 0.39 0.86 
CI 0.23 0.37 0.71 
CF3 0.54 0.43 0.88 
N02 0.78 0.71 -0.28 
a para Hammett constant, b meta Hammett constant, C lipophilicity constant from Hansch and Leo 1979. 
5.4. DISCUSSION 
5.4.1. Effect of the group at the 7 -Position on PK.,1 and pK..z 
As seen from Table 5.2, the pKa of the quinoline ring nitrogen (pKal) is strongly dependent 
on the nature of the group at the 7 -position . This value varies over a range of 2 log units with 
the 7-nitro analogue having the lowest value (6.28 ± 0.03) and the 7-amino analogue having 
the highest value (8 .36 ± 0.02). These findings suggest that good n-electron donors (eg. 
NH2) raise the pKa of the quinoline ring nitrogen whereas strong n-electron withdrawing 
groups (eg . N02) decrease the pKa of the quinoline ring nitrogen. With the exception of the 
OH derivative, this is supported by the existence of good statistical correlations between 
PKal and the meta- or para- Hammett constants (am or ap respectively in Table 5.3) (Figure 
5.3). The apparently anomalous behaviour of the OH derivative may be an indication that the 
pKa of this derivative could correspond to deprotonation of the OH group rather than 



























-0.25 0 .00 0.25 0.50 0 .75 -1.0 -0.6 -0.2 0.2 0.6 
O"m O"p 
Statistical Variables A B 
r" 0.77 0.75 
P 0.0009 0.001 
Derivation from Zero Significant Significant 
Equation Describing PK..1 -1.70am + 8.01 -1.230"p + 7.80 
Figure 5.3. Statistical correlations between the quinoline ring nitrogen pKa (PKa1) and the meta- (A) and (B) para-
Hammett constants (crm and crp respectively) of the group at the 7-position on the quinoline ring . (e) experimental 
data pOints (excluding the 7-0H derivative (""». The straight line represents the best fit of the data to a linear 
equation. Error bars represent one standard deviation of the mean and are smaller than the plotted symbols. 
That a relationship exists between the electronic characteristics of the group at the 7-
position and the pI(" of the quinoline ring nitrogen is to be expected when considering their 
resonance relationship through the 1t quinoline ring system (Figure 5.4). It is somewhat 
surprising however, that the group at the 7-position has a large effect on the pI(" of the 
terminal amino group (pKa2) (Table 5.2). The values of pKa2 for the 7-substituted 4-
aminoquinolines ranges over 2.4 log units with the 7 -NH2 analogue having the highest value 
(10.02 ± 0.01) and the 7 -CF3 analogue having the lowest value (7.65 ± 0.03). Again a 
relationship exists between both the meta- and para-Hammettt constants of the group at the 
7 -position and the value of p~ (Figure 5.5) although in both cases it is far poorer than that 
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A 
Figure 5.4. Resonance relationship between the group at the 7-position and the quinoline ring nitrogen 
A B 
11 11 
10 10 • 
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-0.25 0.00 0.25 0.50 0.75 -1.0 -0.6 -0 .2 0.2 0.6 1.0 
am ap 
Statistical Variables A B 
r" 0.46 0.46 
p 0.02 0.02 
Derivation from Zero Significant Significant 
Equation Describing PK..1 -2.06crm + 9.37 -1.29crp + 8.94 
Figure 5.5. Statistical correlations between the terminal amino group pK. (PKe:!) and the meta- (A) or para-(B) 
Hammett constants (Om or Op respectively) of the group at the 7-position on the quinoline ring. The straight line 
represents the best fit of the data to a linear equation based on Om (for A) and 0p (for B), Error bars represent one 
standard deviation of the mean and are smaller than the plol1ed symbols in most cases. 
The more substituted, lengthened side chain in CQ appears to increase both pKal and pKa2 
relative to the 2-C side chain in the 7-chloro derivative (74) (Table 5.4.). This is presumably 
due to the enhanced a-electron donating ability of the more substituted side chain in CQ 
onto the quinoline ring nitrogen and the terminal-amino nitrogen. It is possible that this 
through-space interaction between the group at the 7-position and the terminal amino group 
in the 7-substituted 4-aminoquinolines would be lessened in an analogous family of 7-
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set of CQ analogues would be similar to that of CQ, and that the PKa1 values would be 
slightly higher than the analogous values for the 7 -substuituted analogues used in this study. 
Table 5.4. Comparison between pKa1 and pl<a2 obtained for CQ and 74. 
CQ 
74 
8.55 ± 0.05 
7.56 ± 0.02 
9.81 ± 0.04 
8.83 ± 0.01 
5.4.2. Relationship Between f}-Haematin Inhibition and Antiplasmodial Activity 
In agreement with the findings in Chapter 4, no quantitative relationship was found between 
the strength of Fe(III)PPIX association and antiplasmodial activity for the 7-substituted 4-
aminoquinoline analogues (Figure 5.6A). Furthermore, no significant correlation was found 
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Variables 
log ICso vs log K 







Deviation from zero 
Not significant 
Not significant 
Figure 5.6. Graphs and statistical variables demonstrating the lack of SignifICant correlation between 
antiplasmidial aclMly and (A) log K and (8) log BHIAoo . The straight line represents the best fit of the data to a 
linear equation. Error bars represent one standard error of the mean. 
The lack of any apparent correlation between antiplasmodial activity and l3-haematin 
inhibititory activity is in line with the structure-activity hypothesis that pH trapping in addition 
to l3-haematin inhibition is important for strong antiplasmodial activity. Since there is a 
substantial variation between the pKa's of the 7-substituted 4-aminoquinoline analogues they 
would be expected to accumulate in the food vacuole to different extents. From knowledge 
of the pK,,'s, the accumulation ratio (concentration of quinoline in the food vacuole relative to 
the medium) of each analogue from the medium (pH 7.4) into the vacuole (pH 5.5) could be 
calculated using Equation 1 (Box 1, See Chapter 7.2 for derivation) and the values are 
presented in Table 5 .5. 
The assumptions made in Equation 1 are that the vacuolar membrane is totally impermeable to the 
mono- and diprotonated 4-aminoquinoline species and that equilibrium concentrations of the neutral 
species is reached between external medium and vacuole. It is likely that these assumptions are not 
entirely correct although the predicted accumulation ratios based on Equation 1 probably give a good 




Here [O]v refers to the total vacuolar concentration of the 4-aminoquinoline and [Ole refers to its total 
extravacuolar concentration. The terms [H), and [H+]e refer to the vacuolar and extravacuolar 
hydrogen ion concentrations respectively and Ka1 and Ka2 refer to the first and second acid 
dissociation constants respectively. 
Box 1. Equation 1 derived from the Hendelson-Hesselbach equation in Section 7.2.3. that was used to calculate 
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If the accumulation ratio for each 7-substituted analogue is normalised relative to CQ (a. in 
Table 5.5), it is evident that the extent of pH trapping between the analogues varies 
substantially (between 9% for the 7-nitro analogue, and 97% for the 7-amino analogue 
relative to CQ). Since different vacuolar concentrations of the analogues may mask their 
inherent ability to exert their toxic effect, the IGso's were normalised to give an ICso value that 
was independent of the pH trapping effect (IGso x a.) (Table 5.5). 
Table 5.5. Accumulation ratios calculated from Equation 1, normalised accumulation ratios (a) and normalised 
ICso values (ICso x a) 
No. X Ace. RatioD aD ICso x at "Me 
83 NH2 5693 0.966 >4830 
82 OH 1347 0.228 700±26 
78 OCH3 5254 0.891 399± 32 
65 H 4963 0.842 893 ± 87 
67 CH3 5302 0.899 74±6 
75 F 3946 0.669 92± 17 
77 I 2937 0.498 17 ± 1 
76 Br 4607 0.781 28± 1 
74 CI 3706 0.628 23±2 
80 CF3 2844 0.482 48± 14 
79 N02 500 0.085 28 ± 15 
CQ 5896 1.000 32±2 
8 Vacuolar accumulation ratio calculated using Equation 1, b normalised vacuolar accumulation ratio relative to 
CQ, C normalised ICso. 
No significant correlation was found between the strength of Fe(III)PPIX-quinoline 
association and antiplasmodial activity, normalised for pH trapping, for the 7-substituted 4-
aminoquinoline analogues (Figure 5.7 A). An impressive correlation (~ = 0.83, P = 0.004) 
was however found between ~-haematin inhibition for the analogues that had measurable 
BHIAso values « 20 equivalents) and antiplasmodial activity normalised for pH trapping 
(Figure 5.7B). Furthermore, the four compounds that had BHIAso values above the 
measurable limit of the experiment, all had normalised antiplasmodial activities higher than 
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Figure 5.7. Graphs and statistical variables demonstrating (A) the lack of any significant correlation between 
normalised antiplasmodial actMty (log IC50xa.) and log K. and (8) the significant correlation obtained between log 
IC5Qxa. and log BHIA50. The straight line represents the best fit of the data to a linear equation. Error bars 
represent one standard error of the mean. 
In support of the findings in Figure 5.7B, Hawley et al. found a good correlation (r = 0.81, P 
= 0.026) between antiplasmodial activity for AQ, CQ and a series of AQ analogues and ~­
haematin inhibition, only when the former was corrected for accumulation into a malaria 
infected red cell (Hawley et al 1998) which had been measured in vitro by the innoculum 
effect. Dorn et al. also observed a good correlation (r = 0.91, P = 0.002) between 
antiplasmodial activity, uncorrected for accumulation, and ~-haematin inhibition for a range 
of structurally diverse known antimalarial drugs (Dom et al. 1998). This correlation is 
questionable when considering the broad spectrum of drugs that the authors included in 
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halofantrine) is thought to form a complex with Fe(III)PPIX via a different mechanism to the 
4-aminoquinolines (see Section 1.5.3.4.). Vippagunta et al. also observed a modest 
correlation (r = 0.61, P = 0.046) for a series of CQ analogues, between antiplasmodial 
activity and ~-haematin inhibition, only when the former was normalised for Fe(III)PPIX 
binding (Vippagunta et al. 1999). We find no such correlation with our data (r = 0.32, P = 
0.19) and indeed, upon closer scrutiny of their data, it appears that the correlation may be 
strongly weighted by a single outlying point. 
5.4.3. Insights into the Molecular Basis of Complex Formation and I3-Haematin 
Inhibition 
Evidence from this study suggests that active antiplasmodials all form strong complexes with 
Fe(III)PPIX, and inhibit ~-haematin formation. Complex formation appears to play an indirect 
role in antiplasmodial activity as not all compounds that associate strongly with Fe(III)PPIX 
exhibit antiplasmodial activity. Also no direct relationship has been found between the 
strength of Fe(III)PPIX-quinoline association and antiplasmodial activity. Since complex 
formation appears to be a prerequisite for antiplasmodial activity it would appear that it 
indirectly facilitates ~-haematin inhibition. 
Since the structures of the Fe(III)PPIX-quinoline complexes are unknown, it is not possible 
to gauge what effect the 7-substituent on the 4-aminoquinoline nucleus has in influencing 
any particular orientation within the complex that may result in ~-haematin inhibition. In order 
to gain some insight into the origin of these interactions, correlations were sought between 
the association constant and ~-haematin inhibitory activity for the 7-substituted 4-
aminoquinolines and tabulated empirical substituent constants (Table 5.3) using multiple 
cOrrelation analysis. 
It was found that a reasonable correlation exists between the association constant and the 
lipophilicity of the group at the 7-position (Figure 5.8A). In agreement with the findings in 
Chapter 4, that the 7-chloro group and the terminal amino-group appear to have a 
synergistic effect on increasing the strength of the association constant relative to other 4-
aminoquinolines, the 7-chloro analogue (74) appeared to be an outlier from the other data 
pOints. Its omission renders the correlation even better (Figure 5.8B). The apparent 
dependence of log K on the lipophilicity is in agreement with previous observations that the 
7t-7t complex arises from hydrophobic interactions between the quinoline and Fe(III)PPIX as 






















-2.0 -1 .5 -1 .0 -0.5 0.0 0.5 1.0 1.5 -1.5 -1 .0 -0.5 0.0 0.5 1.0 
1t 1t 
log Kvs 'It log K vs 'It (excl. el) 
r' 0.41 0.73 
P value 0.035 0.002 
Deviation from zero Significant Significant 
Equation describing log K 0.34x + 4.76 0.25x + 4.69 
Figure 5.S. Graphs and statistical variables demonstrating the dependence of the association constant on the 
lipophilicity of the group at the 7-posilion when (A) all 11 derivatives are correlated and (B) when all the 
derivatives excluding the 7 -chloro analogue ( .... ) are correlated. The straight line in both cases represents the 
best frt to the data using a linear equation. Error bars represent one standard error of the mean. 
The extent of p-haematin inhibition is Significantly correlated with both the strength of 
Fe(III)PPIX-quinoline association and am or a p (Figure 5.9B). The dependence of p-haematin 
inhibition on the strength of the Fe(III)PPIX-quinoline complex supports the hypothesis that 
complex formation is indirectly related to antiplasmodial activity through p-haematin 
inhibition. The finding that p-haematin inhibition is dependent on the electron withdrawing 
capacity of the group at the 7-position most likely highlights the electronic requirements in 
the quinoline ring responsible for adoption of a particular conformational alignment in the 
complex which is important for p-haematin inhibition. The magnitude of the coefficients in the 
correlation equation for am and log K indicate that the electronic effects in the quinoline are 
more important than the strength of association with Fe(III)PPIX in promoting p-haematin 
inhibition. This suggests that the conformational alignment of the compound in the complex 
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Figure 5.9. and statistical variables demonstrating the dependence of p-haematin inhibitory on 
the assodation constant and am (A) or op (B) of the group at the 7-position. The straight line rp""p!':Emtll: the besl 
frt of a linear to the data. Error bars represent one standard error from the mean. 
5.5. CONCLUSIONS 
Evidence from this study supports the hypothesis that 4-aminoquinoline antiplasmodials act 
by accumulating to 
important pH 
in food vacuole of the malaria parasite through an 
that here they exert their antimalarial by 
inhibiting l3-haematin formation. In support of previous observations (Hunter and Sanders 
1991, at 1 
stability appears to be n",,,'om 
found to 
PhD 2001), the Fe(III)PPIX-quinoline rnnnnl,.y 
by hydrophobic interactions. Antiplasmodial activity was 
on Fe(III)PPIX-quinoline association through j3-haematin 
inhibition. The electron withdrawing ability of the substituent at the 7-position was found to 
be of in inhibition than the strength of association 
with Fe(III)PPIX. This is presumably related to the ability of the complex to adopt a particular 
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The results from this study partly explain why CQ is a particularly good antimalarial. The 
chloro-group at the 7 -position is sufficiently lipophilic to promote strong Fe(III)PPIX-quinoline 
association, and sufficiently electron withdrawing to promote strong ~-haematin inhibition. 
This group is however not too electron withdrawing so as not to lower the pKa's of the 
quinoline ring nitrogen and the terminal amino nitrogen to too large an extent, This would 
lower the extent of pH trapping into the food vacuole. 
These results are also consistent with reported antiplasmodial activities for families of 4-
aminoquinolines with varying side-chains (De et a/. 1998). All these compounds exhibited 
strong antiplasmodial activity when the substituent at the 7-position was chloro, bromo or 
iodo. This is presumably because chloro, bromo and iodo are sufficiently lipophilic (1t = 0.71 -
1.12) to interact strongly with Fe(III)PPIX, and are moderately electron withdrawing (crm = 
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CONCLUSIONS AND FUTURE WORK 
6.1. CONCLUSIONS 
In this project, the nature of the ferriprotoporphyrin IX (Fe(III)PPIX) drug target was 
investigated. The critical structural features on CQ-related 4-aminoquinolines responsible for 
Fe(III)PPIX-quinoline complexation, ~-haematin inhibition and pH trapping were also probed 
to investigate the mechanism of action of this class of compounds. 
It was found that haematin in aqueous solution is extensively dimerised and that aggregates 
higher than dimers do not exist. The structure of the haematin dimer is not a IJ.-oXO dimer as 
previously thought (Brown et al. 1970) but is a proposed 7t-7t dimer in which an axial water 
ligand points outwards from each of the iron centres. This was evidenced by the apparent 
pH-independence of the dimerisation constant which was found to have a log KD of 7.2 ± 
0.2, and the apparent differences in the charge transfer region of the uv-vis spectrum of the 
aqueous haematin dimer and the IJ.-OXO dimer. It is also supported by observation of pH-
dependent differences in the charge transfer spectrum of the aqueous dimer that would not 
occur in the IJ.-OXO dimer. 
The proposed structure of the haematin 7t-7t dimer can likely explain why association 
constants obtained between antimalarial drugs in pure aqueous media and 40% DMSO (aq) 
(in which haematin is reported to be strictly monomeric) are very similar (Egan et al. 1997, 
Mavuso PhD Thesis 2001) and follow the same trends (Dom et al. 1998). This is presumably 
because both the structures of the aqueous haematin dimer and the haematin monomer in 

























Fe :.:: ferriprotoporphyrin 
150 
Figure 6.1. Possible structures of the predominant haematin-quinoline complex at pH 7.4 (101 and 103). Here 
the 4-aminoquinoline interacts with the porphyrin of the stacked 1t-'1C dimer on either the top face (103) or in 
between the two monomer units of the dimer (101). For comparison, the structures of the haemalln-
quinoline in 40% DMSO at pH 7.4 (102 and 104) where the fifth coordination site is occupied by the 
oxygen atom of a DMSO molecule (Brown and Lant2i<e 1 Again the 4-aminoquinoline is proposed to interact 
with the porphyrin on either the top (104) or the bottom (102) face of the porphyrin ring. The proposed 
structure of the "It-'1C dimer likely why associatiOn constants obtained in 40% DMSO and in pure aqueous 
solutiOn are similar as both haemalln have oxygen as an axial ligand. 
In this study, interactions between the aminoquinolines haematin-DMSO monomer 
in vitro were used to model interactions that occur between aminoquinolines and the 1t-1t 
dimer in vivo. It was found that 4-aminoquinoline nucleus is critical structural 
in CQ related quinolines Fe(III)PPIX-quinoline complexation. 7-
chloro group the terminal amino group were found to have relatively little on the 
strength of Fe{lIl)PPIX association although a combination of these two structural features 
increased the association constant significantly relative to 4-aminoquinoline. In a series of 7-
substituted 4-aminoquinolines, the association constant was found to depend on the 
lipophilicity of the at 7 -position which is in agreement with 
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In support of previous observations encompassing a wide range of quinoline antimalarial 
(Dom et al. 1998) and antiplasmodials (Vippagunta et al. 1999), no direct relationship was 
found between the strength of Fe(III)PPIX association and antiplasmodial activity. This 
supports the view that formation of a strong complex with the heamatin target is not 
sufficient for antiplasmodial activity. 
It was found that the 7 -chloro group in CQ is the critical structural feature responsible for ~­
haematin inhibition. In the series of 7-substituted 4-aminoquinolines studied, a direct 
relationship was found between antiplasmodial activity and ~-haematin inhibition only when 
the latter was corrected for pH trapping (~ = 0.83, P = 0.004). This result strongly implies 
that 4-aminoquinoline antiplasmodials act bydirecty inhibiting ~-haematin formation. In tum, 
the strength of ~-haematin inhibition was found to depend on both the association constant 
and the electron withdrawing capacity of the group at the 7-position which highlights the 
indirect role that complex formation plays in antiplasmodial activity. A recent study has found 
that saturable CQ uptake is due solely to binding to haematin (Bray et al. 1999). Whilst 
binding to the haematin target is important in overall drug accumulation, the results from this 
study highlight the significant contribution that pH-trapping plays in overall accumulation and 
hence antiplasmodial activity. 
There have been various hypotheses proposed for the resulting toxicity of the haematin-
quinoline complex. These hypothesies are based on the premise that additional haematin 
detoxification mechanisms to haemozoin formation exist in the food vacuole (Loria et al. 
1999) or in the cytosol (Ginsburg et al. 1998) and that CQ and related aminoquinolines act 
by inhibiting these pathways through Fe(III)PPIX-quinoline complexation. There is a 
possibility that ~-haematin inhibitory activity is quantitatively correlated to one or both of 
these putative haematin detoxification pathways thereby masking the true basis of 
anti plasmodial activity and giving rise to the observed correlation between ~-haematin 
formation and antiplasmodial activity. No direct correlation between ~-haematin formation 
and the other two haematin detoxification mechanisms have however been shown to exist. 
In addition, strong evidence that all the haemoglobin-derived haematin is not converted to 
haemozoin has yet to be provided. The most obviOUS interpretation of the observed 
correlation is that the 4-aminoquinoline antiplasmodials act by directly inhibiting ~-haematin 
formation 
Based on these observations the following hypothesis on the mechanism of action of N, N-
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The 4-aminoquinoline antiplasmodials enter the food vacuole via passive diffusion of the free 
base accross the vacuole membrane. Once inside the food vacuole a substantial proportion 
of the 4-aminoquinoline becomes mono- and diprotonated, and binds to the 1t-1t haematin 
dimer. These chemical processes result in more free base diffusing across the membrane by 
Le Chateliers principle until the equilibrium concentrations of free base on both sides of the 
membrane are equal. It is proposed that these two processes account in total for the 
observed 1700 fold accumulation of CQ into the paritisised cell. In tum, these vacuolar 
concentrations are required to inhibit haemozoin formation which results in a build-up of non-
haemozoin haem. This free haem is proposed to cause a toxic effect, possibly by 




~ Fe(1 II lPPIX-quinoline complex 
~ 
..... Haemoz~n 
A = Serum. pH 7.4 
B = Red blood cell. pH 7.4 
C = Parasite cytosol. pH 7.4 
D = Food vacuole. pH 5.2 - 5.6 
Figure 6.2. Proposed model for the mechanism of action of N, N-diethyl-N2-(7X-4...quinolinyf)1 ,2-ethanediamine 
antiplasmodials. The aminoquinolines are proposed to accumulate to the therapeutically required levels through 
a combination of pH trapping and saturable binding to a haematin target in the acidic food vacuole of the 
intraerythrocytic malaria paraSite. Heamatin binding is essential for the aminoquinolines to extert their toxic effect 
by inhibiting the haematin detoxification pathway (haemozoin formation). This results in a build up of free 
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Since close analogues of CQ maintain activity against CQ resistant parasites, it appears that 
the resistance mechanism does not involve any change to the haematin target but rather 
involves a compound specific resistance. Insights gained from this study further enhance our 
understanding of the structural-function relationships in CQ and allow for the rational design 
novel antimalarials based on the CQ template (Figure 6.3). 
Tolerates a broad range of functionality 
H N--(~1r---• ...-:: .... R_2 ___ Ternimal amino-group 




- Moderately electron withdrawing 
Figure 6.3. Proposed structural and electronic requirements for antiplasmodial actMty based on the 4-
aminoquinoUne template. Key: (- ) group at the 7-position required for ~-haematin inhibition, (- ) 4-
aminoquinoline template required for strong association with Fe(III)PPIX, (- ) amino-groups required for pH 
trapping. 
The 4-aminoquinoline template is required for strong association with Fe(III)PPIX and this in 
tum is further influenced by the lipophilicity of the group at the 7 -position. The group at the 7-
position must also be moderately electron withdrawing to promote ~-haematin inhibition, but 
not too electron withdrawing so as to lower the pKa's of the quinoline and terminal amino 
nitrogens and therby lower the extent of pH trapping into the food vacuole. A wide variety of 
functionality can be tolerated in the lateral side chain which must contain a terminal amino 
group for pH-trapping . Literature evidence suggests that this is the key structural feature for 
cross resistance with CQ. Thus sufficient alteration of this group should result in compounds 
active against resistant parasites. 
6.2. FUTURE WORK 
Using the statistical equations obtained in Chapter 5, it is now possible to rationally design 
novel N1-(4-aminoquinolinyl)-~,~-diethylenediamine antimalarials. Choice of the lipophilic 
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aminoquinoline template are predicted to have the strong association constants, good P-
haematin inhibitory activities and strongly active antiplasmodial activities presented in Table 
6.1. 
Table 6.1. (top) Meta-Hammett constant and lipophilicity constants for OCF3 and SCF3 groups. (bottom) 
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63 
Since 2-aminoquinoline associates strongly with Fe(lII )PPIX, it is possible that introduction of 
chlorine or another moderately electron withdrawing group at the 7-position will cause the 
resulting 2-amino-7-chloroquinoline to inhibit p-haematin formation . If so, it may be possible 
to synthesise 2-aminoquinoline antiplasmodials based on this template (for example 101 in 
Figure 6.4). In addition, it has not been established if 2,4-diaminoquinoline has the ability to 
form a strong complex with Fe(III)PPIX and if 2,4-diamino-7 -chloroquinoline has the ability to 
inhibit p-haematin formation. If both the answers to these questions are positive, then a 
disubstituted analogue like 102 may have useful antiplasmodial properties. Since thiophene 
is an isostere for benzene (King 1994), it may be possible that the pyridinethiophene ring 
system (eg in 103) may behave in a similar a manner to quinoline which may provide a new 
template on which to base rationally designed antiplasmodials. 
In order to rationally design antimalarials other than 4-aminoquinolines it will be necessary in 
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inhibition. In this regard, it will be necessary to study the molecular interactions in the 
complex using computational methods, taking into account the molecular orbitals and 
solvent interactions. 
Although evidence from this study supports the hypothesis that CQ-related 4-
aminoquinolines act by inhibiting haemozoin formation, proof for this hypothesis has not 
been provided in vivo. In order to unequivocally establish the validity of this hypothesis, it 
would have to be shown that and 4-aminoquinolines are capable of blocking 
haemozoin formation in vivo, and that this effect is dose dependent. This would presumably 
have to be investigated using a physical technique (eg Mossbauer spectroscopy) which is 
capable of distinguishing unequivocally between haematin iron, haemozoin iron and iron in 
the Fe(lIl)PPIX-quinoline complex. 
a 
103 
Figure 6.4. Proposed compounds that may exhibit antiplasmodial activity 
the to compound specific rather than target 
specific, compounds that act by interacting with the Fe(III)PPIX target and inhibiting 13-
"''''r''''''':,n formation may still find utility in malaria chemotherapy. Since the 4-aminoquinoline 
of compounds acts via this mechanism. it 
aminoquinoline antimalarials based on the in 
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EXPERIMENTAL 
7.1. SYNTHETIC METHODS 
) 
7.1.1. General Procedures 
Reactions were monitored by thin layer chromatography using Merck F254 aluminium-backed 
precoated silica gel plates and were visualised with a combination of ultraviolet light and 
iodine vapour. Silica gel column chromatography was performed using Merck kieselgel 60: 
70 - 230 mesh for gravity columns and 230 - 400 mesh for flash chromaography. Neutral 
alumina chromatography was performed using 70 - 230 mesh (activity 1). Melting points 
were determined either using a Reichert-Jung Thermovar hot stage microscope or using 
Differential Scanning Calorimetry (DSC). Infrared spectra were recorded as DMSO or 
chloroform solutions or as KBr discs using a Perkin Elmer Paragon 1000 FT-IR 
spectrophotometer or a Perkin Elmer 983 IR spectrophotometer in the range 3600 -
800cm-1. 1H and 13C nmr were recorded on a Varian VXR-200 spectrometer at 200MHz, 
Varian Mercury spectrometer at 300M Hz or a Varian Unity spectrometer at 400MHz. All 
spectra were recorded in deuterochloroform or deuterodimethylsulfoxide using internal 
standards for 1H nmr of DH = 7.26ppm and respectively and for 13C nmr of Dc = 54.39ppm 
and 40.35ppm respectively. All chemical shifts are reported in ppm. Elemental analyses 
were performed using a Fison's Instruments Elemental Analyser EA 1108. Mass spectra 
were recorded on a VG micromass 16F spectrometer operating at 70eV with an accelerating 
voltage of 4kV and a variable temperature source. Accurate mass determinations were 
performed on a Kratos Limited MS9/50 spectrometer. All mass spectra were performed 
using electron impact techniques. 
Commercially available chemicals used in the synthetic work were obtained from the 
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A solution of phosphorus oxychloride (5ml, 54mmol) and 2-hydroxyquinoline (25) (0.49g, 
3.4mmol) was heated in a tube, sealed under N2 at 100°C for 2h. The reaction mixture was 
then cooled and NaHC03 (aq) added until pH 8 was obtained. The resulting solid was then 
extracted into ethyl acetate (four times), dried over anhydrous MgS04 and the solvent 
removed under reduced pressure to give, after drying, 1 (0.44g, 79%), mp 32 - 34°C (lit. 
Aldrich Catalogue 2000, 34 - 37°C); (Found MS (EI) mlz% 163 (M+, 100). Requires for 
CJH6NCI: M+, 163). 
Method B 
To a cooled solution of. phosphorus oxychloride (30ml), under N2, quinoline 1-oxide (27a) 
(3.8g, 23mmol) was added slowly over 45mins and then refluxed at 65°C for 1h. The 
reaction mixture was then poured onto ice (150g) and 25% ammonia (aq) added until the 
solution was alkaline. Extraction of the products into ethyl acetate (three times), followed by 
drying over anhydrous MgS04 and evaporation under reduced pressure gave a mixture of 
products which were chromatographed on silica gel using mixtures of ethyl acetate : 
petroleum ether (0:100) to (20:80) as the eluent to give 24 (2 .6g, 69%) and 4-chloroquinoline 
(30a) (0.79g, 21 %). MS for 24 identical to that found for the product in Method A. 1H NMR of 





To a stirred solution of quinoline (5.0cm3 , 42mmol) in glacial acetic acid (13.1cm3 , 228mmol) 
at 65°C was added 30% H20 2 (7.2 cm
3
, 64mmol). After 6h, a further quantity of 30% H20 2 
(7.2cm3 , 64mmol) was added and the reaction mixture heated at 65°C for a further 20h. The 
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products were extracted into chloroform (three times), dried over anhydrous MgS04 and the 
extracts concentrated again. On standing, the residue solidified to give 28a (5.46g, 89%). 
The crude extract was then used directly; (Found MS (EI) mlz% 145 (M+, 100). Requires for 
CgH7NO: M+, 145). 
7 -Methylquinoline-1-oxide (28b) 
To a stirred solution of 7-methylquinoline (0.40g, 2.8mmol) in glacial acetic acid (0.90cm3 , 
16mmol) at 70°C was added 30% H20 2 (0.33cm
3
, 2.9mmol). After 20h, a further quantity of 
30% H20 2 (0.47cm3 , 4.1 mmol) was added and the reaction allowed to proceed at 70°C for a 
further 20h. The reaction mixture was then concentrated in vacuo and basified to pH 8 with 
portions of saturated NaHC03 (aq). The mixture was extracted into chloroform (four times), 
dried over anhydrous Na2C03 and the extracts concentrated again to yield a beige solid 28b 
(0.414g, 93%). The crude extract was then used directly. 
4-Nitroquinoline-1-oxide (29a) 
To a stirred solution of 28a (2.7g, 19mmol) in trifluoroacetic acid (60cm3 , 78mmol) at 60°C, 
was added 5.7g (56mmol) of KN03 in a single addition . After 1 hr at this temperature, the 
reaction mixture was poured onto iced water (400cm\ The solution was basified with cold 
saturated K2C~ (aq) and the products extracted into dichloromethane (four times). The 
solvent was then removed under reduced pressure and brine (100ml) added to the residue. 
The organic products were extracted into dichloromethane (four times), dried over 
anhydrous K2C03 and evaporated under reduced pressure to give two products which were 
separated by silica gel chromatography (60g) using mixtures of acetonitrile : 
dichloromethane (20:80) to (50:50) as the eluent. The major product 29a (2.7g, 77%) was 
crystallised from acetone to give fine yellow needles, mp 157°C (DSC) (lit. Yokoyama et a/. 
1997, 157°C; Ochiai 1953, 153 - 154°C); vmaxfcm·
1 (CH2Cb) 1522, 1345 (Ar-N02) ; OH 
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8.84 (1H, m); (Found: MS (EI) mlz% 190 (M+, 100). Requires: M+, 190); (Found: C, 56.8; H, 
3.1; N, 14.8%. Requires for CgH6N20 3: C, 56.8; H, 3.2; N, 14.7%). 
7 -Methyl-4-nitroqLiinoline-1-oxide 29b 
To a stirred solution of 28b (0.41g, 2.6mmol) in trifluoroacetic acid (20cm3 , 26mmol) at 65°C, 
was added KN03 (0.8g, 7.9mmol) in a single addition. After 1 hr at this temperature, the 
reaction mixture was poured onto ice. The solution was basified with cold saturated K2C03 
and the products extracted into dichloromethane (four times). The combined organic layers 
were evaporated under reduced pressure, washed with brine and the organic products 
reextracted into dichloromethane (four times), dried over anhydrous K2C03 and evaporated 
under reduced pressure. The solid residue was crystallised from acetone to give 29b (0.42g, 
79%), mp 165 - 168°C (lit. Takahash i et al. 1983, 165°C); vrnaxlcm·1 (KBr) 1515,1328,1289, 
1153,823; cH(400MHz, CDCI3 ) 2.63 (3H, s, CH3 ), 7.69 (1H, dd, J 8.9,1.7, H-6), 8.11 (1H, d, 
J 6.8, H-2), 8.47 (1 H, d, J 6.8, H-3), 8.56 (1 H, m, H-8), 8.72 (1 H, d, J 8.9, H-5); (Found: MS 
(EI) mlz% 204 (M+, 57), 30 (100). Requires: M+, 204); (Found: C, 59.1; H, 3.9; N, 13.8%. 
Requires for C1QHsN20 3: C, 58.8; H, 4.0; N, 13.7%). 
4-Chloroquinoline 30a 
To a stirred room temperature solution of 29a (0.98g, 5.2mmol) in dry dichloromethane 
(7cm3 ), was added phosphorus trichloride (5.0cm3 , 57mmol) under nitrogen, dropwise. After 
6h at room temperature, a further quantity of phosphorus trichloride (1.0cm3 , 11 mmol) was 
added and the mixture refluxed under nitrogen at 60°C for a further 50h. The reaction 
mixture was then poured onto ice (100g) and basified with cold saturated NaHC03 (aq) 
followed by saturated KOH (aq). Brine was added to the aqueous phase to facilitate 
extraction of the products into ethyl acetate (four times). The combined organic layers were 
dried over anhydrous MgS04 and evaporated under reduced pressure. The mixture was 
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hexane (1 :99) to (10:90) as the eluent to give 30a (0.66g, 78%) as the major product in the 
form of a pale yellow oil, (lit. mp Aldrich Calatague 2000, 29 - 32°C). 8H (400MHz, CDCI3) 
7.50 (1H, d, J4.8, H-3), 7.67 (1H, td, J7.6, 1.2, H-6 or H-7), 7.80 (1H, td, J7.6, 1.2, H-6 or 
H-7), 8.18 (1 H, dd, J 8.6, 1.2, H-5 or H-8) 8.26 (1 H, dd, J 8.6, 1.2, H-5 or H-8), 8.80 (1 H, d, J 




A minor product of lower polarity, 2,4-dichloroquinoline (32) was isolated (80mg, 6.6%) and 
crystallised from petroleum ether, mp 62 - 64°C (lit. Beak et al. 1972,64.5 - 65.5°C; Shah et 
aI, 1960,66 - 67°C); 8H (200MHz, CDCI3 ) 7.52 (1H, s, H-3), 7.66 (1H, td, J 7.7,1.2),7.80 
(1H, td, 7.7,1.2),8.04 (1H, d, J 8.4),8.20 (1H, dd, J 8.4,1.2); 8c(50.3MHz, CDCI3 ) 121.9, 
124.2, 125.2, 127.9, 129.0, 131.5, 144.3, 148.1, 149.8; (Found: MS (EI) mlzO!6 197 (M+, 100). 




A slightly less polar product than 30a, 2-chloro-4-nitroquinoline (33) (40mg, 3.1 %) was also 
isolated from the reaction and crystallised from petroleum ether, mp 82 - 84°C (lit. Belli 1963, 
81 - 81.5°C); vrnax lcm,1 (KBr) 1523, 1341 (Ar- NOz); 8H (400MHz, CDCh) 7.78 (1H, td, J7.8, 
1.2), 7.90 (1H, td, J 7.8, 1.2), 7.95 (1H, s, H-3), 8.17 (1H, dq, J 8.6, 1.2,0.6),8.37 (1 H, dq, J 
8.6,1.2,0.6); 8c(100.6MHz, CDCh) 117.0,117.7,123.0,129.4,130.0,132.2,149.8,150.6, 
153.8; (Found: MS (EI) mlzO!6 208 (M+, 91),150 (100). Requires: M+, 208); (Found: C, 51.9; 
H, 2.5; N, 13.4%. Requires for CJH5NzOzCI: C, 51.8; H, 2.4; N, 13.4%). 
7 -Methyl-4-chloroquinoline (30b) 
To a stirred room temperature solution of 29b (0.16g, 0.79mmol) in dry dichloromethane 
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at room temperature, a further quantity of phosphorus trichloride (0.3cm3 , 3.4mmol) was 
added and the mixture refluxed under nitrogen at 55°C for a further 40h. The reaction 
mixture was then poured into iced water (20ml), basified with cold NaHC03 (aq) followed by 
KOH (aq). The products were extracted into ethyl acetate (four times), dried over anhydrous 
MgS04 and evaporated under reduced pressure. The residue was chromatographed on 
silica gel (15g) using elution mixtures of ethyl acetate: petroleum ether (1 :99) to (9:91) to 
give the major product 30b (0.11g, 75%) as an oil, (lit. mp Breslow et a/. 1946, 28°C); 
(Found: MS (EI) mlzO/o 177 (M+, 100). Requires for ClOHsNCI: M+, 177). 





A mixture of 3-fluoroaniline (8.7ml, 90mmol) and diethyl ethoxymethylenemalonate (18 .2ml, 
90.0mmol) was stirred in an open flask at room temperature for 0.5hr. The reaction mixture 
was then heated for 2h at 70De on the rotary evaporator. Upon standing at room 
temperature overnight. 51a precipitated out of solution. Collection of the solid by filtration 
followed by recrystallisation from ethanol yielded a hard pale yellow solid (21g. 83%), mp 
44.7 - 45.9°C (lit. Shah and Coats 1977.47 - 48°C); ~ (300MHz. CDCb) 1.32 (3H. t. J 7.2. 
CH3). 1.37 (3H. t. J 7.2, CH3). 4.25 (2H. q. J 7.2, CH2), 4.30 (2H. q. J 7.2. CH2). 6.85 (3H, m, 
Ar-H), 7.31 (1H, m, H-5), 8.44 (1H. d. J 13.5, vinylic H), 10.97 (1H. bd. J 13.5. NH); Oc 
(75.5MHz, CDCb) 14.2 (CH3). 14.4 (CH3 ). 60.2 (CH 2). 60.5 (CH 2), 94.6 (C=CH). 104.3 (Jc-F 
26. C-2 or C-4), 111.5 (JC-F 21. C-2 or C-4). 112.8 (JC-F 3. C-6), 131.2 (JC-F 10. C-5). 141.0, 
(JC-F 10. C-1). 151.3 (C=CH), 163.6 (J248. C-3), 165.4 (C=O). 168.9 (C=O); (Found: MS (EI) 
mlz% 281 (M+, 100). Requires: M+, 281); (Found: C, 59.5; H, 5.7; N, 4.9%. Requires for 
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A mixture of 3-bromoaniline (10g. 58mmol) and diethyl ethoxymethylenemalonate (13g, 
60mmol) was stirred at room temperature for 0.5h and then heated under reduced pressure 
at 60°C for 2h. Initially a lot of bubbling was observed 'as the ethanol produced was 
liberated. Upon cooling. a red/rust solid came out of solution. This was crystallised twice 
from ethanol to yield 51b (18g, 88%), mp 70 - 72°C (lit. Conroy et a/1949, 70 - 71°C); OH 
(300MHz, COCb) 1.33 (3H, t, J 7.2, CH3), 1.37 (3H, t, J 7.2, CH3), 4.22 - 4.34 (4H, m, J 7.2, 
2 x CH2), 7.05 (1 H, dt, J 7.5,2.0,2.0, Ar-H), 7.20 - 7.30 (3H, m, 3 x Ar-H), 8.44 (1 H, d, J 
13.4, vinylic H), 11.0 (1 H, bd, J 13.4, NH); Oc (75.5MHz, COCh) 14.2 (CH3), 14.4 (CH3). 60.3 
(CH2), 60.6 (CH2), 94.7 (C=CH), 115.8 (Ar-CH), 120.1 (Ar-CH), 123.5 (C-3), 127.7(Ar-CH), 
131.1 (Ar-CH), 140.6 (C-1), 151.2 (C=CH), 165.5 (C=O). 168.9 (C=O); (Found: MS (EI) 
mlzO/o 343 «M+2r, 88), 341 (M+, 89),297 (89),295 (87),29 (100). Requires: (M+2r, 343; 
M+, 341); (Found: C, 49.3; H, 4.5; N, 4.0%. Requires for C14H16N04Br: C, 49.1; H, 4.7; N, 
4.1%). 
Ethyl 2-ethoxycarbonyl-3-(3-iodoanilino)-3-propenoate (51c) 
A mixture of 3-iodoaniline (10g. 46mmol) and diethyl ethoxymethylenemalonate (11g, 
50mmol) was stirred at room temperature for 0.5h and then under reduced pressure for 
10mins. Initially a lot of bubbling was observed as the ethanol produced was liberated, The 
resulting solid was crystallised from ethanol to give 51c (15, 83%), mp 90 - 92°C (lit. Conroy 
et a/1949, 92 - 93°C; Counsell et a/1967, 88 - 89°C); 8ri (400MHz, COCb) 1.33 (3H, t, J 7.2, 
CH3), 1.37 (3H, t, J 7.2, CH3), 4.25 (2H, q, J 7.2, CH2), 4.30 (2H, q, J 7.2, CH2), 7.08 (2H, m, 
2 x Ar-H), 7.47 (2H, m, 2 x Ar-H), 8.42 (1H, d, J 13.8, vinylic H), 10.93 (1H, bd, J 13.8, NH); 
eSc (100.6MHz, COCh) 14.2 (CH3), 14.4 (CH3), 60.3 (CH2), 60.5 (CH2), 94.8 (C=CH), 94.9 (C-
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165.5 (C=O), 168.9 (C=O); (Found: MS (EI) mlz% 389 (M+, 100). Requires: M+, 389); 
(Found: C, 43.5; H. 3.9; N, 4.0%. Requires for C14H1e1\1041: C, 43.2; H. 4.1; N, 3.6%). 
Ethyl 2-ethoxycarbonyl-3-(3-nitroanilino)-3-propenoate (51 d) 
A mixture of 3-methoxyaniline (10g. 81mmol) and diethyl ethoxymethylenemalonate (17ml. 
83mmol) was heated in an open flask at 105°C for 1 h. Petroleum ether was added to the 
warm reaction mixture and the insoluble starting material filtered off. The residue was 
evaporated under reduced pressure and dried to give 5id (23g, 91%), mp 39 - 41°C; OH 
(400MHz, CDCla) 1.30 (3H, t. J 7.2. CHa), 1.36 (3H, t, J 7.2, CHa), 3.80 (3H, s, OCHa). 4.22 
(2H, q, J 7.2. CH2). 4.29 (2H. q. J 7.2, CH2), 6.63 (1 H, t, J 2.4, H-2), 6.67 (1 H, ddd, J 8.2, 
2.4, 0.8, Ar-H), 6.71 (1H, dd, J 8.2,2.4, Ar-H), 7.24 (1 H, t, J 8.2, H-5), 8.48 (1H, d, J 14, 
C=CH), 10.93 (1 H, d, J 14, NH); Be (100.6MHz, CDCb) 14.3 (CHa), 14.4 (CH3). 55.4 (OCH3), 
60.1 (CH2), 60.4 (CH2), 93.7 (C=CH), 103.3 (C-2), 109.4 (Ar-CH).110.3 (Ar-CH), 130.7 (C-
5), 140.5 (C-1), 151.8 (HC=C), 160.9 (C-3), 165.7 (C=O), 169.0 (C=O); (Found: MS (EI) 
mlz% 293 (M+, 87). 247 (100). Requires: M+. 293); (Found: C. 61.7; H. 6.7; N, 4.8%. 
Requires for C15H19N05: C. 61.4; H. 6.5; N. 4.8%). 




A solution of 3-nitroaniline (50g, 0.36mol) and diethyl ethoxymethylenemalonate (80g. 
0.37mol) was stirred in an open flask at 110°C for 1hr. The mixture was then cooled slightly 
and hot ethanol (400ml) added. Upon cooling, canary-yellow crystals of 51e were obtained 
(1 06g, 95.3%), mp 82 - 83°C (lit. Vippagunta et al. 1999, 81 - 82°C); OH (300M Hz, de DMSO) 
1.26 (6H, t, J 7.2,2 x CH3). 4.18 (4H. bs, 2 x CH2), 7.65 (1 H, t, J 8.2. H-5), 7.85 (1 H. ddd. J 
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C=CH), 10.71 (1H, s, NH); (Found: MS (EI) mlz% 308 (M+, 82).206 (100). Requires: M+, 
308); (Found: C, 54.8; H, 5.6; N, 9.2%. Requires for C14H1SN20S: C, 54.6; H, 5.2; N, 9.1 %). 
Ethyl 24thoxycarbonyl-3-(3-hydroxyanilino)-3-propenoate (51f) 
A vigorously stirred mixture of 3-hydroxyaniline (20.1 g, 184mmol), diethyl ethoxy-
methylenemalonate (38.0ml, 188mmol) and methanol (20ml) was refluxed at 80°C for 0.5h. 
During this time, the insoluble white f1akey starting material changed to a powdery white 
solid. This solid was crystallised from methanol and ethanol directly from the reaction flask. 
Collection of the crystals by filtration followed by drying gave 51f (48g, 91 %), mp 151 -
153°C; vrnaJcm,1 (KBr) 3337,1691,1648,1593,1320,1256,1216,1159,1089,1080; OH 
(300MHz. ds DMSO) 1.25 (6H, m, 2 x CH3), 4.12 (2H, q, J9.6, CH2), 4.20 (2H, q, J9.6, CH2), 
6.58 (1 H, ddd, J 10.9, 2.9, 1.1, Ar-H), 6.70 (1 H, t, J 2.9, H-2), 6.75 (1 H, ddd, J 10.9, 2.9, 1.1 
Ar-H), 7.17 (1H, t, J 10.9, H-5), 8.34 (1H, d, J 13.8, C=CH), 9.68 (1H, bs, OH), 10.57 (1H, d, 
J 13.8, NH); Oc (75.5MHz, ds DMSO) 14.1 (CHa), 14.2 (CH3), 59.4 (CH2), 59.6 (CH2), 92.9 
~=CH), 104.1 (C-2), 108.2 (Ar-CH), 111.9 (Ar-CH), 130.5 (C-S), 140.4 (C-1), 150.8 (C=CH), 
158.5 (C-3), 164.8 (C=O), 167.3 (C=O); (Found: MS (EI) mlz.% 279 (M+, 55), 187 (100). 
Requires: M+, 279); (Found: C, 60.5; H, 6.4 N, 5.0%. Requires for C14H17N05: C, 60.2; H, 
6.1; N, 5.0%). 
7-Fluoro-4-hydroxyquinoline-3-carboxylic acid ethyl ester (52a)a 
OH 0 
OEt 
To a refluxing solution of diphenyl ether (60ml) at 260°C, crushed 51a (10g, 36m mol) was 
• 4-hydroxyquinoline exists in tautomeric equiHbrium with 4-quinolone. For simplicity. the quinoline lautomer has been shown 
throughout the thesis but in some cases the protons assigned as OH in the 1H NMR spectrum may likely be NH protons from 
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added slowly over 20 mins. Whilst performing the addition, the water in the condenser was 
switched off to allow the ethanol formed to escape. Thereafter the mixture was refluxed for a 
further 20mins. Once the solution had cooled to room temperature, hexane (20ml) was 
added, and the solid white precipitate was collected by filtration, washed with hexane and 
dried in vacuo over P20s. Any remaining diphenyl ether was removed in the next step; 
(Found: MS (EI) mlz% 235 (M+, 48), 189 (100). Requires for C12H10N03F: M', 235). 




Over a period of 20mins, 51b (10g, 29mmol) was added to refluxing diphenyl ether (50ml) 
and then refluxed for a further 25mins. After cooling to room temperature, petroleum ether 
(15ml) was added and the powdery, white precipitate collected by filtration and washed with 
large volumes of petroleum ether to give 52b (1. 7g, 20%), mp 285 ~ 288°C (lit. Conroy et al. 
1949, 307 - 309°C); (Found: MS (EI) mlzO/o 297 ({M+2f, 42), 295 (M+, 43), 251 (97), 249 
(100). Requires: (M+2r, 297; M+, 295); (Found: C, 49.0; H, 3.1; N, 4.6%. Requires for 
C12H10N03Br: C, 48.7; H, 3.4; N, 4.7%). 
4-Hydroxy-7-iodoquinoline-3-carboxylic acid ethyl ester (52c) 
OH 0 
OEt 
To a boiling solution of diphenyl ether (60ml), crushed 51c (6.1g, 16mmol) was added over 
10mins. During this time, the condenser was switched off to allow the ethanol formed to 
escape. Thereafter the mixture was refluxed for a further 40mins. Once the solution had 
cooled to room temperature the resulting white precipite was filtered and washed extensively 
with methanol to remove all the diphenyl ether to give, after drying, 52c (4.2g, 77%), mp 287 
- 295°C (lit. Conroy at al. 1949,302 - 304°C; Counsell at al. 1967, 255°C); (Found: MS (EI) 
mlzO/o 343 (M+, 75), 297 (100). Requires for M+, 343); (Found: C, 42.0; H, 2.7; N, 4.0%. 
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4-Hydroxy-7 .. methoxyquinoline:.a-carboxylic acid ethyl ester (52d) 
OH 0 
OEt 
To a stirred, refluxing solution of diphenyl ether (60ml), was added 51d (10g, 34mmol) and 
the resulting mixture refluxed for 0.5hr. After cooling to room temperature, the precipitate 
was filtered, washed extensively with cold dichloromethane and dried to give 52d (4.5g, 
54%) in the form of a pale beige-pink solid, mp 269 - 273°C (lit. Lauer et a/. 1946, 275°C 
dec.); &i (400MHz, dE> DMSO) 1.26 (3H, t, J 7.2, CH3), 3.85 (3H, s, OCH3), 4.18 (2H, q, J7.2, 
CH2), 6.98 (2H, m, H-6 and H-8), 8.04 (1H, d, J7.6, H-5), 8.45 (1H, s, H-2), 12.02 (1H, s, Ar-
OH); &i (300MHz, CsDE>1 dE> DMSO) 1.08 (3H, t, J 7.2, CH3), 3.60 (3H, s, OCH3), 4.08 (2H, q, 
J7.2, CH2), 6.83 (1H, dd, J8.3, 2.5, H-6), 6.94 (1H, d, J2.5, H-8), 8.16 (1H, d, J 8.3,1.0, H-
5), 8.42 (1H, s, H-2); (Found: MS (EI) mlZOJ6 247 (M''', 38), 201 (100). Requires for 
C13H13N04: M+, 247). 
4-Hydroxy-S-nitroquinoline-3-carboxylic acid ethyl ester (52e). and 4-hydroxy-7-
nitroquinoline-3-carboxylic acid ethyl ester (52e) 
OH 0 
OEt 
51e (25g, 81mmol) was added over 10mins to vigorously stirred, refluxing diphenyl ether 
(160ml) at 265°C, and then refluxed for 5hr. Upon cooling to room temperature, petroleum 
ether was added (150ml) and the powdery yellow product filtered and washed extensively 
with cold acetone (important) and petroleum ether to remove any unreacted starting material 
and diphenyl ether. Treatment of the dried product with boiling methanol selectively 
solubilised the 5-nitro isomer 52e, which was collected as a filtrate, by filtration. Evaporation 
of the filtrate under reduced pressure followed by crystallisation from methanol yielded 52e 
(2.1g, 11%), mp 267 - 272°C; vmaJcm-1 (KBr) 3082,1684,1624,1588,1529,1465,1357, 
1206; OH (300MHz, dE> DMSO) 1.27 (3H, t, J 7.0, CH3 ), 4.22 (2H, q, J 7.0, CH2), 7.62 (1 H, t, J 
4.2, H-7), 7.84 (2H, m, J 4.2, H-6 and H-8), 8.63 (1H, s, H-2); oc (75.5MHz, dE> DMSO) 14.2 
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2), 146.4, 164.2 (C=O), 170.4 (Ar-OH); (Found: MS (HRMS) m/z% 262.05626. Requires: 
262.05697); (Found: C, 55.3; H, 3.6; N. 10.6%. Requires forC12H1oN20s: C, 55.0; H, 3.6; N. 
10.7%). 
OEt 
The remaining yellow solid was crystallised from a large volume of DMSO and washed 
extensively with water and methanol to afford 53e (5.0g, 23%). mp 293 - 295°C (lit. 
Vippagunta et a/. 1999,290 -2,96°C); 5H (400MHz. ds DMSO) 1.26 (3H, t, J 7.0, CH3), 4.23 
(2H, q, J 7.0, CH2), 6.11 (1 H, dd, J 6.6, 2.3, H-6), 6.35 (1 H, d, J 6.6, H-5), 6.46 (1 H, d, J 2.3. 
H-6), 6.70 (1H. s, H-2), 14.63 (1H, bs, OH); (Found MS (HRMS) m/zO/o 262.05762. Requires: 
262.05697; (Found: C, 55.2; H, 3.6; N, 10.7%. Requires for C12H10N~s: C, 55.0; H, 3.6; N, 
10.7%). 
7-Fluoro-4-hydroxyquinoline-3-carboxylic acid (54a) , 
OH 0 
OH 
The crude ester 52a (6.0g, 34mmol) and 10% NaOH (60ml) was heated at 110°C for 2hr 
and subsequently stirred at room temperature overnight. Any remaining diphenyl ether was 
then extracted into hexane (three times) after which dropwise addition of 10% HCr to the 
aqueous phase resulted in precipitation of the white powdery acid 54a. This product was 
collected by filtration and dried in vacuo over P20s. The product obtained (6.5g, 66% yield) 
was recrystallised from methanol to give a white, feathery solid, mp 259 - 260°C (lit. Shah 
and Coats 1977, 267 - 266°C), 5H (400MHz, ds DMSO) 7.45 (1 H, ddd, J 6.9, 6.6, 2.4, H-6), 
7.55 (1H. dd, J9.6, 2.4, H-6), 6.33 (1H, dd, J6.9, 6.4, H-5), 6.90 (1H, s, H-2), 13.32 (1H, bs, 
RCOOH), 15.09 (1H, s, Ar-Otl); 5c (100.6MHz. ds DMSO) 105.6 (JC-F 25, C-6), 106.6 (C-3 ). 
115.9 (JC-F 24, C-6), 122.2 (JC-F 2, C4a), 129.3 (JC-F 11, C-5), 141.6 (Jc-F 13, C-6a), 146.6 (C-
2), 165.4 (JC-F 253, C-7), 166.6 (C=O). 176.5 (Ar-OH); (Found MS (EI) m/zO/o 207 (M+, 29), 
169,(52). 163 (100), 135 (36). Requires: M+, 207); (Found: C, 57.3; H, 3.0; N, 6.6%. 
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Vippagunta et al. 1999,274 - 275°C); Ori (300MHz, d6 OMSO) 8.26 (1H, dd, J 9.2,2.3, H-6), 
8.50 (1 H, d, J 9.2, H-5), 8.81 (1H, d, J 2.3, H-8), 8.94 (1 H, s, H-2), 14.49 (1H, bs, Ar-OH); 8c 
(75.5MHz, de OMSO) 109.0 (C-3), 115.7 (C-8), 119.5 (C-6), 127.5 (C-5), 128.0 (C-4a), 139.4 
(C-8a) , 146.8 (C-2), 149.9 (C-7), 165.7 (C=O), 177.5 (Ar-OH); (Found MS (EI) mlz% 234 
(M+, 16),216 (43),190 (100), 144 (56), 53 (71 ).Requires: M\ 234); (Found: C, 51.3; H, 2.5; 




To refluxing diphenyl ether (264°C), was added 54a (1.3g, 6.1 mmol) and the mixture 
refluxed for 50mins. The reaction could be monitored by solubilisation of the product in the 
biphenyl ether. Upon cooling to room temperature, petroleum ether (12ml) was added and 
the subsequent beige solid filtered, washed with cold ethyl acetate: petroleum ether (2:1) 
, and dried to give 56a (0.81g. 81%). This product was crystallised from water, mp 247 -
248°C (lit. Shah and Coats 1977,247 - 249°C); Ori (400MHz, d6 OM SO) 6.01 (1 H, d, J 7.4, H-
3), 7.14 (1H, ddd, J 8.9,8.8,2.4, H-6), 7.26 (1H, dd, J 10.4, 2.4, H-8), 7.88 (1 H, d, J 7.4, H-
2),8.12 (1H, dd, J 8.9,6.4, H-5), 11.71 (1H, bs, OH); 8c(100.6MHz, ds DMSO) 1.04.0 (JC-F 
25, C-8), 109.7 (C-3), 112.6 (Jc-F 24, C-6), 123.5 (C-4a), 129.0 (JC-F 11, C-5), 140.6 (C-2); 
142.1 (Jc-F13, C-8a), 164.4 (Jc_F 248, C-7), 177.0 (Ar-OH); (Found MS (EI) mlz% 163 (M+, 




A vigorously stirred mixture of 54b (1.2g, 4.5mmol) and diphenyl ether (10ml) was heated to 
260°C over 40mins, and then refluxed at this temperature for a further 30mins. After cooling 
this mixture to room temperature, petroleum ether was added, and the light brown, powdery 
precipitate was collected by filtration and washed extensively (important) with cold petroleum 
ether. After drying in vacuo, 56b was obtained (0.99g, 99%). This product was crystallised 
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1949,289 - 291°C); OH (400MHz, ds OMSO) 6.03 (1 H, d, J 7.0, H-3), 7.42 (1H, dd, J 8.5,1.8, 
H-6), 7.78 (1H, s, H-8), 7.87 (1H, d, J 7.0, H-2), 7.99 (1H, d, J 8.5, H-5), 11.9 (1H, bs, Ar-
OH); Oc (100.6MHz, ds DMSO) 109.3 (C-3), 120.4 (C-8), 124.7, 124.9, 126.0 (C-6), 127.3 (C-
5), 139.7 (C-2), 141.0 (C-8a), 176.4 (Ar-OH); (Found: MS (EI) mlz% 225 «M+2)+' 98), 223 
(M+, 100). Requires: (M+2)\ 225; M+, 223); (Found: C, 48.3; H, 2.6; N, 6.2%. Requires for 
CgHsNOBr: C, 48.2; H, 2.7; N, 6.3%). 
4-Hydroxy-7-iodoquinoline (56e) 
OH 
54e (2.8g, 9.0mmol) and diphenyl ether (15ml) were heated to 264°C over 45mins and then 
refluxed at this temperature for a further 30mins. After cooling to room temperature, the 
resulting precipitate was filtered and washed thoroughly with petroleum ether to give, after 
drying, 56e (2.4g, 97%). This product was crystallised from water and methanol, mp >315°C 
(lit. Conroy et al. 1949, 306 - 308°C; Surrey and Hammer 1946, 346 - 348°C); (Found: MS 
(EI) mlz% 271 (M+, 100). Requires for CgHsNOI: M+, 271). 
4-Hydroxy-7-methoxyquinoline (56d) 
OH 
The crushed HCI salt of 54d (3.9g, 15mmol) was added slowly to refluxing diphenyl ether 
(40ml) resulting in effervescence. After 10 mins at this temperature, the insoluble starting 
material had been converted to soluble product. The reaction was stopped after 0.5h and 
allowed to cool to room temperature. Petroleum ether (40ml) was then added and the white 
precipitate washed extenSively with ethyl acetate:petroleum ether (2:1) to remove the 
diphenyl ether and then dried to give 56d (2.2g, 82%), mp 210 - 215°C (lit. Lauer et al. 1946, 
215°C); OH (300MHz, ds DMSO) 3.84 (3H, s, OCHs), 5.92 (1H, d, J 7.3, H-3), 6.89 (1H, dd, J 
9.2, 2.4, H-6), 7.02 (1 H, d, J 2.4, H-8), 7.78 (1 H, d, J 7.3, H-2), 7.97 (1 H, d, J 9.2, H-5), 11.9 
(1H, bs, Ar-OH); oc(75.5MHz, ds DMSO) 55.3 (OCHs), 99.1 (C-8), 108.4 (C-3). 113.0 (C-6), 
120.1 (C-4a), 126.7 (C-5), 138.9 (C-2), 141.8 (C-8a), 161.6 (C-7), 176.4 (Ar-OH); (Found: 
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4-Hydroxy .. 7-nitroquinoline (5Se) 
OH 
02N 
54e was decarboxylated according to the method of Baker et al. 1946 {187} by way of its 
silver salt. This was prepared by addition of 25% NHa (aq) (0.64ml, 9.4mmol) to a slurry of 
54e (2.1, 8.9mmol) in deionised water (25ml) at 100°C, followed by addition of a saturated 
solution of AgNOa (1.5g, 9.1 mmol). The reaction mixture was then refluxed and vigorously 
stirred (important) at 100°C for 16hr. The mixture was then cooled on ice and the beige, 
powdery solid precipitate filtered, washed with water and dried in vacuo over P205 to yield 
the silver salt of 54e (2.7g, 90%); 8ri (300MHz. da DMSO) 8.15 (1H, dd, J 8.9,2.3, H-6), 8.47 
(1H, d, J 8.9, H-5), 8.79 (1H, d, J 2.3, H-8), 9.04 (1H, s, H-2), 16.33 (1H, s, Ar-OH); ()c 
(100.6MHz, da DMSO) 109.4,117.2 (C-6), 123.8 (C-8), 127.1 (C-5), 130.1, 149.3, 149.9, 
154.8 (C-2), 169.8, 174.9. This solid was added slowly to refluxing diphenyl ether (260°C), 
as effervescence upon addition was observed. The mixture was refluxed for 45mins, cooled 
to room temperature and the resulting grey solid washed thoroughly with ethyl acetate : 
• 
petroleum ether (2:1). This product was then refluxed in ethanol (100ml) at 90°C for 5hr. Hot 
filtration of the resulting mixture followed by removal of the ethanol under reduced pressure 
yielded a yellow, powdery solid 56e (0.38g, 13%), mp 312 - 317°C dec. (lit. Ellis et al. 1973, 
317 - 320°C; Vippagunta et al. 1999,314 - 317°C dec.); 8ri (200M Hz, da DMSO) 6.18 (1H, d, 
J 7.5, H-3), 8.04 (1 H, dd, J 8.9, 2.1, H-6), 8.11 (1 H, d, J 7.5, H-2), 8.29 (1 H, d, J 8.9, H-5), 
8.44 (1H, d, J 2.1, H-8); (Found: MS (EI) mlz.% 190 (M+, 100). Requires for CgHsN20a: M+, 
190). 
4-Chloro-7 .. fluoroquinoline (57 a) 
CI 
F 
56a (0.73g, 4.5mmol) was treated with phosphorus oxychloride (7.0ml, 74mmol) and the 
mixture refluxed under N2 at 115°C for 1 hr. The reaction mixture was then poured onto ice 
followed by neutralisation with 10% NaOH (aq). The white preCipitate was extracted into 
ethyl acetate, dried over MgS04 and evaporated to dryness under reduced pressure to give 
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Snyder et al. 1947,73.5 -74°C); oH(300MHz, ds DMSO) 7.70 (1H, ddd, J 9.3,8.5,2.4, H-6), 
7.76 (1H, d, J 4.5, H-3), 7.87 (1H, dd, J 9.9,2.4, H-8), 8.29 (1H, dd, J 9.3,5.7, H-5), 8.87 
(1 H, d, J 4.5, H-2); Oc (75.5MHz, ds DMSO) 113.0 (JC-F 21, C-8), 118.3 (JC-F 25, C-6), 121.1 
(C-3), 122.8 (C-4a) 126.6 (JC-F 10, C-5), 141.3 (C-4), 149.5 (JC-F 13, C-8a), 151.8 (C-2), 
162.8 (Jc-F 250, C-7); (Found: MS (EI) mlz% 181 (M\ 100). Requires: M+, 181); (Found: C, 
59.3; H, 2.7; N, 7.6%. Requires for CsHsNCIF: C, 59.5; H, 2.8; N, 7.7%). 
7-Brom0-4-chloroquinoline (57b) 
CI 
To a stirred mixture of phosphorus oxychloride (4.5ml, 48mmol) and phosphorus 
pentachloride (0.93g, 4.2mmol) under N2, 56b (0.93g, 4.2mmol) was added and the mixture 
refluxed at 120°C for 0.5hr. The reaction mixture was then poured onto ice followed by 
neutralisation with cold 10% NaOH (aq). The cream white precipitate was collected by 
filtration, washed with water and dried in vacuo over P20s. The dried material was then 
dissolved in benzene and unreacted 56b removed by filtration to give 57b (0.74g, 73%) 
which was crystallised from hexane, mp 100 -105°C (lit. Surrey and Hammer 1946, 100.5-
101.5°C, Conroy et al. 1949, 105 - 106°C); ~ (300MHz, CDCb) 7.50 (1H, d, J .4.8, H-3), 
7.73 (1H, dd, J 9.0, 1.8, H-6), 8.10 (1H, d, J 9.0, H-5), 8.31 (1H, d, J 1.8, H-8), 8.77 (1H, d, J 
4.8, H-2); Dc (75.5MHz. CD Cia) 121.5, 124.8, 125.3, 125.6, 131.2, 132.1, 142.8, 149.7, 
150.9; (Found: MS (EI) mlz% 243 «M+2r, 100),241 (M\ 80). Requires: (M+2)\ 243; M+, 
241); (Found: C, 44.7; H, 1.8; N, 5.8%. Requires for CsHsNBrCl: C, 44.6; H, 2.0; N, 5.8%). 
4-Chloro-7-iodoquinoline (57 e) 
CI 
A mixture of 56e (1.8g, 6.6mmol), phosphorus oxychloride (5ml, 53mmol) and phosphorus 
pentachloride (1.7g, 7.9mmol) was refluxed under N2 at 120°C for 0.5hr. The reaction 
mixture was then poured onto ice followed by neutralisation with 10% NaOH (aq). The 
yellow precipitate was then filtered, washed with water and dried in vacuo over P20 S. The 
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was crystallised from heptane and benzene to give 57 c (1.2g, 62 %), mp 97 - 101°C (lit. 
Conroy et al. 1949, 101 - 102°C; Surrey and Hammer 1946, 95.5 - 97°C; Counsell et al. 
1967,97 - 98°C); 8rt (300MHz, CDCh) 7.49 (1H, d, J 4.8, H-3), 7.91 (2H, m, H-5 and H-6), 
8.55 (1 H, d, J 1.2, H-8), 8.76 (1 H, d, J 4.8, H-2); Be (75.5MHz, CDCh) 96.8 (C-7), 121.7 (C-
3), 125.4 (C-5), 125.7 (C-4a), 136.4 (C-6), 138.8 (C-8), 142.8 (C-4), 149.7 (C-8a), 150.6 (C-
2); (Found: MS (EI) mlzO/o 289 (M+, 100). Requires: M+, 289); (Found: C, 37.7; H, 1.4; N, 
4.7%. Requires for ~H5NCII: C, 37.3; H, 1.7; N, 4.8%). 
4-Chloro-7-methoxyquinoline (57d) 
CI 
56d (2.0g, 12mmol) was treated with phosphorus oxychloride (14ml) and the mixture was 
refluxed under N2 at 110°C for 20mins. The reaction mixture was then poured onto ice and 
neutralised with 10% NaOH (aq). The white-poVlldery precipitate was then extracted into 
dichloromethane (four times), dried (MgS04), and evaporated to dryness under reduced 
pressure to give the HCI salt of 57d (2.2g, 80%). Crystallisation from ethyl acetate yielded 
the HCI salt of 57d (1.3g, 49%), mp 180 - 186°C; 8rt (300M Hz, de DMSO) 4.00 (3H, s, 
OCH3), 5.06 (1H, bs, NH), 7.59 (1H, dd, J 9.3,2.6, H-6), 7.75 (1H, d, J 2.6, H-8), 7.94 (1H, d, 
J 5.4, H-3), 8.26 (1 H, d, J 9.3, H-5). 9.03 (1 H, d, J 5.4, H-2); Be (75.5MHz, de DMSO) 56.3 
(OCH3). 102.7 (C-8), 119.9 (C-3), 121.5 (C-4a), 122.6 (C-6) , 126.1 (C-5), 144.2 (C-4), 146.5 
(C-2), 147.4 (C-8a), 163.1 (C-7). Extraction of this product from water (pH 7) into ethyl 
acetate gave the free base of 57d, mp 84 - 85°C (Lauer et al. 1946, 82 - 83°C), BH (400MHz, 
DMSO) 3.94 (3H, s, OCH3), 7.39 (1H, dd, J9.2, 2.6, H-6), 7.46 (1H, d, J2.6, H-8), 7.56 (1H, 
d, J 4.6, H-3), 8.08 (1H, d, J 9.2, H-5). 8.74 (1H. d. J 4.6, H-2); Be (100.6MHz, de DMSO) 
56.4 (OCH3), 108.6 (C-8), 120.1 (C-3), 121.0 (C-4a) , 121.4 (C-6), 125.6 (C-5), 141.6 (C-4). 
151.5 (C-2). 153.5 (C-8a), 161.7 (C-7); (Found: MS (EI) mlzO/o 193 (M+, 100). Requires: M+, 
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4-Chloro-7-nitroquinoline (57e) 
a 
A mixture of 56e (0.36g, 1.9mmol) and phosphorus oxychloride (3.0ml) was refluxed under 
N2 at 115°C for 0.5hr. The reaction mixture was then poured onto ice followed by 
neutralisation with 10% NaOH (aq). The peach coloured precipitate was extracted into ethyl 
acetate, dried over MgS04 and evaporated under reduced pressure. The residue was 
chromatographed on silica gel (70: 1) using dichloromethane as the eluent. Subsequent 
crystallisation from heptane and toluene yielded 57e (0.30g, 76%), mp 169 - 172°C (lit. Ellis 
et al. 1973, 171 - 173°C; Vippagunta et at 1999, 156 -160°C); 8ti (300MHz, COCb) 7.67 (1H. 
d, J 4.7, H-3), 8.41 (2H, m, 2 x Ar-H), 8.95 (1H, d, J 4.7, H-2), 9.02 (1H, m, Ar-H); Be 
(100.6MHz, CDCb) 121.0 (Ar-CH), 123.8 (C-3), 126.1 (Ar-CH), 126.3 (Ar-CH), 129.7, 142.9, 
148.3, 148.7, 152.2 (C-2); (Found: MS (EI) mlz% 208 (M+, 100). Requires for CsH5N202CI: 
M",208). 
2-Amlnoquinoline (58) 
A mixture of 24 (0.44g, 2.7mmol), 25% NH3 (aq) (1 Oml) and a catalytic amount of ZnCI2 were 
placed in a sealed glass tube and heated at 140°C for 65h. The product was then extracted 
into ethyl acetate (four times), dried over anhydrous MgS04 and concentrated under 
reduced pressure to giv~ a white crystalline residue which was crystallised from benzene to 
give 58 (0.30g, 78%), mp 129°C (OSC) (lit. Brown and Plasz 1970, 128 - 129°C); vrnaxlcm-1 
(KBr) 3402 and 3336 (Ar-NH2); OH (400MHz, CDCI3) 4.68 (2H. bs, NH2), 6.61 (1H, d, J 8.9, H-
3), 7.15 (1H, td, J 7.6, 1.3), 7.45 (1 H, td, 7.6, 1.3), 7.53 (1 H, dd, J 8.2, 1.3), 7.58 (1 H, dd, J 
8.2, 1.3), 7.78 (1 H, d, J 8.9, H4); oe (100.6MHz, COCh) 111.6 (C-3), 122.7 (C-6), 123.6 (C-
4a or C-8a), 126.0 (C-8), 127.5 (C-5), 129.7 (C-7), 138.0 (C-4), 147.7 (C4a or C-8a), 156.9 
(C-2); (Found MS (HRMS) mlz% 144.0690. Requires: 144.0687); (Found: C, 75.3; H, 5.6; N, 










Chapter 7.1: Experimental (Synthetic Methods) 177 
2-Methylaminoquinoline (59) 
ml~ ~ h . N N% 
H 
A mixture of 24 (0.50g, 3.1 mmol) and 33% methylamine: methanol (33:66) (4ml) was placed 
in a sealed tube and the mixture heated at 120°C for 20h. The methylamine was then 
removed under reduced pressure and Na2C03 (aq) added. The products were extracted into 
ethyl acetate (three times), dried over anhydrous MgS04 and the solvent removed under 
reduced pressure. The residue was chromatographed on silica gel using triethylamine: ethyl 
acetate: petroleum ether (10:30:60) as the eluent to give 59 (0.39g, 81 %) which was then 
crystallised from benzene and petroleum ether, mp 70 - 72°C (lit. Watanabe et a/. 1980,69-
71°C); 0ti(200MHz, CDCIa) 3.09 (3H, d, J5.1, NCH3), 4.78 (1H, bs, NH), 6.63 (1H, d, J9.0, 
H-3), 7.21 (1H, td, 7.7,1.4, Ar-H), 7.51 ('IH, td, J 7.7,1.4, Ar-H), 7.58 (1H, d, Ar-H), 7.71 
(1H, d, J8.3, Ar-H), 7.81 ('IH, d, J 9.0, H4); Be (50.3MHz, CDCIa) 28.7 (CH3), 111.1 (C-3), 
121.9 (C-6), 123.3 (C4a or C-8a), 126.1 (C-8), 127.4 (C-5), 129.5 (C-7), 137.2 (C-4), 148.1 
(C-4a or C-8a), 157.6 (C-2); (Found: MS (EI) mlz% 159 (M+, 100). Requires: M+, 159); 
(Found; C, 76.1; H, 6.5; N,17.4%. Requires for 1QHmN2: C, 75.9; H, 6.4; N,17.7%). 
N-(2-Quinolinyl)-1,2-ethanediamine monohydrochloride (60) 
A mixture of 24 (2.7g, 16mmol) and excess 90% ethylenediamine (aq) (10ml) were heated in 
a 25ml sealed tube at 105°C for 19h. The reaction mixture was then concentrated under 
reduced pressure and the residue chromatographed on silica gel (40:1). The unreacted 
starting material was first eluted with petroleum ether followed by product elution using 25% 
NH3 (aq) : methanol (1 :99) to afford 60 as a hydrochloride salt (3.0g, 82%) which was 
crystallised from ethanol to give white needles, mp 174- 178°C;. vmax/cm-1 (KBr) 3259, 3132, 
3051,2954,2892,2076,1625,1540,1148,813; OH (400MHz, de DMSO) 3.06 (2H, t, J6.2, 
CH2"«) , 3.61 (2H, m, CH~J), 6.80 (1H, dd, J9.0, 1.2, H-3), 7.16 (1H, dt, H-6), 7.44 (1H, bs, 
NH), 7.48 (1H, dt, H-7), 7.56 (1H, dd, J 8.0, 1.0, H-8), 7.63 (1H, dd, J 8.0, 1.0, H-S), 7.88 
(1 H, d, J 9.0, H4), 8.15 - 8.25 (2H, bs, NH2 ) ; oc(100.6MHz, de DMSO) 39.0 (CH2"«), 39.1 
(CH~f3), 113.7 (C-3), 122.0 (C-6), 123.4 (C4a or C-8a), 125.9 (C-8), 127.9 (C-5), 129.6 (C-
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(41), 157 (100), 145 (46), 144 (50), 129 (50), 128 (66). Requires: M" (free base), 187); 




To a solution of dry, distilled liquid ammonia (50ml) and freshly prepared potassium amide 
(1.1g, 19mmol) in a sealed tube at -40DC, quinoline (1.0g, 7.7mmol) was added. The clear 
yellow solution that resulted upon quinoline addition changed to opaque dark green upon 
warming to room temperature. After 1 hr at room temperature, the tube was recooled to-
40°C, opened and the contents transferred to a wide-necked conical flask in a bath at _40DC. 
Potassium permanganate was then added (4.3g, 27mmol) slowly, with stirring. After 15mins 
the reaction temperature was raised very slowly to ODC during which time the ammonia 
slowly evaporated off. The mixture was then quenched dropwise with cold (NH4):$04 (aq), 
filtered through celite, extracted into ethyl acetate (four times), dried over anhydrous MgS04 
and evaporated under reduced pressure. The residue was chromatographed on silica gel 
using mixtures of triethylamine : ethyl acetate (0:100) to (10:90) as the eluent and 
crystallised from benzene to afford 61 (0.26mg, 26%). mp 151 -153°C (lit. Den Hertog et al. 
1967, 151 - 152°C; Tondys et al. 1985, 149 - 150°C); vmaJcm·1 (KBr) 3402 and 3336 (Ar-
NH2); &.i (200MHz, CDCIa) 5.02 (2H, bs, NH2), 6.56 (1H, d, J 5.1, H-3), 7.41 (1H. td, H-6), 
7.62 (1H, td, H-7), 7.78 (1H, dd, J8.4, 0.8, H-8), 7.95 (1H, dd, J8.5, 0.7, H-5), 8.51 (1H. d, J 
5.1, H-2), Oc (50.3MHz, CDCIa) 103.6 (C-3), 118.8, 120.3 (C-5), 124.7 (C-6) , 129.3 (C-7), 
129.7 (C-8), 148.8 (C-4 or C-8a), 149.8 (C-4 or C-8a), 150.6 (C-2); (Found: MS (EI) mlzOAi 
144 (M+, 100). Requires: M+, 144); (Found: C, 74.8; H. 5.7; N, 19.6%. Requires for CgHaN2: 
C, 75.0; H, 5.6; N. 19.4%). 
Method B 
A mixture of30a (0.11 g, 0.66mmol), 25% NHa (aq) (3ml) and a catalytic amount of ZnCI2 
were placed in a sealed glass tube. After 35h at 150°C, the product was extracted into ethyl 
acetate (three times), dried over anhydrous MgS04 and evaporated under reduced pressure. 
The product was chromatographed on silica gel (5g) using mixtures of triethylamine: ethyl 
acetate (0:100) to (10:90) as the eluent and crystallised from benzene to give 61 (57mg. 
60%), mp 149 - 152°C; 1H NMR (CDCIa) identical to that found with the reference compound 
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Method C 
A mixture of 29a (0.95g, 5.0mmol), 10% Pd-C (2.7g, 2.6mmol), glacial acetic acid (7ml), 
acetic anhydride (1.5ml) and ethanol (5ml) was placed in a three-necked round bottomed 
flask. Hydrogen was bubbled through the reaction mixture at room temperature for 7.5h. The 
mixture was then filtered through Celite and a solution of potassium hydroxide in ethanol 
added to the filtrate until an alkaline solution was obtained. The organic phase were then 
removed under reduced pressure and the products extracted into ethyl acetate (three times), 
dried over anhydrous MgS04 and the extracts concentrated again. The products were 
adsorbed onto a silica gel column (60g) and eluted using mixtures of triethylamine: ethyl 
acetate (0:100) to (10:90) to obtain 61 (0.50g, 69%) which was crystallised from benzene. 
mp 152 - 155°C. 1H NMR (CDCIa) identical to that found with the reference compound 
(Method A); (Found: MS (EI) mI;tJ/o 144 (M+, 100). Requires for CgHsN2: M\ 144). 
4-Methylaminoquinoline (62) 
A solution of 30a (0.53g, 3.2mmol) and excess methylamine: methanol (1 :2) (4ml) was 
heated in a sealed tube at 154°C for 20h. The reaction mixture was then concentrated under 
reduced pressure and the residue chromatographed using flash column chromatography 
(80:1). Any un reacted starting material was first eluted using triethylamine: methanol: ethyl 
acetate (1: 1 :98), followed by product elution using mixtures of triethylamine: methanol : 
ethyl acetate (2:5:93) to (10:10:80) to afford 62 (0.48g, 94%) which was crystallised from 
ethyl acetate and ethanol, mp 233°C (DSC) (lit. Luthy et al. 1949,227 - 227.5°C; Watanabe 
et al. 1980,231 - 232°C; VtmJcm,1 (de DMSO) 3484,3432,1662, 1586, 1545, 1343,1152; OH 
(400MHz, de DMSO) 2.87 (3H, d, J 4.5, CH3), 6.35 (1H, d, J 5.3, H-3), 7.25 (1H, bd, J 4.5, 
NH), 7.40 (1H, ddd, J 8.0,7.5,0.9, H-6), 7.56 (1H, ddd, J 8.0,7.5,0.9, H-7), 7.75 (1H, d, J 
8.0, H-8), 8.10 (1H, d, J 8.0, H-5), 8.40 (1H, d, J 5.3, H-2); Dc (100.6MHz, de DMSO) 29.7 
(CH3), 98.3 (C-3), 119.2 (C-4a), 121.8 (C-5), 124.2 (C-6), 129.1 (C-7), 129.4 (C-8), 148.5 (C-
8a or C-4), 151.2 (C-2), 151.2 (C-8a orC-4); (Found: MS (EI) mlz% 158 (M+, 100). Requires: 


















A solution of lOa (0.20g, 1.2mmol) and ethanolamine (3ml) was heated in a sealed tube at 
120°C for 4.5h. The product was then extracted into ethyl acetate (three times) from Na2C03 
(aq), dried over anhydrous MgS04 and evaporated under reduced pressure. Crystallisation. 
from ethyl acetate and methanol followed by drying in vacuo over P205 afforded 63 (86mg, 
37%), mp 139°C (OSC); vmwlcm,1 (KBr) 3322, 1585, 1546, 1340, 1070; OH (400MHz, ds 
OMSO) 3.35 (2H, m, CH2), 3.65 (2H. m, CH2), 4.82 (1 H, bs, OH), 6.45 (1 H, d, J 5.4, H-3), 
7.05 (1H, t, J 5.5, NH), 7.39 (1H, td, H-6), 7.58 (1H, td, H-7), 7.75 (1H, dd, J 8.3,0.9, H-8), 
8.18 (1 H, dd, J 8.5, 1.1, H-5), 8.36 (1 H, d, J 5.4, H-2); Oc (100.6MHz, ds OMSO) 45.5 (CH2), 
59.2 (CH2), 98.6 (C-3), 119.2 (C4a), 122.0 (C-5), 124.2 (C-6), 129.1 (C-7), 129.4 (C-8) , 
148.7 (C-8a or C-4),.150.5 (C-8a orC-4), 151.1 (C-2); (Found: MS (EI) mlzO/o 188 (ryI+, 48), 
157 (100). Requires: M+, 188); (Found: C, 69.6; H, 6.7; N. 14.0%. Requires for C11H12N20: 
C, 70.2; H, 6.4; N, 14.9%). 
N-(4-Quinolinyl)-1,2-ethanediamine monohydrochloride (64) 
A solution of 30a (0.57g, 3.5mmol) in excess 90% ethylenediamine (aq) was heated in a 
sealed tube at 120°C for 5h. The reaction mixture was then concentrated under reduced 
pressure and the residue chromatographed on silica gel (60: 1) using mixtures of 25% NH3 
(aq) : methanol (0.5:95.5) to (3.5:96.5) as the eluent to yield 64 as the hydrochloride salt. 
This was crystallised from ethyl acetate and methanol to afford 64 as a powdery beige solid 
(0.60g, 92%), mp 211 - 212°C; vmaJcm,1 (ds OMSO) 3482, 3314, 2971, 1663, 1583, 1543, 
1342; OH (400MHz, ds OMSO) 3.10 (2H, t, J 6.3, CHr (3). 3.56 (2H. t, J 6.3, CHz-a), 3.2 - 4.2 
(3H, bs, NH2 and NH), 6.56 (1H, d, J 5.4, H-3), 7.44 (1H, td. H-6), 7.63 (1H, td, H-7), 7.80 
(1H, dd, J 8.4,0.6, H-8), 8.33 (1H, d, J 8.5, H-5), 8.43 (1 H, d. J 5.4, H-2); oe (100.6MHz. ds 
OMSO) 38.3 (CHr (3), 41.2 (CH2-a.), 99.2 (C-3), 119.7 (C4a), 123.0 (C-5),124.8 (C-6), 129.4 
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187.1116. Requires: 187.1109 (free base)); (Found: C, 59.0; H, 6.5; N, 18.6%. Requires for 






A mixture of 30a (0.40g, 2.5mmol) in excess N,N-diethylethylenediamine (1.5ml) was heated 
in a sealed tube at 150°C for 8h. The reaction mixture was then concentrated under reduced 
pressure and the residue extracted into dichloromethane (four times) from K2COa (aq), 
evaporated under reduced pressure, dried over anhydrous MgS04 and chromatographed on 
silica gel (60:1) using mixtures of triethylamine: ethyl acetate (0:100) to (2.5:97.5) to elute 
65 as a brown solid (0.46g, 77%), mp 82°C; vmaJcm-1 (KBr) 3202, 2965,1581,1550,1167, 
1092, 809; cSH (400MHz,CDCh) 1.08 (6H, t, J 7.1, 2xCH3). 2.61 (4H. q, J 7.1, 2xCH2). 2.83 
(2H. t, J 6.0, CHz-J), 3.27 (2H, m, CHz-a), 6.07 (1H, bs, NH), 6.38 (1 H, d, J 5.4. H-3), 7.43 
(1H, td. H-6). 7.62 (1H. td, H-7), 7.74 (1H, dd, J8.3, 1.1, H-8), 7.97 (1H, dd, J 8.5,0.7, H-5), 
8.55 (1H, d, J 5.4, H-2); 6c(100.6MHz, CDCIa) 12.1 (2 x CH3), 39.8 (CHz-a). 46.6 (2 x CH2). 
50.8 (CHz-J). 99.0 (C-3), 119.1 (C-5),119.6 (C-4a). 124.5 (C-6), 128.9 (C-7), 129.8 (C-8). 
148.4 (C-8a or C-4). 149.9 (C-8a or C-4), 151.1 (C-2); (Found MS (HRMS) mlz% 243.1731. 
Bequires: 243.1735); (Found: C. 74.0; H. 8.8; N,17.2%. RequiresforC15H21N3: C, 74.0; H. 
8.7; N, 17.3%). 
4·Amino-7 -methylquinoline (66) 
8 
A solution of 30b (0.14g, 0.79mmol) in 25% ammonia (aq) (3ml) and a catalytiC amount of 
ZnCI2 was heated in a sealed tube at 145°C for 18h. followed by a further 24h at 160°C. The 
products were then extracted into ethyl acetate (four times), dried over anhydrous MgS04 
and the solvent evaporated under reduced pressure. The residue was chromatographed on 
silica gel (15g) using mixtures of triethylamine: ethyl acetate (0:100) to (1 :99) as the eluent. 
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vmaJcm-1 (KBr) 3428, 3315, 3160-2970, 1652, 1582, 1511, 1455, 1332, 1291, 1224; OH 
(400MHz, CDCb) 2.52 (3H, s, CH3), 4.76 (2H, s, NH2), 6.53 (1 H, d, J 5.1, H-3), 7.27 (1 H, dd, 
J 8.6,1.7, H-6), 7.65 (1H, d, J 8.6, H-5), 7.77 (1H, m, H-8,), 8.47 (1H, d, J 5.1, H-2); Oc 
(100.6MHz, CDCI3) 21.6 (CH3), 103.2 (C-3), 116.7 (C-4a), 119.9 (C-5), 127.0 (C-6), 128.9 
(C-8), 139.5 (C-7), 149.1 (C-8a or C-4). 149.4 (C-8a or C-4). 150.7 (C-2); (Found: MS (EI) 
mlzO~ 158 (M+' 100). Requires: M+, 158); (Found: C, 75.7; H, 6.5; N, 17.7%. Requires for 
C10H10N2: C. 75.9; H. 6.4; N, 17.7%). 
tt,tt...()iethyl-fl-(7-methyl-4-quinolinyl)-1.2-ethanediamine (67) 
A solution of 30b (0.14g, 0.79mmol) and excess N,N-diethylethylenediamine (3ml) was 
heated in a sealed tube at 130°C for 18h followed by a further 6h at 150°C. The reaction 
mixture was then concentrated under reduced pressure. The products were extracted into 
dichloromethane (four times) from aqueous K2C03, dried over anhydrous MgS04 and the 
solvent evaporated under reduced pressure. The residue was chromatographed on silica gel 
(15g) using mixtures of triethylamine: 'ethyl acetate (0:100) to (2:98) as the eluent to give a 
solid that was crystallised from hexane to give white crystals of 67 (0.16g, 78%), mp 102 -
105°C (lit. Patent US2940974 1960,99 -103.6°C); vmaJcm-1 (KBr) 3195,2964,1591.1580. 
1552,1455,1380,1230,1165,809; OH (400MHz, CDCb) 1.07 (6H. t, J 7.2.2 x CH3), 2.51 
(3H, s, CH3), 2.60 (4H, q, J 7.2,2 x CH2), 2.82 (2H, t, CHrf), 3.26 (2H, m, CHz-a), 6.02 (1 H, 
s, NH), 6.33 (1H, d, J 5.3, H-3), 7.26 (1H, dd, J 8.6, 1.7, H-6), 7.63 (1H, d, J 8.6, H-5), 7.75 
(1 H, m, H-8,), 8.50 (1 H, d, J 5.3, H-2); Oc (100.6MHz, CDCb) 12.1 (2 x CH3), 21.6 (CH3), 
39.8 (CHz-a), 46.5 (2 x CH2), 50.8 (CH2-f), 98.5 (C-3), 116.9 (C-4a), 119.3 (C-5), 126.6 (C-
6), 128.9 (C-8), 139.0 (C-7), 148.6 (C-8a or C-4), 149.9 (C-8a or C-4). 151.1 (C-2); (Found: 
MS (EI) mlzO~ 257 (M+, 13), 171 (14), 115 (19), 86 (100), 58 (38), 30 (58). Requires: M+, 
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4-Amino-7 -chloroquinoline (68) 
68 was prepared via reaction of 4, 7 ~ichloroquinoline with aqueous ammonia and ZnCb. The 
material was then crystallised from benzene and ethanol to give 68, mp 134°C (lit. Price et 
al. 1946, 105 -110°C; Roseman et al. 1970,152 -154.4I>C; Lin and Loo 1978, 146 -1471>C); 
vmaxlcm-1 (KBr) 3460,3358,3242,3428, 1643,1613,1578,1510, 1284,878; 8ri (200MHz. dEl 
Acetone) 6.35 (2H, bs, NH2), 6.67 (1H. d, J 5.1, H-3), 7.36 ('I H, dd, J 9.0,2.1, H-6), 7.85 
(1H, d, J2.1, H-8), 8.14 (1H, d, J 9.0, H-S), 8.38 (1H, d, J 5.1, H-2); 3c(100.6MHz, dEl DMSO) 
103.1 (C-3), 117.5 (C-4a), 124.2 (C-6), 125.1 (C-S), 127.7 (C-8), 133.9 (C-7), 149.9 (C-8a or 
C-4), 151.9 (C-2), 152.1 (C-8a or C-4); (Found: MS (EI) mlzOJ6 178 (M+, 100). Requires for 
CgH7N2CI: M+, 178). 
7 -Chlor0-4-methylaminoquinoline (69) 
~ 
CI~} 
69 was prepared via 4-substitution of 4,7~ichloroquinoline with methylamine: methanol 
(1 :2) and then crystallised from ethyl acetate and ethanol to give 69, mp 245°C (lit. Craig 
and Pearson 1968,245 - 246°C); vroaxlcm-1 (KBr) 3201, 3060,1580.1436,1369,1280,1203, 
1146, 1080.867; OH (400MHz, dEl DMSO) 2.86 (3H, d, J 4.8, CH3). 6.38 (1H, d, J 5.4, H-3), 
7.42 (2H, m, H-6 and NH), 7.77 (1H, d, J 2.4, H-8), 8.16 (1H, d, J 9.0, H-S). 8.40 (1H, d. J 
5.4, H-2); Oc (100.6MHz, dEl DMSO) 29.7 (CH3). 98.8 (C-3), 117.8 (C-4a), 124.2 (C-6), 124.5 
(C-5). 127.9 (C-8), 133.7 (C-7) , 149.3 (C-8a or C-4), 151.3 (C-8a or C-4), 152.4 (C-2); 
(Found: MS (EI) mlz% 192 (M+, 100). Requires: M+, 192); (Found: C, 62.2; H, 4.6; N, 14.5%. 
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N-(7 -Chloro4-quinolinyl)-aminopropane (70) 
A mixture of 4,7-dichloroquinoline (2.0g, 10mmol) and propylamine (15ml) were heated in a 
tube, sealed under N2 at 95°C for 20h. After cooling to room temperature, the tube was 
reopened and the propylamine evaporated off under reduced pressure. 0.95M potassium 
hydroxide (40ml) was added and the white solid residue collected by filtration and washed 
with cold ether. The crude solid was dried in vacuo over P205, and then crystallised from 
ethanol and ethyl acetate to give 70 (0.91g, 37%), mp 146 - 148°C; 8rI (300MHz, ds DMSO) 
0.96 (3H, t, J7.3, CH3), 1.67 (2H, sext, J 7.3, 4.8, CHrl), 3.21 (2H, m, CHz-(X), 6.45 (1H, d, 
J 5.1, H-3), 7.29 (1H, t, J 5.3, NH), 7.43 (1H, dd, J 8.9, 2.3, H-6), 7.78 (1H, d, J2.3, H-8), 
8.28 (1 H, d, J 8.9, H-5), 8.38 (1 H. d. J 5.1, H-2); oe (75.5MHz, ds DMSO) 11.5 (CH3), 21.0 
(CHrl), 44.1 (CHrIX), 98.6 (C-3), 117.4 (C-4a), 123.9 (C-6), 124.1 (C-5), 127.4 (C-8), 133.3 
(C-7), 149.1 (C-8a or C-4), 150.1 (C-8a or C-4), 151.8 (C-2); (Found MS (HRMS) mlzO/O 
220.07708. Requires: 220.07673); (Found: C, 65.5; H, 6.1 N, 12.5%. Requires for 









71 was obtained via 4-substitution of 4,7-dichloroquinoline with ethanolamine (aq) and 
subsequent crystallisation from ethanol to give 71, mp 217 - 218°C (lit. Elderfield et a/. 1946, 
214°C); vmaJcm-1 (KBr) 3311,3100-2845, 1583, 1453, 1344, 1081,803; 8rI (400MHz, ds 
DMSO) 3.35 (2H, t. CHrl), 3.65 (2H, m, CHz-(X), 4.84 (1H, bs, OH). 6.49 (1H. d, J 5.5, H-3), 
7.25 (1H, bt, J 5.3, NH), 7.43 (1H, dd, J 9.0,2.2, H-6), 7.77 (1H, d, J2.2, H-8), 8.25 (1H, d. J 
9.0, H-5), 8.38 (1 H. d, J 5.5, H-2); oe (1 00.6MHz, dEl DMSO) 45.5 (CHrl). 59.1 (CHz-(X), 99.1 
(C-3), 117.8 (C-4a). 2 x 124.4 (C-5 and C-6), 127.9 (C-8), 133.7 (C-7), 149.5 (C-8a orC-4), 
150.6 (C-8a or C-4), 152.3 (C-2); (Found: MS (EI) mlzO/O 222 (M+, 60). 191 (100), 156 (70). 
Requires: M+, 222); (Found: C, 59.2; H, 5.0; N, 12.5%. Requires for C11H11N20CI: C, 59.3; H, 
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N-(7 -Chloro-4-quinolinyl)-1 ,2-ethanediamine (72) 
72 was prepared via 4~substitution of 4,7-dichloroquinoline with 90% ethylenediamine (aq). 
The material was then crystallised from acetonitrile and methanol to give 72 mp 137 - 139°C 
(lit. Pecketa/1959, 137 -139°C); vma!cm-
1 (ds DMSO) 3490, 1660, 1580, 1450,1366, 1280; 
bH (400MHz, ds DMSO) 2.80 (2H, t, J 6.5, CH2"'~). 3.23 (2H, m, CH2"'u), 3.30 (2H, bs, NH2), 
6.47 (1 H, d, J 5.4, H-3), 7.21 (1H, bs, NH), 7.41 (1 H, dd, J 9.0, 2.1, H-6), 7.76 (1 H, d, J 2.1, 
H-B), 8.26 (1H, d, J 9.0, H-5), 8.36 (1H, d, J 5.4, H-2); be (100.6MHz, ds DMSO) 40.5 (CH2'" 
~), 46.5 (CH2"'IX), 99.1 (C-3), 117.9 (C-4a), 124.4 (C-5), 124.5 (C-6), 127.9 (C-8), 133.8 (C-
7). 149.5 (C-8a or C-4), 150.7 (C-Ba or C-4). 152.3 (C-2); (Found: MS (EI) mlz% 221 (M', 
46), 191 (77), 163 (23), 156 (37),30 (100). Requires: M\ 221); (Found: C, 59.6; H, 5.6; N, 
18.9%. Requires for C11H1~3CI: C, 59.6; H, 5.5; N, 19.0%). 





A solution of 4,7~ichloroquinoline (0.53g, 2.7mmol) and excess N,N~imethylenediamine 
(5ml) was heated in a sealed tube at 140°C for 3.5h. The reaction mixture was then 
concentrated under reduced 'pressure to give a solid residue, which was crystallised from 
benzene to afford colourless crystals of 73 (0.36g, 54%), mp 122 - 124°C (lit. Surrey et al. 
1959, 121 - 122.8°C); bH (400MHz, ds DMSO) 2.20 (6H, s, 2 x CH3), 2.49 (2H, m, CH2"'~)' 
3.36 (2H, m, CH2"'IX), 6.47 (1 H, d, J 5.3, H~3), 7.14 (1 H, bt, NH), 7.42 (2H, dd, J 9.1, 2.3, H-
6),7.77 (1H, d, J2.3, H-B), 8.20 (1H, d, J9.1, H-5), 8.38 (1H, d, J5.3, H-2); be (100.6MHz, 
ds DMSO) 41.2 (CH2), 45.9 (2 x CH3), 57.6 (CH2), 99.4 (C-3), 118.1 (C-4a) , 124.6 (C-5). 
124.8 (C-6), 128.2 (C-8), 134.1 (C-7), 149.7 (C-8a or C-4), 150.7 (C-8a or C-4), 152.6 (C-2); 
(Found: MS (EI) mlzOA> 249 (M+, 33), 59 (100),42 (88),30 (70). Requires: M+, 249); (Found: 

















A solution of 2,4-dichloroquinoline (2.1g, 10mmol) and excess N,N-diethylethylenediamine 
(6ml) was heated in a sealed tube at 150°C for 5h. The reaction mixture was then 
concentrated under reduced pressure and the solid residue crystallised from petroleum ether 
and ethyl acetate to give glassy-like colourless crystals of 74 (0.94g, 33%), mp 106 -108°C 
(lit. De et al. 1997, 92°C); OH (400MHz, COCh) 1.07 (6H, t, J 7.1,2 x CH3), 2.60 (4H, q. J 7.1, 
2 x CH2), 2.82 (2H, t, J6.0, CHT~)' 3.25 (2H, m, CH2-a), 6.10 (1H, bs, NH), 6.36 (1H, d, J 
5.4, H-3), 7.36 (1H. dd, J 8.9,2.2, H-6), 7.65 (1H, d, J 8.9, H-5), 7.94 (1H, d, J 2.2, H-8,), 
8.52 (1H, d, J 5.4, H-2); Oc (100.6MHz, COCb) 12.0 (2 x CH3), 39.7 (CHT<X), 46.5 (2 x CH2), 
50.6 (CHT~)' 99.3 (C-3), 117.4 (C-4a), 121.1 (C-5) , 125.2 (C-6), 128.7 (C-8), 134.7 (C-7), 
149.1 (C-8a or C-4), 149.8 (C-8a or C-4), 152.1 ( -2); (Found: MS (EI) mlz% 277 (M+, 1),86 
(100),58 (6), 30 (12). Requires: M+, 277); (Found: C, 64.7; H, 7.3; N, 15.1%. Requires for 
C15H20N3CI: C, 64.9; H, 7.3; N, 15.1%). 
N,N -Diethyl .. ~-(7 -fluoro-4-quinolinyl)-1,2-ethanediamine (75) 
32a (0.43g, 2.4mmol) and N,N-diethylethylenediamine (4ml) were heated under N2 in a 
sealed tube at 160°C for 6hr. Excess reagent was then removed under reduced pressure to 
give a brown oil. This oil was then treated with Na2C03 (aq) and the product extracted into 
ethyl acetate (four times), dried (MgS04 ) and evaporated to dryness under reduced 
pressure. This crude material was chromatographed on silica gel (60:1) using triethylamine: 
ethyl acetate (2:98) as the eluent. The residue was crystallised from heptane to give 75 
(0.39g. 62%), mp 81 - 82°C (lit. De et a/1998, 72 - 73°C); OH (300MHz. CDC b) 1.07 (6H, t, J 
7.2, 2 x CH3), 2.59 (4H, q, J 7.2,2 x CH2), 2.81 (2H, t, J 6.3, CHT~), 3.25 (2H, m, CHT<X), 
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2.7, H-8), 7.71 (1H. dd, J 9.3,6.0, H-5), 8.51 (1 H, d, J 5.4, H-2); Oc (75.5MHz. CDCb) 12.1 (2 
X CH3), 39.7 (CHz-<:x;), 46.5 (2 X CH2), 50.7 (CHz-P), 98.7 (C-3), 113.3 (JC' F 20, C-8), 114.3 
(JC-F 25, C-6). 115.9 (C-4a), 121.8 (JC-F 10, C-5), 149.9 (JC-F 12, C-8a), 150.0 (C-4). 152.2 
(C-2), 162.9 (JC-F 249, C-7); (Found: MS (EI) mlz% 261 (M+, 2), 86 (100), 58 (7), 30 (12). 
Requires: M+, 261}; (Found: C, 69.1; H, 7.8; N, 16.2%. Requires for C1sH20N3F: C, 68.9; H, 
7.7; N, 16.1%). 
N-(7-Bromo-4-quinolinyl)-N',N' -diethyl-1,2-ethanediamine (76) 
( 
mIHN~~ ~ A Br 
57b (0.69g, 2.8mmol) and N,N-diethylethylenediamine (7ml) were heated in a sealed tube at 
135°C for 6hr. The excess reagent was then removed under reduced pressure and 10% 
NaOH added. The product was extracted into dichloromethane (three times), dried (MgS04 ) 
and evaporated under reduced pressure. The solid residue was crystallised from ethyl 
acetate to give glassy-like, flat, white, transparent crystals of 76 (0.52g, 570.10), mp 120 -
121°C (lit. De et al. 1998, 111 - 112°C); OH (300MHz, CDCb) 1.07 (6H, t, J 7.1, 2 X CH3), 
2.60 (4H, q, J 7.2,2 x CH2), 2.82 (2H, t, J 5.9, CHz-a.), 3.25 (2H, m, CHz-P), 6.07 (1H, bs, 
NH), 6.38 (1H, d, J 5.4, H-3), 7.49 (1H, dd, J 8.9,2.0, H-6), 7.58 (1H, d, J 8.9, H-5), 8.13 
(1 H, d, J 2.0, H-8), 8.52 ('I H, d, J 5.4, H-2); Oc (75.5MHz, CDCb) 12.1 (2 x CH3), 39.8 (CHz-
11.), 46.5 (2 x CH2), 50.7 (CHz-P), 99.4 (C-3), 117.8 (C-4a), 121.2 (C-5), 123.0 (C-7), 127.8 
(C-6), 132.1 (C-8), 149.4 (C-8a or C-4). 149.9 (C-8a or C-4), 152.1 (C-2); (Found: MS (EI) 
mlz.% 323 «M+2f, 1). 321 (M+, 1), 155 (3),86 (100), 58 (9), 30 (15). Requires: (M+2f, 323; 
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N1,N1-Diethyl.1I-(7 -iodo-4-quinolinyl).1 ,2-ethanediamine (77) 
57c (0.97g, 3.4mmol) and N,N-diethylethylenediamine (8ml) were heated in a tube, sealed 
under N2 , at 120°C for 8hr. The excess reagent was then removed under reduced pressure 
and 10% NaOH added to the residue. The resulting precipitate was extracted into 
dichloromethane (three times), dried (MgS04) and the solvent removed under reduced 
pressure. The solid was crystallised from ethyl acetate to give 77 (0.83g, 67%), mp 133 -
136°C (lit. 131 -132°C, De et a/1998); ~ (300MHz, CDCI3) 1.07 (6H, t, J 7.1,2 x CH3), 2.60 
(4H, q. J 7.1.2 x CH2), 2.81 (2H, t, J 6.3, CHZ"~), 3.25 (2H, m, CH2-a.), 6.07 (1H, bs, NH), 
6.37 (1H, d, J 5.3, H-3), 7.43 (1H, d, J 8.8, H-5), 7.68 (1H, dd, 8.8,1.8, H-6), 8.37 (1H, d, J 
1.8, H-8), 8.50 (1H, d, J 5.3, H-2); oe (75.5MHz, CDCh) 12.1 (2 x CH3), 39.8 (CHz-a), 46.5 (2 
x CH2), 50.7 (CHZ"~), 94.8 (C-7), 99.5 (C-3), 118.2 (C-4a), 121.1 (C-5), 133.0 (C-6), 138.7 
(C-8), 149.5 (C-8a or C-4), 150.0 (C-8a or C-4), 151.8 (C-2); (Found: MS (EI) mlzO/o 369 (M+, 
1),155 (2), 86 (100), 58 (6),30 (10). Requires: M+, 369); (Found: C, 48.8; H, 5.7; N, 11.4%. 
Requires for C15HzoN31: C, 48.8; H, 5.5; N, 11.4%). 
tI,tI-Diethyl.1I-(7 -methoxy-4-quinolinyl)-1 ,2-ethanediamine (78) 
57d (1.2g, 5.3mmol) and N, N-diethytethytenediamine (6ml) were heated in a tube, sealed 
under N2, at 140°C for 5h. The reagent was then removed under reduced pressure to give a 
thick, yellow oil, to which 10% NaOH (aq) was added. The product was extracted into 
dichloromethane (four times), dried (MgS04 ) and evaporated under reduced pressure. The 
resulting solid was crystallised from heptane to give 78 as a white solid (1.1 g, 75%), mp 98 -
99°C (lit. De et a/1998, 94 - 95°C), &.! (400MHz,CDCb) 1.08 (6H, 1. 2 x CH3), 2.60 (4H, q, J 
7.2,2 x CH2), 2.81 (2H, t, J 6.0, CHZ"~), 3.26 (2H, m, CHz-a), 3.93 (3H, s, OCH3), 5.97 (1H, 
bs, NH), 6.30 (1 H, d, J 5.2, H-3), 7.07 (1 H, dd, J 9.2,2.6, H-6), 7.33 (1 H, d, J2.6, H-8), 7.62 
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a.), 46.6 (2 x CH2). 50.8 (CHz-J3), 55.4 (OCH3), 98.1 (C-3), 108.1 (C-8), 113.5 (C-4a), 116.9 
(C-6) , 120.9 (C-S), 150.1 (C-8a or C-4), 150.2 (C-8a or C-4), 151.3 (C-2), 160.3 (C-7); 
(Found: MS (EI) rnIz% 273 (M+, 5), 86 (100), 58 (9), 30 (15). Requires: M+, 273); (Found; C, 
70.4; H, 8.8; N, 15.2.%. Requires for C16H23N30: C, 70.3; H, 8.5; N, 15.4%). 
/tI./tI -Diethyl.~-(7 -nitro-4-quinoUnyl)-1 ,2-ethanediamine (79) 
A mixture of 57e (0.16g, 0.77mmol) and N,N-diethylethylenediamine (7ml) were heated at 
85°C, under N2, for 5h. The reaction mixture was then cooled to room temperature and 
Na2C03 (aq) added. The organic material was extracted into ethyl acetate (three times), 
dried over MgS04 , and the solvent removed under reduced pressure. The residue was 
chromatographed firstly on silica gel (150:1) using ethyl acetate as the eluent to remove the 
excess reagent and then on silica gel (200: 1) using mixtures of triethylamine : ethyl acetate 
(0.5:99.5) to (3:97) as the eluent to isolate 79 (0.14g, 63%), mp 110 - 113°C; vrnaxlcm-1 
(COCh) 3018, 2972, 1754,1590,1546,1479, 1374, 1352; OH (300MHz, COCb) 1.09 (6H, t, J 
7.2,2 x CH3), 2.63 (4H, q, J 7.2,2 x CH2), 2.85 (2H, t, J 5.9, CHz-(3), 3.28 (2H, m, CHz-a), 
6.28 (1H. s, NH), 6.49 (1H, d, J 5.4, H-3), 7.85 (1H. d, J 9.0, H-5), 8.17 (1H, dd, J 9.0,2.3, 
H-6), 8.65 (1H, d, J 5.4, H-2), 8.84 (1H, d, J 2.3, H-8); Oc (75.5MHz, COCb) 12.1 (2 x CH3), 
39.8 (CHz-a), 46.5 (2 x CH2), 50.5 (CHz-J3), 101.1 (C-3), 117.7 (C-6), 121.5 (C-S), 122.5 (C-
4a), 125.9 (C-8), 147.9, 147.9, 149.7, 153.2 (C-2); (Found: MS (EI) mlzOAi 288 (M", 1), 155 
(3), 86 (100), 58 (21), 30 (29). Requires: M+, 288); (Found: C, 62.8; H, 6.7; N, 19.1.%. 
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N1,N' -Diethyl-AP -(7 -trifluoromethyl-4-quinolinyl)-1,2-ethanediamine (SO) 
( 
HN~~ 
A mixture of 4-chloro-7 -trifJuoromethylquinoline (0.29g, 1.3mmol) and N,N-diethyl-
ethylenediamine (7ml) were heated in a tube, sealed under N2, at 145°C for 7h. Most of the 
excess reagent was then removed under reduced pressure and the product selectively 
dissolved in hot petroleum ether. This was then decanted and evaporated under reduced 
pressure to afford SO after crystallisation from heptane (0.22g, 56%), mp 121. -123°C (lit. De 
et a/1998, 122 -123°C); ()H(400MHz, COCh) 1.07 (6H, t, J7.2, 2 x CH3), 2.61 (4H, q, J 7.2, 
2 x CH2), 2.83 (2H, t, J 6.0, CH2'"~)' 3.27 (2H, m, CHra.), 6.20 (1H, s, NH), 6.43 (1H, d, J 
5.2, H-3), 7.58 (1 H, dd, J 9.0, 1.5, H-6), 7.84 (1 H, d, J 9.0, H-5), 8.24 (1 H, d, J 1.5, H-8), 
8.59 (1 H, d, J 5.2, H-2); ()e (100.6MHz, COCh) 12.1 (2 x CH3), 39.8 (CHra.). 46.6 (2 x CH2), 
50.6 (CHr~). 100.3 (C-3), 120.1 (C-6), 120.1 (C-4a), 121.0 (C-5), 127.6 (C-8), 127.6 (C-7), 
147.7 (C-8a or C-4), 149.7 (C-8a or C-4), 152.3 (C-2); (Found: MS (EI) mlzO/o 311 (M+, 1),86 
(100).58 (11), 30 (20). Requires: M+, 311); (Found: C, 61.9; H, 6.4; N, 13.4%. Requires for 







To a stirred solution under N2 at O°C of 64 (0.17g, 0.92mmol) in THF (0.5ml) was added 
triethylamine (O.17ml, 1.2mmol) and acetic anhydride (0.11g, 1.1mmol) and the resulting 
solution was stirred at this temperature for 1 hr, followed by 2.5hr at ambient temperature. 
The reaction mixture was then extracted into ethyl acetate (three times) from Na2C03 (aq), 
dried over anhydrous MgS04 and evaporated under reduced pressure. The residue (0.16g, 
78%) was crystallised from ethyl acetate and ethanol to give S1, mp 200 - 202°C; vmaJcm-1 
(ds OMSO) 3463,3300,3062, 1666, 1583. 1542, 1285; ()H (400MHz, ds OMSO) 1.82 (3H, s, 
CH3), 3.30 - 3.37 (4H, m, 2 x CH2), 6.49 (1H, d, J5.3, H-3), 7.22 (1H, bt, NH), 7.40 (1H, dt, 










Chapter 7. 1: Experimental (Synthetic Methods) 191 
5.3, H-2); Be (100.6MHz, de DMSO) 23.0 (CH3), 37.8 (CH2), 42.9 (CH2), 98.5 (C-3), 119.2 (C-
4a), 121.8 (C-5), 124.3 (C-6), 129.1 (C-7), 129.4 (C-8), 148.7 (C-8a or C-4), 150.2 (C-8a or 
C-4), 151.1 (C-2), 170.5 (C=O); (Found: MS (EI) mlz.% 229 (M+, 39), 170 (28), 157 (100). 
Requires: M+, 229); (Found: C, 67.9; H, 6.6; N, 18.3%. Requires for C13H1sN30: C, 68.1; H, 
6.6; N, 18.3%). 




A solution of 78 (1.1g, 4.0mmol) in dry dichloromethane (15ml) was cooled under N2, to-
78°C. BBr3 (4.0g, 16mmol) was added to this solution and the mixture stirred at -78°C for 
1 hr. The reaction mixture was then placed in the freezer at -13°C for 40h. Work-up involved 
recooling the mixture to -78°C and basification by dropwise addition of K2C03 (aq). Upon 
heating to room temperature, a white solid precipitate formed This was filtered, washed with 
water and dried in vacuo over P20S. The dried organic material was extracted into methanol 
and the insoluble material filtered off. The product was then chromatographed on silica gel 
(three times) (20:1) using ethyl acetate to pack the column and methanol to load the 
material. Elution using triethylamine: methanol: ethyl acetate (2:20:78) afforded mono-aqua 
82 (0.685g, 61.6%) as a luminous, yellow-green, thick oil, vmaxfcm·
1 (DMSO) 3257, 1617, 
1584, 1545, 1458, 1346, 1301, 1235; OH (400MHz, de DMSO) 0.95 (6H, t, J 7.2, 2 x CH3), 
2.53 (4H, q, J 7.0,2 x CH2), 2.66 (2H, t, J 7.0, CHr [3), 3.35 (2H, t, CHz-a), 6.38 (1 H, d, J 6.2, 
H-3), 6.99 (1 H, dd, J 9.1,2.5, H-6), 7.04 (1 H, d, J 2.5, H-8), 7.10 (1 H, bs, NH), 8.02 (1 H, d, J 
9.1, H-5), 8.25 (1H, d, J 6.2, H-2); Be (100.6MHz, de DMSO) 12.5 (2 x CH3), 41.5 (CHz-a), 
47.4 (2 x CH2), 51.4 (CHr [3), 97.3 (C-3), 108.5 (C-8), 112.3 (C-4a), 117.3 (C-6), 124.0 (C-5), 
147.6 (C-8a or C-4), 148.5 (C-2), 152.3 (C-8a or C-4), 159.9 (C-7); (Found MS (HRMS) 















A mixture of 79 (0.11g, 0.38mmol) and 10% Pd-C (12mg, 0.011mmol) in ethanol (15ml) was 
stirred under Hz for 22h. The mixture was then filtered through Celite and washed with large 
volumes of ethanol. The filtrate was evaporated under reduced pressure and the residue 
adsorbed onto silica gel (80:1) and eluted using mixtures of methanol: triethylamine: ethyl 
acetate (0.5:10:89.5) to (1.5:10:88.5). Purification was achieved by neutral alumina 
chromatography (70:1) eluting firstly with large volumes of ethyl acetate and then methanol: 
25% NH3 (aq) : ethyl acetate (10:2:88) to obtain 83 (76mg, 78%) in the form of a brown oil; 
vmaJcm-
1 (COCh) 3402, 3382, 3020, 1631, 1586, 1538, 1471, 1329, 1224; OH (400MHz, 
. COCh) 1.06 (6H, t, J 7.2,2 x CH3), 2:58 (4H, q, J 7.2,2 x CHz), 2.78 (2H, t, J 6.0, CHr~). 
3.23 (2H, m, CHra), 3.96 (2H, bs, NHz), 5.86 (1H, s, NH), 6.20 (1 H, d, J 5.2, H-3), 6.84 (1H, 
dd J9.0, 2.4, H-6), 7.11 (1H, d, J2.4, H-8), 7.54 (1H, d, J9.0, H-5), 8.40 (1H, d, J 5.2, H-2); 
Oc (1 00.6MHz, COCh) 12.0 (2 x CH3), 39.8 (CHra), 46.5 (2 x CHz). 50.9 (CHr~), 97.1 (C-3), 
110.4 (C-8), 112.3 (C-4a), 116.0 (C-6), 120.9 (C-5), 147.2 (C-7), 150.0 (C-8a or C-4), 150.0 











Chapter 7.2: Experimental (Physical Methods) 193 
7.2. PHYSICAL METHODS 
7.2.1. Commercially Available Chemicals Used 







Dimethyl Sulphoxide (DMSO) 
Haematin 
Haemin 
Hydrochloric Acid (HCI) 
2-[N-Morpholino]ethanesulfonic acid (MES acid) 
2-[N-Morpholino]ethanesulfonic sodium salt (MES salt) 
N-[2-HydroxyethylJpiperazine-N'-2-ethanesulfonic acid] (HEPES acid) 
N-[2-Hydroxyethyl]piperazine-N'-2-ethanesulfonic sodium salt] (HEPES 
salt) 
Sodium Hydrogen Phthalate (KHP) 
2-[N-Cyclohexyiamino]ethanesulfonic acid (CHES acid) 
Methanol for HPLC 




Sodium Dodecyl Sulphate (SDS) 
Polyoxoethylene (10) lsooctylpentyl Ether (TRITON X-100) 






BDH Laboratory Supplies 
Sigma 
Sigma 
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7.2.2. Haematin Dimerisation Methods 
7.2.2.1. Instrumentation and General Methods 
The pH measurements were carried out using a Crison MicropH 2000 pH meter. Standard 
phosphate buffer solutions, from BDH laboratory supplies, at pH 4.00 ± 0.02 and 7.00 ± 0.02 
were used to calibrate the meter prior to use. Samples were mixed on a Snijders Magnetic 
Stirrer 34521. vortexed using a press-to-mix Snijders Analyser 34524 and centrifuged using 
a Centrifuge 5410 for Eppendorf. Volumes were delivered using combinations of Gilson's 
Pipetman and Hamilton syringes. Uv-vis readings for haematin dimerisation titrations were 
done on a CARY 3E using 10cm quartz cuvettes with temperature control using a 
thermostated Haoke waterbath. Uv-vis readings for spectra collected between 700 and 
450nm were obtained on a Beckman DU-68 spectrophotometer using 1 cm quartz cuvettes 
with temperature control using a circulating YIH DER BL-710 thermostated waterbath. 
Methanol was dried over 4A molecular sieves in a tightly sealed, parafilmed bottle for one 
week prior to use. Water was purified by glass distillation and pyridine was distilled and 
stored over KOH. Cuvettes and volumetric flasks used in the work were prepared by 
washing with detergent followed by rinSing with 30% nitric acid and drying in an oven 
overnight. Sample vials used for storage f solutions were used only once, as new, and then 
discarded. 
7.2.2.2. Methods for Determination of Kobs. (X and J3 
7.2.2.2.1. Preparation of HEPES Buffers 
The 50mM HEPES Buffers were prepared by dissolving HEPES acid (2.98g, 12.5mmol) and 
sodium perchlorate (see Table 7.2) in less than 250ml of distilled water in a beaker. The pH 
was then adjusted using concentrated sodium hydroxide and the solution transferred 
carefully to a volumetriC flask, taking care to transfer all the dissolved material with distilled 
water. The final volume was then adjusted to the mark with distilled water. 
7.2.2.2.2. Calculation of Ionic Strength 
Since only the HEPES base contributes to the ionic strength, the eqUilibrium proportions of 
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using the derivation below, the ionic strength was then adjusted to the desired value with 





Substitute (9) into (8) 
Kg[BrJ-Kg[K] =[B1 [F] 
Kg[BrJ=[KJ([Jt} + Ka) 
Si!,ce [BT] = 50mM and Ka = 10'7.5 = 3.16x 10-6M 






[B1 can be calculated at the five different pH's (Table 3.1.). 













The ionic strength, J.1, is defined as J.1 = % 2:miZi2, where mj is the molarity of species (i) and Zi 
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J..L = % {mB-.(~1 t + mNa+.(+1 )2} 
= % {(10.0mM x 1) + (10.0mM x 1)} 
= 10.0mM 
ie. the contribution to J..L from B' = [B1 
To obtain J..LTotal = 154mM; [NaCI04.H20] added = 154mM - [B1 (Table 7.3). 
196 
Table 7.3. Amounts of NaCI04.H20 added to adjust the ionic strength of the 50mM HEPES solutions (V = 250m I) 
to 154mM. 
pH [Bl/mM NaCI~.H20 I 9 [NaCI04.H20] I J.i.Totall mM 
mM 
6.9 10.0 5.065 144.2 154.2 
7.2 16.7 4.832 137.6 154.3 
7.4 22.1 4.635 132.0 .154.1 
7.7 30.7 4.333 123.4 154.1 
8.0 38.0 4.075 116.0 154.0 
7.2.2.2.3. Preparation of Haematin Solutions 
A 0.1 M NaOH solution was prepared by dissolving NaOH (405.2mg, 1 0.13mol) in distilled 
water (100ml) in a volumetric flask. This solution was flushed with argon (20mins) and then 
used to prepare the haematin stock solutions C1, C2 and Cl. 
C1 2.68x10-3M: Haematin (17.0mg, 2.68x10'5mol) was dissolved in 0.1M NaOH (10ml) in a 
-
volumetric flask. This solution had to be shaken vigorously and was left to stand in the dark 
for 0.5h before further use as the large haematin crystals were slow in dissolving in 0.1 M 
NaOH. 
C2 5.79x10-4M: An aliquot of C1 (2.160ml) was diluted to 10ml with 0.1M NaOH in a 
volumetric flask. 
Cl 9.92x10·5M: An aliquot of C2 (1.713ml) was diluted to 10ml with 0.1M NaOH in a 
volumetric flask. 
The stock solutions C1, C2 and Cl were then transferred to 10ml sample vials that had been 
wrapped in aluminium foil, stoppered with septums and deoxygenated with argon for 
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7.2.2.2.4. Collection of Titrcition Data 
Titrations were performed in 50mM HEPES buffer, J..I. = 154mM at pHs 6.92, 7.19, 7.39, 7.69 
and 7.99 in a haematin concentration range 2x10·7M - 4.2x10-GM: Typically, the buffer 
solution (20ml) was placed in duplicate into two 10cm, quartz cuvettes. Parafilm was placed 
over the top of the cuvettes and argon bubbled through the solutions for 10mins. Thereafter 
the cuvettes were placed in the spectrophotometer at 25°C and the compartment continually 
flushed with a strong argon flow. The buffer solutions were aI/owed to equilibrate under 
these conditions for 10mins before the titrations were commenced. The titrations were 
performed by adding 160J..l.I of C3 in 2-10J..l.I aliquots followed by 120J..l.I of C2 in 5-20J..l.I aliquots 
to give a final haematin concentration of 4.2x10-GM. After each addition, the same volume of 
0.1 M NaOH was dispensed into the reference cuvette and both solutions were stirred about 
10 times each in a back and forth motion with a spatula. The data was fitted to a 
dimerisation model (derived in 7.2.2.2.5. below) using non-linear-least squares fitting 
procedures with the program FIT. 
7.2.2.2.5. Derivation of the Haematin Dimerisation Model 
7.2.2.2.5.1. Methods for Determination of Kobs, ex. and f3 
Brown et al. proposed the following relationship for haematin dimerisation (Brown et al. 
1970): 
K 
2M :::;:oc==~ (11 ) 
where M is the haematin monomer. M2 is the haematin dimer, K is the eqUilibrium constant 
and n is an integer or zero corresponding to the number of protons released in the 
dimerisation process. 
The equilibrium constant for Equation (11) can be written as follows: 
K= [M2 ][H+ r 
[M]2 
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The total haematin concentration, Mr , can be written in terms of M and M2: 
[Mr} = [MJ + 2[M2J, therefore [MJ = [Mr} - 2[M2J (14) 
Substituting (14) into (13) where Mr, M and M2 all refer to concentrations: 
Solving for M2 
2a 
where a=4Kobs, b=-(4KobNT+ 1), C=KobsM/ 




We now have an expression for M2 in terms of Kobs and Mr (Equation 15) and an expression 
for M in terms of M2 and Mr (Equation 14). 
The absorbance ratio at any particular haematin concentration is a weighted average of the 
absorbance ratio due to the fraction of haematin in the monomer (fM) and the absorbance 
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(
A395 J = IM(A395 J + 1M (A395 J 
A361 T A361 M 2 A361 M 
2 
(16) 
Where the fraction of haematin in the form of the monomer is: 
and the fraction of haematin in the form of the dimer is: 
Let the observed absorbance ratio be Rabs where: 
Let the absorbance ratio of the pure monomer be a, such that: 
(
A395 J 
a= A361 M 






Using Equation 17 it is now possible to calculate a, p and Kobs using non-linear least squares 
fitting procedures where: A39r1Aas1 is the experimentally determined absorbance ratio, Mr is 
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In solving for M2. only the negative root was used as the positive root gave negative values 
for a. and ~. 
7.2.2.2.5.2. Methods for Determination of K and n 
K and n were determined by the method of Brown et al. where Koos is defined as: 
Taking logs of both sides gives a linear relationship between log Kobs and pH: 
IZOgKobS=ZOgK+nPH I 
Hence a plot of log Kobs against pH should give a straight line with slope equal to the number 
• 
of protons involved in dimerisation and the y-intercept equal to log K. 
7.2.2.3. Derivation of the Model for Single Deprotonation 
An equilibrium expression for single deprotonation can be written as follows: 
(18) 
Where AH is the protonated species and A- is the deprotonated species. The equilibrium 
constant for Equation 18 can then be written: 
(19) 
The total concentration of A (AT) can be written as in Equation 20 where AT. A- and AH all 
refer to concentrations: 
(20) 
An expression for A- can now be formulated in terms of AT. H+ and Ka by substituting 
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Ka(AT - A) = A-.F 
KaAT - KaA- =A-.F 
KaAT = A".F + KaA-
201 
(21) 
An expression for AH can also be formulated (Equation 22) in terms of AT. Wand Ka by 
substituting Equation 21 into Equation 20. 
(22) 
The absorbance ratio A39,jA361 at any particular concentration of A· (<Xobs) is a weighted 
average of the absorbance ratio due to the fraction of A in the form of AH (!AH) and the 
absorbance ratio due to the fraction of A in the form of A - (fM2) (Equation 23): 
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andJA- is the fraction of A in the form of A-: 
(25) 
Let the absorbance ratio of pure AH be (X.AH such that: 
(26) 
Let the absorbance ratio of pure A- be (J,A- such that: 
(27) 
Substituting Equations 24. 25. 26 and 27 into Equation 23 gives Equation 28 which can be 








7.2.2.4. Methods for Determination of (J, in Detergent and Methanol Solutions 
7.2.2.4.1. Preparation of Buffer Solutions 
7.2.2.4.1.1. Preparation of SOS Solution 
(28) 
Solutions of 0.25 - 3% SDS in 50mM HEPES buffer with an ionic strength corrected to 










Chapter 7.2: Experimental (Physical Methods) 203 
Table 7.4. Quantities of SDS, HEPES and NaCI04.H20 used to make the SDS Detergent Solutions 
%SDS SDS/g pH HEPES/g [HEPES] I NaCI04.H20 I fJ./mM VTota11 ml 
mM 9 
2.0 2.002 7.24 1.192 50.0 0.955 154.0 100 
2.0 2.002 8.00 1.193 50.0 0.655 154.2 100 
2.0 1.001 10.13 0.592 49.7 0.592 153.7 50 
0.25 0.249 8.01 1.192 50.0 1.509 154.0 100 
0.5 0.501 8.01 1.192 50.0 1.382 153.8 100 
1.0 1.001 8.00 1.192 50.0 1.141 153.9 100 
2.5 1.251 8.02 0.596 50.0 0.208 154.4 50 
3.0 3.003 8.01 1.193 50.1 0.169 154.1 100 
7.2.2.4.1.2. Preparation of TRITON X-100 and TWEEN 20 Solutions 
Solutions of 3% TRITON X-100 and 2% TWEEN 20 were prepared by dissolving TRITON X-
100 (1.5g) or TWEEN-20 (1 g) with HEPES acid (1.19g, 5.00mmol) and NaCI04.H~ (see 
Table 7.5.) in less than 100ml deionised,water and the pH was adjusted using concentrated 
NaOH. The total volume was then adjusted to 100ml using distilled water (Table 7.5.). 


















The 50mM buffer solutions were prepared by dissolving MES acid, HE PES acid or CHES 
acid and NaCI04.H~ in less than the total volume of distilled water in a beaker. The pH was 
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Table 7.6. Preparation of 50mM Buffers, Jl = 154mM from pH 5.99 to 10.03 
pH NaCI04.H20 I 9 VTota11 ml J..L/mM 
MES acid (0.976g. 5.00mmol) 
5.99 1.855 100 154.2 
6.51 1.659 100 153.9 
HEPES acid (2.98g, 12.5mmol) 
6.89 5.056 250 154.0 
7.19 4.816 250 153.9 
7.41 4.632 250 154.0 
7.73 4.332 250 153.9 
8.00 4.074 250 154.0 . 
CHES acid (0.518g. 2.50mmol) , 
9.22 0.963 50 159.8 
10.03 0.516 50 154.0 
The buffered water-methanol mixtures were prepared by pipetting the required amount of 
50mM HEPES. MES or CHES solution into a 1 Oml volumetric flask and adjusting to the mark 
with dry methanol. 
7.2.2.4.2. Preparation of Haematin Stock Solutions and Water-Methanol Solutions 
Haematin stock solution for determination of ex. in the detergent solutions (H1): haematin 
(8.6mg, 1.36x1O-5mol) was dissolved in 0.1M NaOH in a volumetric flask. This solution was 
then transferred to a 10ml sample vial and covered with aluminium foil. 
Haematin stock solution for determination of ex. in the water-methanol solutions (H2): a 
saturated solution of haematin in dry methanol (2ml) was centrifuged at 10rpm for 10mins. 
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7.2.2.4.3. Collection of Spectra 
Determination of a. in the detergent solution and water-methanol solutions: the relevant 
buffer solution (2ml) was placed in a 1 cm cuvette and a baseline between 700 and 450nm 
recorded. To this solution, H1 (45ml) or H2 (75ml) was added and the resulting solution was 
stirred with a spatula. The spectrum then rescanned between 700 and 450nm to obtain the 
individual absorbances at 395 and 361nm and a. was collected from the ratio. 
7.2.2.5. Determination of Haematin Solubility in Aqueous Solution 
7.2.2.5.1. Preparation of KHP, MES and HEPES Buffers 
The 50mM buffer solutions were prepared using either KHP, MES salt or HEPES salt and 
sodium chloride was used to adjust the ionic strength. For buffers at pH 5.06,5.27 and 5.38, 
KHP (2.55g, 12.5mmol) was dissolved in less than the total volume of distilled water. The pH 
was then adjusted with concentrated NaOH (aq) from which the eqUilibrium concentrations 
of the monodeprotonated (B-) and dideprotonated (B2-) KHP species were calculated (Table 
7.7.). The ionic strength was then corrected to 154mM using NaCI and the final volume 






























MES salt was used to make buffers at pH 5.54,5.60, 5.94, 6.24 and 6.55 by dissolving MES 
salt (2.72g, 12.5mmol) and NaCI (1.52g, 26.0mmol) in less than 250ml of distilled water. The 
pH was then adjusted using concentrated HCI and the total volume adjusted to 250ml in a 
volumetric flask. 
HEPES acid was used to make buffers at pH 6.85, 7.11 and 7.97 by dissolving HEPES acid 
(3.26g, 12.5mmol) and NaCI (1.52g, 26.0mmol) in less than 250ml of distilled water. The pH 
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7.2.2.S.2. Preparation of Haematin Stock Solution and Collection of Spectra 
The haematin stock solution (H3: 1.94x10·3M) was prepared by dissolving haemin (12.3mg, 
18.9mmol) in OM SO (10ml) in a volumetric flask. The haematin solutions (H4: 1.01x10·8M) 
were then prepared by dissolving H3 (26,...1) in the relevant buffer solution (SOml) in a 
volumetric flask. The solution was stirred in the dark for O.Sh and then centrifuged. The 
supernatent was removed and the absorbance at 39Snm recorded. 
7.2.2.6. Spectra of Haematin Solutions Between 700nm and 450nm 
7.2.2.6.1. Spectra of Haematin in HEPES Buffer with Pyridine. NaCI or NaCI04 
The relevant HEPES buffer solution (2ml) was placed in a 1cm cuvette and the background 
absorbance scanned. H2 (7S,...I) was then added to the buffer, the mixture stirred with a 
spatula and the resulting spectrum scanned between 700 to 4S0nm. Thereafter. either 
pyridine (SO,...I). saturating NaCI or saturating NaCI04 was added to the cuvette mixture and 
the resulting spectrum recorded again in the same absorbance range. 
7.2.2.6.2. Spectra of Haematin in 20% HEPES-Methanol Mixtures 
A SOmM HEPES buffer that had not been pH adjusted was prepared by dissolving HEPES 
acid (0.S96g. 2.S0mmol) in distilled water (SOml). This solution was used to make a 20% 
water-methanol mixture by pipetting the SOmM HEPES buffer (2ml) into a 10ml volumetric 
flask and filling to the mark with dry methanol. The initial pH of this mixture was measured. 
This solution (2ml) was then placed in a 1 cm cuvette and the background absorption 
between 700 and 4S0nm recorded. H2 (70,...1) was then added, the mixture stirred with a 
spatula. and the absorption spectrum recorded again. Thereafter 1M NaOH (20,...1) was 
added in 2,...1 aliquots and the spectrum recorded after each addition. At the end, the final pH 
was recorded again. 
7.2.3. Methods for Determination of Haematin-Quinoline Association Constants 
7.2.3.1. Instrumentation Used 
The pH measurements were carried out using a Crison MicropH 2000 pH meter. Standard 
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to calibrate the meter prior to use. Spectrophotometric titration data for compounds 58, 61-
63 were collected on a Hewlet-Packard 8450A diode array spectrophotometer and the 
remaining compounds were collected on a on a Beckman DU-68 spectrophotometer. The 
latter uv-vis spectrophotometer was used to record all spectra. Cuvettes for spectroscopic 
titrations were connected to a thermostated YIH DER BL-710 waterbath. Volumes were 
delivered using combinations of Gilson's Pipetman and Hamilton syringes and compounds 
were weighed on a E. Mettler or Sartorius balance. 
7.2.3.2. Preparation of Buffers 
The 0.2M HEPES and MES buffers were made by dissolving HEPES acid (4.77g, 20mmol) 
or MES salt (4.34g, 20mmol) in less than 100ml of distilled water. To this solution 
concentrated NaOH was added until the desired pH was obtained. The mixture was then 
transferred to a 100ml volumetric flask taking care to transfer all the dissolved material with 
distilled water and the total volume was adjusted with distilled water. 
7.2.3.3. Preparation of Stock Solutions 
It has been found that scrupiously clean glassware can help to stabilise the haematin 
solutions in the 40% DMSO (aq). This was done by washing the 10m! volumetric flasks and 
cuvettes in concentrated NaOH, followed by concentrated nitric acid then rinsing with 
acetone and drying in an oven overnight. 
81 (1.23x10·3M): Haematin (8.0rng, 1.23x10'5mol) was dissolved in DMSO (10ml). This 
solution was stored in the dark and could be used for up to a week. 
82 (1.97x10-6M): DMSO (4ml). and O.2M HEPES or MES buffers (1ml) were mixed together 
in a 10ml volumetric flask. To this solution 81 (16~1) was added and the resulting solution 
was mixed again. The volume was then adjusted to 10ml with distilled water. 82 was then 
stored in a new, unused vial (important for maintaining stability of the solution) which had 
been wrapped in aluminium foil and was used within a few hours. 
B1: The blank solution was prepared by mixing DMSO (4ml) and 0.2M HEPES or MES 
buffers (1ml) in a 10ml volumetric flask. The volume was then adjusted to 10ml with distilled 
water. 
01: The quinoline solution was prepared by dissolving the quinoline (2.0x1O,5 mol) in DMSO 










Chapter 7.2: Experimental (Physical Methods) 208 
adjusted with distilled water. The solution was then stored in a sample vial and after use and 
kept in the fridge. 
7.2.3.4. Collection of Spectra 
The blank solution 81 (2ml) was placed in a 1 cm thermostated cuvette at 2SoC in the uv-vis 
spectrophotometer. After Smins at this temperature, a baseline was recorded between the 
appropriate wavelengths. This solution was then discarded and 82 (2ml) placed in the 
cuvette. The spectrum was then recorded between the same wavelengths as 81 after an 
equilibration period of Smins. D1 was then added in microlitre aliquots up to a total volume of 
1ml and resulting spectrum was recorded after each addition. 
7.2.3.S. Spectrophotometric Titrations 
The blank solution 81 (2ml) was placed in a 1 em thermostated cuvette at 2SoC in the uv-vis 
spectrophotometer. After Smins at this temperature, the instrument was zeroed at 402nm. 
This solution was then discarded and 82 (2ml) was placed in the cuvette. In general, the 
absorbance at 402nm dropped slightly over 10 mins but was stable thereafter. In the case 
where the absorbance at 402nm continued to drop, the 82 solution was discarded and a 
fresh stock solution was made. To the stable 82 solution, D1 was added in microlitre 
aliquots over about 37 additions until a total of 1 ml had been added. After each addition the 
resulting solution was stirred with a spatula in a back and forth motion and the stabilised 
absorbance at 402nm recorded (see Appendix for raw titration data). 
The absorbance data at 402nm was corrected for dilution. Where the compound exhibited 
significant absorbance at 402nm, a blank titration was preformed and the absorbance of the 
compound subtracted from the titration data. The resulting data was fitted to either 1: 1 
association model (Equation 30) or a stepwise 2:1 model (quinoline:haematin) (Equation 33) 
using non-linear least squares fitting methods. For the derivation of these equations see 
Mavuso (Mavuso PhD thesiS 2001 ). 
7.2.3.S.1. The 1:1 (quinoline:haematin) Association Model (Model 1) 
The equation representing 1:1 (quinoline:haematin) association can be written as follows: 
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Where 0 represents the quinoline, M represents haematin and OM represents the haematin-
quinoline complex. The equation to describe model 1 is: 
A = An + AwK[Q] free 
1 +K[Q]free 
(30) 
Where A is the corrected absorbance at 402nm, Ao is the absorbance of the haematin before 
the quinoline is added, Aoo is the corrected absorbance at the end of the titration, K is the 
association constant for the process and [O]frea is the concentration of the uncomplexed 
quinoline. 
7.2.3.5.2. The 2:1 (quinoline:haematin) Association Model (Model 2) 
The equation representing 2:1 (quinoline:haematin) stepwise association can be written as 
follows: 
Q +M <c K/ • QM 
QM+M Kz ... QM .... 2 
(31) 
(32) 
where K1 is the first association constant and K2 is the second association constant. The 
equation to describe model 2 is: 
(33) 
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7.2.3. Derivation of the Equation for Vacuolar Accumulation Ratio 
The equations representing deprotonation of a diprotic base (H:A) can be written as follows: 
(34) 
HA .... (35) 
Where HA represents the singly deprotonated species of H:A and A represents the doubly 
deprotonated species H2A. The equilibrium constant for Equations 34 and 35 can then be 
written: 
K - [HA}[H+} 
a1 - [H2A} therefore (36) 
K - [H+ J[ A] 
a2 - [ HA ] therefore 
[HA} == [H+}[ A] 
Ka2 
(37) 
The total concentration of A (Atat ) can be written as in Equation 38 where Atat • A, H:A and HA 
all refer to concentrations: 
(38) 
Substituting Equations 36 and 37 into Equation 38, it is possible to obtain an expression in 
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If (Atot}v is the total vacuolar concentration of A and (Atot)e is the total extravacuolar 
concentration of A then from Equation 40: 
therefore (41) 
7.2.4. p-Haematin Inhibition 
7.2.4.1. IR Method (Egan et al. 1994) 
7.2.4.1.1. Instrumentation and General Methods 
The f3-haematin reaction was carried out in a glass titration cell connected to a GRANT Y6 
thermostated water bath set at 60°C. Compounds were weighed on a E. Mettler or Sartorius 
balance and volumes of solutions were delivered using a Gilson's Pipetman. Infrared disks 
of the product were pressed on a 30 Ton Press and the spectrum was recorded using a 
Perkin-Elmer 983 infrared spectrophotometer. 
7.2.4.1.2. Assay 
The inhibition experiments for the compounds were always done in duplicate and compared 
to a single control experiment in every case. 
Control: f3-Haematin was prepared by dissolving haemin (6mg, 9.2x1 O~mol) in 0.1 M NaOH 
(1.2ml) and the resulting solution stirred in a glass titration cell connected to a thermostated 
water bath at 60°C for Smins. 1.0M HCI (0.120ml) was then added followed by 12.9M 
acetate (0.707ml), which had been preincubated at the same temperature, to give a final 
acetate concentration in the mixture of 4.SM. After 30m ins at this temperature, the reaction 
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filtration on a cellulose nitrate disc (0.22j.lm), washed extensively with water and dried over 
phosphorous pentoxide for two days. 
Compounds: The same procedure was followed as for the control except that the compound 
(4eq, 3.68x10-smol) was added to the haematin-NaOH solution and the resulting mixture 
allowed to stir for 10mins before addition of the 1.0M HCI. 
The infrared sample was prepared by grinding the dried product (1.5mg) with KBr (250mg) 
to form a homogeneous mixture which was subsequently pressed into a pellet under 15 tons 
for 1min. Two peaks around 1660 and 1210cm-1 in the infrared spectrum of the product 
characterise the ~-haematin product. Therefore, the absence of these two peaks in the 
product spectrum indicates that the compound is inhibitory. 
7.2.4.2. BHIA Method (Parapini et al. 2000) 
The compounds were. sent away to the laboratory of Prof. D. Taramelli, University of Milan, 
Italy to test for ~-haematin inhibition using the BHIA method. 
7.2.5. pI<. Determinations 
Two pKa's were determined the 4-aminoquinoline analogues 65, 67, 74-80, 82-83. Solutions 
for potentiometry were prepared in glass-distilled, deionised water which had been boiled to 
remove CO2. Solutions of NaOH were prepared form Merck Titisol ampoules and stored 
under an atmosphere of N2 (g) in high-densisty polyethylene bottles. These solutions were 
standardised againsed recrystallised potassium hydrogen phthalate and used within one 
week of preparation or discarded. The HCI solutions were also. prepared from ampoules and 
standardised againsat recrystallised sodium tetrabarate and the previously standerdised 
NaOH. The titration procedure followed has been described previously (Jackson and Kelley 
1989, Jackson et a/. 1996) except that the 4-aminoquinolines were weighed directly into the 
titration vessel (2.04.0 mM) and the electrode system was callibrated in situ. To measure 
the potential, a 6.0133.100 glass electrode and a 6.0726.100 reference electrode was used. 
Protonation constants were determined under stirring. at 25°C and at an ionic strength of 
0.15M NaC!. Three independent titrations were measured in each case and between 100 
and 120 data points were collected per titration. The data was then analysed by Mr 
Thembalani E Nomkoko using the programme ESTA (Murray and May 1984, May et a/. 
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7.2.6. Antiplasmodial Testing 
All compounds were tested for anti plasmodial activity against the CQ-sensitive D1 0 strain of 
P. fa/ciparum. Compounds 58-62, 63-74 and 81 were tested by Jason Waldon, Dept of 
Pharmacology. UCT and compounds 65 and 74 were retested along with compounds 67, 
75-80, 82-83 in the laboratory of Prof. D. Taramelli, University of Milan, Italy. In both 
laboratories, the compounds were cultured continuously according to the method of Trager 
and Jensen (Trager and Jensen 1976). Chloroquine diphosphate was dissolved in water and 
all other compounds were dissolved in methanol and then diluted with medium to obtain the 
required concentrations (final concentrations all contained less than 1 % methanol which was 
found to be non toxic to the parasites). Antiplasmodial activity was assessed by measuring 
the activity of the paraSite lactate dehydrogenase enzyme, according to a modified method 
of the method of Makler et al. (Makler et a/. 1993). All antiplasmodial testing was performed 
at 1 % hematocrit and 2% parasitemia. Compounds were added at the late trophozoite stage 
for a period of 48h before LDH measurement. Each IC50 measurement is the result of at 












1.1. Spectroscopic Titration Curves 
Titration curves for compounds 58 - 83 fitted to a 1: 1 association model for 58 - 60, 62 - 70, 72, 75 - 80, 82, 83 
and a 2:1 association model (quinoline:Fe(III)PPIX) for 61,65, 71, 73 -74,81. the solid line represents a best fit 
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APPENDIX 2 
Infrared spectra of the preducts of all the compounds in the project tested for ~-Haematin inhibitory actMty by the 
IR method of Egan at aI. (Egan et al. 1994) . 
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